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Abstract 
The development of a single celled embryo to a fully developed organism is tightly 
controlled by gene expression. Different genes are temporally and spatially regulated 
to form different cell types. Genes regulate each other to produce products that give 
rise to distinct cell fates and these interactions are referred to as gene regulatory 
networks (GRNs). Haematopoiesis is modulated by a complex GRN and one critical 
factor in this developmental pathway is GA TA2. Gata2 is a transcription factor and 
when it is inactivated in mice no erythrocytes develop. Xenopus laevis gata2 
expression is itself regulated by another transcription factor, CCAA T box 
transcription factor (CBTF). CBTF is a mUlti-protein complex and one subunit in 
particular has been shown to be critical for gala2 activation, ilO. Xenopus laevis ilO 
contains two double stranded RNA-binding domains (dsRBDs) that are necessary 
for its DNA binding and transcriptional activity. Binding to DNA is unusual for 
dsRBDs. It has been hypothesised that the ilO dsRBDs can bind the gata2 promoter 
and activate transcription only because binding is mediated by the partial A-form 
structure of the gata2 promoter, which mimics dsRNA. This hypothesis was tested 
by altering the degree of A-form structure in the promoter, then measuring binding 
of CBTF and transcriptional activation of gata2. Data presented in this thesis show 
that A-form structure is important for binding of CBTF and transcriptional activation 
at the gata2 promoter; however the presence of the inverted CCAA T box is an 
absolute requirement. In the absence of the inverted CCAA T box a strongly A-form 
sequence is not sufficient for activity. Secondly, the promoter region used in these 
experiments was shown to give correct temporal expression but not spatial. 
Suggesting a region(s) elsewhere directs correct spatial expression. Finally, the 
residues of ilO critical for dsRNA binding were examined to see if they were also 
critical for DNA binding. Those residues involved in binding dsRNA are almost all 
involved in binding DNA, although one mutant (K455A) reduced dsRNA binding 
but had no effect on DNA binding. 
Acknowledgements 
I would first like to thank my supervisor Garry Scarlett for giving me the 
opportunity to carry out a PhD at the University of Portsmouth. He has given me 
endless support, encouragement, guidance and has become a valued friend. I would 
like to acknowledge my second supervisor Matt Guille for his advice and greatly 
appreciated support. I would also like to thank Pete Cary for his extensive help and 
expertise with the C.D. work. I wish to also thank everyone who worked with me 
during my time at Portsmouth for assistance with challenging experiments, 
something all scientists are familiar with! They made my time at Portsmouth 
enjoyable and memorable, especially Kerry, Claire, Page, John, Alex, Laurence and 
Michelle. 
I would like to thank my other friends who have been supportive with coffee breaks 
and listening to my rants about "bad gels", in particular Kath, Jude, Dani, Jen and 
Nik. Lastly I would like to thank my family, my sister Kayleigh who had to endure 
many ranting phone calls, my two brothers Andrew and Sam for making me laugh, 
my dog Oscar who sadly didn't survive the PhD and finally my parents David and 
Victoria. Who I dedicate this thesis to, you always believed I could do it and with 
your help I did. 
2 
Table of Contents 
Abstract 1 
Acknowledgements 2 
Table of Contents 3 
List of Figures 7 
List of tables 10 
Abrevations 11 
Chal'j:~J): Introduction 15 
1.1 General introduction 15 
1.2 Xenopus as a model system 16 
1.3 Early development in Xenopus 17 
1.3.1 Maternal determinants 18 
1.3.2 Mid-blastula transition 20 
1.3.3 Mesoendoderm induction 21 
1.3.4 Induction of the Spemann Organiser 23 
1.3.5 Gastrulation 24 
1.3.6 Bmp4 signals 26 
1.4 Transcription 27 
1.4.1 Initiation'complex 28 
1.4.2 Gene-specificity transcription factors 28 
1.4.2.1 Helix-turn-helix 30 
1.4.2.2 Zinc finger 30 
1.4.2.3 Homeodomain 31 
1.4.2.4 Leucine zipper 31 
1.4.2.5 Other DNA and protein-binding domains 31 
1.4.3 Other factors involved in regulation 32 
1.4.3.1 Chromatin remodelling 32 
1.4.3.2 Co-activators 33 
1.4.4 Promoters' 33 
1.4.4.1 Core promoter 33 
1.4.4.2 Proximal control elements 35 
1.4.4.3 Enhancers and Silencers 36 
1.4.5 Transcription factor families and their mechanisms of regulation 36 
1.4.5.1 Nuclear receptors 36 
1.4.5.2 NFKb 38 
1.4.5.3 Smads and their interactions 39 
1.4.5.4 MRFs/MEF 39 
1.4.6 The GATA family of transcription factors 40 
1.4.7 Regulation of the GATA2 promoter 43 
1.4.8 CBTF 44 
1.4.9 CBTF subunit ilD 45 
1.5 Double stranded RNA binding domains (dsRBDs) 47 
1.6 DNA structure 51 
1.6.1 A-form 51 
1.6.2 B-form 51 
3 
1.6.3 Z-form 
1.7 Aims 
Chapter 2: Materials and methods 
2.1 Nucleic acid methods 
2.1.1 Small scale preparation of plasmid DNA (mini-prep) 
2.1.2 Purification of plasmid DNA using Qiagen midi and maxi kits 
2.1.3 Restriction enzyme digest of DNA 
2.1.4 DNA purification by phenol/chloroform extraction 
2.1.5 Ethanol precipitation of DNA 
2.1.6 Polymerase chain reaction (PCR) 
2.1.7 PCR based site directed mutagenesis 
2.1.8 DNA Ligation 
2.1.9 Caesium chloride gradient DNA purification 
2.1.10 Obtaining oligonucleotides 
2.1.11 Annealing oligonucleotides 
2.1.12 Eluting DNA from agarose gels 
2.1.13 Phosphatase reaction 
2.1.14 Phosphodiesterase I (Snake venom digest) 
2.1.15 Radioactive labelling of nucleic acid probes 
2.2 Protein methods 
2.2.1 Expression of proteins 
2.2.2 Sonication 
2.2.3 Protamine sulphate treatment and purification of proteins 
2.2.4 Filter binding assay 
2.3 Electrophoresis and Spectroscopy 
2.3.1 Agarose gel electrophoresis 
2.3.2 Native polyacrylamide gel electrophoresis 
2.3.3 SDS gel electrophoresis 
2.3.4 Electrophoretic mobility shift assay (EMSA) analysis of embryo\ 
extracts 
2.3.5 Ultraviolet (UV) spectroscopy 
2.3.6 Circular Dichroism (CD) spectroscopy 
2.4 Bacterial and embryological methods 
2.4.1 Growth and maintenance of bacterial strains 
2.4.2 Competent cell preparation 
2.4.3 Care and maintenance of Xenopus laevis embryos 
2.4.4 Micro-injections of Xenopus laevis embryos 
2.4.5 Dual-Luciferase reporter assay 
2.4.6 Transgenesis in Xenopus laevis 
Chapter 3: The effects of A and B form DNA structure on transcriptional 
activity at the Xenopus gala2 promoter 
3.1 Introduction 
3.1.1 Experimental strategy 
3.2 Design and validation of DNA structure variants 
3.2.1 Mutant design 
3.2.2 Calculation of extinction coefficients of DNA duplexes 
4 
52 
54 
55 
55 
55 
56 
57 
57 
57 
58 
58 
59 
60 
61 
61 
61 
62 
62 
62 
63 
63 
63 
64 
65 
66 
66 
67 
68 
69 
70 
70 
71 
71 
71 
72 
73 
73 
74 
75 
75 
77 
79 
79 
82 
3.2.3 Circular Dichroism (CD) 86 
3.3 Competition EMSA 94 
3.4 The luciferase assay 97 
3.4.1 SV40 promoter driving firefly luciferase 97 
3.5 Luciferase assay with gata2 promoter 103 
3.6 Summary 110 
Chapter 4: Contribution of an A-form element at the gala2 promoter to 
transcriptional activity 112 
4.1 Introduction 112 
4.2 Design of oligonucleotides 113 
4.3 Formation of duplexes and circular Dichorism (CD) 114 
4.4 Competition EMSA 120 
4.5 Luciferase assays 124 
4.6 Summary 126 
4.6.1 Chapter 4 126 
4.6.2 A dual-mechanism of gala2 promoter regulation 127 
Chapter 5: Transgenic gala2 Xenopus laevis 130 
5.1 Introduction 130 
5.2 Transgenic methods 132 
5.2.1 REMI and transposon meditated insertion 132 
5.2.2 I-see! restriction site and 5'HS4 chicken insulator transgenic 
methodology 133 
5.3 Cloning of the GFP gene into the pGEM3Z plasmid 136 
5.4 Sub-cloning 417WT and 417NC promoters into pGEM2T.GFP 139 
5.5 I-SeeI digest and injection into Xenopus laevis embryos 139 
5.6 Assaying 417WT.GFP and 417NC.GFP Transgenic Xenopus laevis 143 
5.7 Summary 151 
Chapter 6: Investigation into the amino acids involved in binding of the 
dsRBDs ofilf3 to dsRNA and dsDNA 153 
6.1 Introduction 153 
6.2 Design of Mutants ilf3(28.5)_GST 157 
6.2.1 Knock-outs of 2 'hydroxyl contacts 157 
6.2.2 Addition of a Proline 160 
6.2.3 Knock outs of critical lysine contacts 160 
6.3 Creation of mutant ilf3(28.5) regions with site directed mutagenesis 162 
6.4 Expression and purification of the mutant Ilf3(28.5)_GST proteins 165 
6.5 Binding of mutant Ilf3(28.5)_GST proteins to DNA and RNA 170 
6.5.1 Radio-active labelling of RNA and DNA 170 
6.5.2 The filter binding assay 170 
6.5.3 Testing the assay with WT and RBD- 174 
6.5.4 Assessing 2'hydroxyl knock-outs 174 
6.5.5 Mutant N530A 178 
6.5.6 Mutant V428P 180 
6.5.7 Assessing lysine mutants 180 
6.6 Summary 186 
6.6.1 2 'hydroxyl mutations 186 
5 
6.6.2 Lysine mutations 
Chapter 7: Discussion and future work 
7.1 Discussion 
7.2 Future work 
References: 
Appendix I: Solutions 
Appendix II: Sequence of primers 
Appendix III: Clone sequences 
Appendix IV: Plasmid maps 
Appendix V: Nucleic acids and protein markers 
Appendix VI: Triplet code table for predicting A-form propensity. 
6 
188 
190 
190 
194 
195 
215 
219 
225 
235 
241 
244 
List of figures 
1.1 A model for early pattern formation in Xenopus laevis 19 
1.2 Gastrulation 25 
1.3 NMR Structure ofa double stranded RNA-binding domain (dsRBD) 50 
1.4 Alternative DNA structures 53 
3.1 Sequence and structure homology of gala2 promoters 76 
3.2 Flow diagram of experimental strategy 78 
3.3 Footprinting summary of CBTF 81 
3.4 Prediction graphs of A-form and B-form preference 84 
3.5 10% polyacrylamide gel showing annealed duplex oligonucleotides 85 
3.6 Phosphodiesterase I digest of the oligonucleotide duplex WT 88 
3.7 Schematic of circularly polarised light 89 
3.8 Circular dichorism of duplex oligonucleotides WT, AFl, AF2, AF3 and BF 92 
3.9 Competition EMSA with mutant oligonucleotides 96 
3.10 Graph of competition EMSA data 98 
3.11 Optimisation of the luciferase assay 100 
3.12 Annotated 417 base pairs of the Xenopus Laevis gala2 
promoter with exon 1 
3.13 Preliminary luciferase assay experiments with gata2 promoter 417WT and 
31WT 
3.14 Transcriptional from gata2 mutant promoters 
4.1 Prediction graphs of A and B-form preference 
4.2 10% Polyacrylamide gel showing annealed oligonucleotides 
4.3 Circular dichorism of duplex oligonucleotides WT, TAF, NC, 
BFNC and RAN 
4.4 Competition EMSA with mutant oligonucleotides 
4.5 Summary graph of competition EMSA results 
4.6 Transcriptional levels from mutant gata2 promoters 
4.7 Summary EMSA and luciferase data from chapter 3 and 4 
relative to wild-type 
7 
104 
105 
108 
116 
117 
119 
122 
123 
125 
128 
5.1 Plan for creation of transgenic Xenopus laevis 135 
5.2 Design of the steps involved in sub-cloning 417WT.GFP and 
417NC.GFP 138 
5.3 1 % agarose gel showing a PCR product containing the GFP gene 140 
5.4 Restriction enzyme digest confirmation of inserted PCR product 
into pGEM3Z creating pGEM3Z.GFP 141 
5.5 Restriction enzyme digest confirmation of the pGEM3Z.GFP 
plasmid with inserted 417WT and 417NC promoters 142 
5.6 Restriction enzyme digest confirmation of the I-SceI digest 
of the 417WT.GFPplasmid 144 
5.7 Mosaic GFP expression from 417WT transgenic Xenopus laevis 145 
5.8 GFP expression is not tissue specific with the 417WT promoter 147 
5.9 Expression of GFP from 417WT on one side of a Xenopus laevis tadpole 148 
5.10 Table and graph comparing 417WT and 417NC transgenic 
Xenopus laevis with visible GFP expression 150 
6.1 Diagram of XlrbpA dsRBD bound to dsRNA 155 
6.2 The dsRBDs consensus sequence compared with the dsRBDs of 
ilf3 and Xlrbpa2 156 
6.3 Annotated amino acid sequence of ilf3 158 
6.4 Schematic of SDM procedure used to create insert DNA coding mutant 
ilf3(28.5) proteins 163 
6.5 PCR fragments containing mutant sequences 164 
6.6 10% SDS-page assaying for correctly expressing putative clones 166 
6.7 1 % agarose gel assaying for correct size of DNA insert 167 
6.8 Preliminary expression assays with recombinant ilf3(28.5)-GST 
fusion protein by 10% SDS-PAGE 169 
6.9 Purification of ilf3(28.5)-GST protein 171 
6.10 Purified 55.5 kDa ilf3(28.5)-GST mutants 172 
6.11 Annealed 36 bp DNA and RNA oligonucleotide duplexes 
corresponding to the gata2 promoter 173 
8 
6.12 ilf3(28.5)-GST or ilf3(28.5)F433A1F551A-GST percentage 
binding with DNA or RNA 175 
6.13 Mutant ilf3(28.5)H430G-GST or ilf3(28.5)H430G/H547G-GST 
percentage binding with DNA or RNA 177 
6.14 Mutant Xilf3(28.5)V429P-GST or Xilf3(28.5)N529A-GST 
percentage binding with DNA or RNA 179 
6.15 Mutants K452A or K452A1K469A percentage 
binding with DNA or RNA 182 
6.16 Mutant K454A or K454A/K481A percentage binding 
with DNA or RNA 184 
6.17 Mutant K457 A or K457 A/K484A percentage binding 
with DNA or RNA 185 
6.18 Percentage binding of all ilf3(28.5)-GST proteins at 25 nM 
with DNA or RNA duplex oligonucleotide 187 
9 
List of tables 
Table 3.1 Wild type oligonucleotide design and all mutants 
Table 3.2 Observed extinction coefficients for WT and 
mutant oligonucleotide duplexes 
Table 4.1 Wild-type and mutant duplexes 
Table 4.2 Extinction coefficients for WT and mutant 
83 
87 
115 
oligonucleotide duplexes 118 
Table 6.1 List of mutations of the dsRBDs ofXilD used in this chapter 161 
10 
List of Abrevations 
Ala (A): Alanine 
Arg (R): Arginine 
APE: A-fonn DNA propensity energy 
APS: Ammonium persulphate 
Asn (N): Asparagine 
A TP: Adenosine triphosphate 
BMP: Bone morphogenetic protein 
Bp: Base pairs 
BRE: TFIIB recognition element 
CaM Kl V: Calmodulin-dependent protein kinase IV 
CA T: Chloramphenicol acetyl transferase 
CBTF: CCAA T -box transcription factor 
CD: Circular dichorism 
CTP: Cytidine triphosphate 
DLP: Dorsal lateral plate 
ds: Double-stranded 
DMS: Dimethyl sulphate 
DNA: Deoxyribonucleic acid 
DNaseI: Deoxyribonuclease I 
DPE: Downstream promoter element 
dsRBD: Double-stranded RNA-binding domain 
11 
DTT: Dithreitol 
EMSA: Electrophoretic mobility shift assay 
fmol: Moles x 10-15 
GFP: Green fluorescent protein 
Gin (Q): Glutamine 
Glu (E): Glutamic acid 
Gly (G): Glycine 
GnRH: Gonadotropic Releasing Hormone 
GR: Glucocorticoid receptor 
GST: Glutathione-s-transferase 
GTP: Guanosine triphosphate 
HAT: Histone acetyltransferase 
His (H): Histidine 
HSC: Haematopoietic stem cells 
ILF3: Interleukin enhancer binding factor 3 
Inr: Initiator element 
IPTG: isopropyl (3-D-thiogalactopyranoside 
kb: base x 103 
kDa: Daltons x 103 
LarII: luciferase assay reagent II 
Lys (K): Lysine 
Luc: Luciferase gene 
M: Molar 
12 
MBT: Mid-blastula transition 
Ilg: Grams x 10-6 
Ill: Litres x 10-6 
IlM: Molar x 10-6 
Ilmol: Moles x 10-6 
mM: Molar x 10-3 
mmol: Moles x 10-3 
mw: Molecular weight 
ng: Grams x 10-9 
NLS: Nuclear localization signal 
nmol: Moles x 10-9 
NR: Nuclear receptors 
NTP: Nucleotide triphosphates 
peR: Polymerase chain reaction 
pg: Grams x 10-12 
Phe (F): Phenylalanine 
PLB: Passive lysis buffer 
Pol II: RNA polymerase II 
pmol: Moles x 10-12 
Pro (P): Proline 
RGN: Regulatory gene network 
RNA: Ribonucleic acid 
RT -peR: Reverse transcriptase polymerase chain reaction 
13 
SDM: Site-directed mutagenesis 
SDS: Sodium dodecyl sulphate 
SDS-PAGE: Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
ss: Single stranded 
SV 40: Simian virus 40 promoter 
TBP: TATA-binding protein 
TEMED: N,N,N',N'-Tetramethylethylenediamine 
TGF/3: Transforming growth factor {3 
TK: thymidine kinase 
TTP: Thymidine triphosphate 
UTP: Uridine triphosphate 
UV: Ultra violet 
V: Volts 
Val (V): Valine 
VBI: Ventral blood islands 
VMZ: ventral marginal zone 
W: Watts 
Xlrbpa: Xenopus laevis RNA-binding protein A 
14 
Chapter 1: Introduction 
1.1 General introduction 
In this thesis the binding of the double stranded RNA binding domains (dsRBDs) of 
Xenopus laevis ilD to a region of the Xenopus laevis gala2 promoter, critical to its 
activity at gastula stages, was investigated. IlO is a sub-unit of the multi-protein 
complex CBTF, which has been shown to activate transcription of the gala2 
promoter (Brewer et aI., 1995). More recently the dsRBDs of ilD in particular have 
been shown to be critical for gala2 transcription (Scarlett et aI., 2004). Binding to 
dsDNA is an unusual role for dsRBDs as they have previously been reported as 
binding solely to dsRNA (Bass et aI., 1994). Under physiological conditions dsRNA 
forms an A-form helix, whereas dsDNA, forms a B-form helix. Experiments have 
shown the critical region of the gala2 promoter is partially A-form, at least in vitro, 
and it was hypothesised that this structure facilitated binding of the dsRBDs to the 
critical gala2 promoter region (Scarlett et aI., 2004). Evidence supporting this 
hypothesis is shown in this thesis, along with a study that determined which residues 
of ilO are critical for dsRNA and dsDNA binding respectively. In this chapter an 
introduction on early Xenopus development, transcription factors, promoters, 
mechanisms of transcriptional regulation, dsRBDs and DNA structure will be given 
with emphasis on the Xenopus laevis gala2 promoter and the ilO transcription factor 
interaction. 
The interaction investigated in this thesis is only a small part of the mechanisms 
involved in the development of a fully formed organism from a fertilised egg. The 
embryo goes from a mass of multipotent cells, to cells that have different and 
distinct cell fates. The development of an organism is fundamental to multicellular 
life and studying it can help understand the critical processes that are involved. By 
understanding these processes, we can gain insight into what causes developmental 
and genetic diseases. Understanding what causes a developmental defect, for 
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example a possible gene mutation, can help find cures for such diseases. However 
none of this would be possible without an understanding of the underlying processes 
and mechanisms behind them. The main aim of the research carried out in this thesis 
is to increase our knowledge of the molecular mechanisms involved In 
developmental processes to help better understand their cellular activity. 
1.2 Xenopus as a model system 
Xenopus laevis is one of the main organisms used as a biological model in molecular 
and cell biology. It is commonly known as the African clawed frog and originates 
from the cape uplands in Africa. The first use of Xenopus laevis dates back to the 
1930's when they were used as an early pregnancy test in hospitals. Pregnant women 
produce chorionic gonadotrophin hormone which is found in their urine. If the urine 
was injected into the dorsal lymph sacs of adult Xenopus females the frogs would 
ovulate and lay eggs the next day, providing a simple pregnancy test (Landgrebe, 
1939). The use of Xenopus for this purpose meant Xenopus husbandry was 
developed and established early on. Xenopus are easy to keep; they require little 
space, are hardy and can be kept in good condition with the minimum of equipment. 
Xenopus laevis are no longer used as a way of testing for pregnancy since there are 
more advanced techniques available, but their use as a developmental model has 
become popular. This is because Xenopus ovulation is straightforward to induce, the 
embryos develop externally, which makes development easy to observe. The 
embryos are also very large and robust so basic surgical manipulations can be 
performed. They also have a high fecundity and are sexually reproductive all year 
round. This means a high number of embryos to work with whenever they are 
needed, because of these reasons a great deal of study of development has been 
carried out using Xenopus. This has resulted in the isolation of molecular markers 
for specific cell types and stages of differentiation and many researchers have added 
to this vast knowledge (BoIce et al., 1992; Cho et al., 1991; Cooke and Smith, 1987; 
Hawley et al., 1995; Piccolo et al., 1996; Zimmerman et al., 1996). There is also 
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Piccolo et al., 1996; Zimmerman et al., 1996). There is also detailed knowledge of 
pattern formation (Piccolo et al., 1996; Shih and Keller, 1992). A range of species 
specific techniques have also been developed (Guille, 1999). More recently the use 
of gain of function assays by microinjection of mRNA (Gurdon and Wickens, 1983), 
depletion of target protein levels by morpholino antisense technology (Heasman, 
2002) and an extensive expressed sequence tag (EST) library have extended the 
versatility of the frog as a model system. 
On a molecular level many developmental processes are highly conserved between 
humans and the main model organisms, mice, chicken, zebrafish and Xenopus. 
Taken with the already described benefits of Xenopus this makes Xenopus an 
excellent model for studying biological molecular interactions and applying them to 
ourselves. However there are some drawbacks with using Xenopus laevis, these are 
that it has a long generation time (approximately two years) and a pseudotetraploid 
genome (Hughes and Hughes, 1993). This means that genetic experiments are 
difficult to control and are generally not carried out in Xenopus laevis. There is a 
closely related species to Xenopus laevis called Xenopus tropicalis that has increased 
in popularity due to a quicker generation time, less than 6 months, and the Xenopus 
tropicalis genome is diploid. Xenopus tropicalis is a better choice for some 
experiments but the relatively small embryos and less developed husbandary 
techniques for this species mean that Xenopus laevis still has an active role as a 
model in developmental and molecular biology. First the early developmental events 
that take place in Xenopus laevis are discussed below. 
1.3 Early development in Xenopus 
Transcriptional regulation is critical in the development of any organism and 
Xenopus laevis is no different. The early developmental events and the key 
molecules and interactions are discussed below. 
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1.3.1 Maternal determinants 
In the Xenopus oocyte there are several localised maternal proteins and mRNAs that 
are involved in initiating development of the different cell layers (Schnapp et aI., 
1997). These include aT-box transcription factor, VegT, which is localised to the 
presumptive mesoendodenn and is involved in detennining the endodennal and 
mesodennal cell lineages (Clements et aI., 1999; Horb and Thomsen, 1997; Lustig et 
aI., 1996; Souopgui et aI., 2008; Xanthos et aI., 2001; Zhang et aI., 1998), the TGFfj 
signalling molecule V g 1, which is localised to the most vegetal endodenn and is 
involved in mesodenn induction and the expression of several key BMP antagonists 
(Birsoy et aI., 2006; Weeks and Melton, 1987). The region containing Vgl and other 
factors, the cortical cytoplasm, is relocated during cortical rotation and microtubule 
dependent transport that follow fertilisation (Sakai, 1996). Cortical rotation sets up 
the dorsal-ventral axis of the embryo, at the point of spenn entry the ventral region 
will fonn and opposite is the dorsal region (figure 1.1). If cortical rotation is 
blocked, there is no dorsal development only ventral, and the embryo dies as a 
consequence (Vincent and Gerhart, 1987). At the end of the cortical rotation the 
origins of the three cell layers and the dorsal-ventral axis have been established. 
Although further development of these regions is thought to be paused at this point 
until the end of cleavage and the start of zygotic transcription in the late blastula, 
when many different genes are activated. These interactions will be discussed in 
more detail later. 
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(a) (b) 
• Nieuwkoop centre 
V I I Dorsal determinants egeta po e Xwnt, VgJ, Dsh 
(c) 
Mesoderm 
Endoderm 
(d) 
Spemann organiser 
! 
Spemann organiser factors 
1---------"'=9 Xnrs, Derriere, ~-catenin, Noggin 
Figure 1.1 A model for early pattern formation in Xenopus laevis. 
(a, b) Fertilisation triggers cortical rotation where dorsal determinants 
are moved 30° towards the dorsal mesoderm, so that the determinants 
are almost opposite the site of sperm entry. The Neiuwkoop centre, 
which leads to the formation of the spemann organiser, is located here. 
(c) Mesoderm and endoderm are induced. VegT localised to the vegetal 
pole activates expression of Xnrs and derriere, involved in specifying 
the endoderm and mesoderm. Siamos is activated by the Wnt signalling 
pathway and contributes to dorsal mesoderm specification. (d) Dorsal-
ventral patterning, a gradient of bmp4 from the ventral region diffuses 
out towards the dorsal side; bmp antagonists are expressed in the 
Spemann Organiser, repressing bmp allowing the formation of dorsal 
structures. 
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1.3.2 Mid-blastula transition 
A one celled embryo divides into many cells to form the blastula. This occurs after 
fertilisation and cortical rotation. In Xenopus laevis cleavage is symmetrical and 
holoblastic, although this is affected by the high levels of yolk present in the vegetal 
pole of the embryo. Yolk hinders cleavage and so the first division begins in the 
animal pole and slowly extends to the vegetal pole. The second division is at right 
angles to the first cleavage. This second cleavage begins in the animal pole before 
the first cleavage is finished in the vegetal pole. The third cleavage is between the 
animal pole and vegetal pole at the equatorial line. In Xenopus this cleavage, due to 
the yolky vegetal region is displaced further up than the equator towards the animal 
pole. This divides the embryo into eight blastomeres, four small ones in the animal 
pole and four large ones in the vegetal pole. This leads to a rapidly dividing region 
of micromeres near the animal pole and a more slowly dividing region of 
macromeres in the vegetal pole (Beams and Kessel, 1976). 
Cleavage proceeds for 12 cell divisions (Nieuwkoop and Faber, 1967) and the 
timing of development of Xenopus laevis can be altered by manipulation of the 
temperature they are kept at. The blastocoel, a cavity inside the Xenopus embryo, is 
formed from the first cleavage and expands during subsequent cleavages (Kalt, 
1971). The blastocoel serves two main functions; these are to pennit cell migration 
during gastrulation, discussed in more detail later, and to prevent the cells beneath it 
from interacting prematurely with the cells above it. Cleavage separates the blastula 
so that each cell contains a slightly different composition of cytoplasm, depending 
on the location of the cell within the embryo. Although there seems to be no 
alteration of cell fate until zygotic gene activation, some tissue grafting experiments 
have suggested that the mesodenn can be considered detennined before the start of 
zygotic transcription, due to this compartmentation (Jones and Woodland, 1987). At 
the end of cleavage these cells that have different compositions of maternal factors 
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are able to signal to one another to complete the primary cell layer specification and 
continue formation of the axis. 
From a molecular point of view only a few genes are transcribed during early 
cleavage (Yang et aI., 2002). It is during the mid-blastula transition (MBT) that most 
zygotic genes are activated. The MBT occurs in the twelfth cell cycle, when most 
maternal proteins become depleted and the rate and synchrony of cell division is 
reduced (Newport and Kirschner, 1982a). At this point mass zygotic transcription 
begins and is thought to be activated by a variety of events including: a titration of 
cytoplasmic histones into freshly synthesised DNA (Newport and Kirschner, 1982b; 
Prioleau et aI., 1994); the demethylation of certain promoters (Stancheva et aI., 
2002); the translational regulation of TFIIB synthesis (Veenstra et aI., 1999); a 
deficiency of transcriptional cofactors (Veenstra et aI., 1999). At this point the 
localised maternal factors now activate regional zygotic signals that are involved in 
the first physiological differences between the three cell layers and dorsal-ventral 
polarity is initiated. 
1.3.3 Mesoendoderm induction 
The mesoenododerm is embryonic tissue which will differentiate into mesoderm and 
endoderm. The VegT transcription factor is involved in the formation of mesodermal 
and endodermal cell lineages and experiments depleting or overexpressing maternal 
VegT show that it functions by activating transcription of activin-like ligands 
including Xnrs and derriere (Clements et aI., 1999; Kofron et aI., 1999; Xanthos et 
aI., 2001). It also activates endodermal genes such as mix.i, mixer, bix4, soxi7{3, 
sox7 and endoderm in (Engleka et aI., 20ot; Taverner et aI., 2005; White et aI., 2002; 
Zhang et aI., 2005). The Xnr activin-like signals can also diffuse into the overlying 
marginal zone cells and induce these cells to express mesodermal markers (Clements 
et aI., 1999; Zhang et aI., 1998). Figure 1.1 illustrates these interactions. 
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VegT also activates the TGF/3 signal and this interaction has been studied in detail 
and is relatively well understood (Heldin et aI., 1997; Massague et aI., 1997; 
Massangue, 1996). There are two classes of transmembrane receptors, the activin 
type IB and type II receptors (ActRIBI ActRII) both of these feature an integral 
kinase activity within the cytosolic domain. The type II receptors recognise and bind 
extracellular activin-like ligands, the resulting receptor-ligand complex is then 
recognised by the type I receptor next to the cytoplasmic domains. Finally, the C-
terminal kinase domain of the type II receptor phosphorylates the adjacent kinase 
domain of the type I receptor to activate its cytoplasmic kinase domain. Smad2 is 
then used by this activated tetramer to transduce the signal to the nucleus. Smad2 
exists as an inactive cytosolic monomer and is thought to do so by an interaction 
between its N-terminaIlC-terminal that inhibits the molecule. This interaction is 
destablised by phosphorylation of the ActRIB receptor and Smad2 dimerises with 
Smad4. This Smad2/Smad4 heterodimer is then actively translocated to the nucleus 
where it either interacts directly with promoter sequences to activate transcription or 
forms a heterodimer with the forkhead activin sensitive transcription factor FAST-l 
(Chen et aI., 1996; Henningfeld et aI., 2000; Watanabe and Whitman, 1999). This 
then activates transcription of downstream mesoendoderrnal genes including vent2, 
Mix2,){bra and goosecoid (Heasman, 1997; Henningfeld et a1., 2000; Watanabe and 
Whitman, 1999). 
This ActRIB/Smad2 interaction acts as the main channel through which all the 
nodal-related ligands (Xnrs) operate (Chang et aI., 1997). Xnrs are part of the TGF/3 
superfamily and section 1.5.5.3 describes the interactions between TGF/3 molecules 
and Smad transcription factors in more detail. How these ligand specific effects 
happen has yet to be determined, since overexpression of different nodal-related 
ligands promotes different cell fates. For example it has been suggested that Xnrl 
and 2 are involved in anterior specification whereas derriere is involved in posterior 
specification (Kofron et a1., 1999). The reasons for this are unclear but it is possible 
that there are unidentified receptors for activin-like ligands that modulate the Smad2 
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signal or that alternative pathways exist that control the response of a given region of 
the embryo to Smad2 mediated signals. 
1.3.4 Induction of the Spemann Organiser 
The Spemann organiser was first discovered by transplantation experiments by 
Spemann and Mangold in 1924. They found that by transplanting the dorsal 
blastopore of one salamander embryo to the ventral side of a colourless salamander 
embryo resulted in two conjoined salamanders, distinguished from the host or the 
donor by colour (Harland and Gerhart, 1997). Spemann named this region, 
containing the dorsal lip cells and their derivatives (notochord, prechordal 
mesoderm), the organizer, now commonly known as the Spemann organiser. The 
donor cells induced the host's ventral tissues to change their fates to form a neural 
tube and dorsal mesodermal tissue (such as somites) and they organised the host and 
donor tissues to form a secondary embryo, conjoined to the first primary embryo, 
with clear anterior-posterior and dorsal-ventral axis (Harland and Gerhart, 1997). 
The Spemann organiser itself is induced by another set of signals. Nakamura and 
Takasaki did transplantation experiments and found that the vegetal region induces 
the regions of the animal pole it is in contact with to form mesoderm (Nakamura and 
Takasaki, 1970). This induction is polar, the animal pole cells are induced to form 
dorsal and ventral mesoderm, and the polarity of the induction is dependent on the 
polarity of the vegetal region. Ventral and lateral vegetal cells induce ventral 
mesoderm, mesenchyme and blood, and intermediate mesoderm, muscle and kidney. 
The dorsal most vegetal cells induce dorsal mesoderm, somites and notochord. 
These cells also induce the organiser and have been named the Nieuwkoop centre 
after the investigator that discovered these signalling interactions. This was 
demonstrated by tissue grafting experiments (Nieuwkoop, 1973). The Neiuwkoop 
centre has also been demonstrated with similar transplantation experiments as those 
of Spemann and Mangold 1924, but with younger blastula stage embryos. The 
results of the two experiments were the same with two axis formed showing the 
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Neiuwkoop centre must be involved in induction of the organiser (Gimlich and 
Gerhart, 1984). 
1.3.5 Gastrulation 
An embryo is made up of three different germ layers, these are the endoderm, 
ectoderm and the mesoderm. The endoderm forms the internal organs and the gut the 
ectoderm forms the surrounding skin tissue and some neural tissue. The mesoderm 
forms some neural tissue and the organs and blood located between the endoderm 
and ectoderm. Before the embryo undergoes gastrulation these three regions are not 
located in the correct places and so the embryo must rearrange itself to move these 
cells to their appropriate locations (Figure 1.2). Fate mapping has shown that the 
cells of the Xenopus blastula have different fates depending on their location. The 
ectoderm cells are located in the animal pole and the endoderm cells are located in 
the vegetal pole with the mesoderm cells in-between these two tissues (Keller, 1975; 
Landstrom and Lovtrup, 1979). This general fate map is thought to be controlled by 
a transcription factor called VegT and the TGF{3 family paracrine factor Vgl (Joseph 
and Melton, 1998; White and Heasman, 2008; Zhang et aI., 1998). 
Gastrulation in Xenopus starts on the side of the embryo that will form the dorsal 
region. The dorsal blastopore lip is formed as cells in the marginal zone invaginate 
and change shape to form bottle cells, where the main body of the cell is in contact 
with the embryo and each cell has a slender neck that is in contact with the outside 
surface. The marginal zone cells then undergo involution and the animal cells 
migrate to cover the embryo, a process known as epiboly, and stop when they meet 
each other at the blastopore lip. All animal cells are then on the outside of the 
embryo and form the epidermis and neural ectoderm. When the migrating marginal 
cells reach the dorsal lip of the blastopore, they tum inward and travel along the 
inner surface of the outer animal hemisphere cells. At the end of gastrulation the 
mesodermal, ectodermal and endodermal cells are situated in the correct place, so 
that these regions can now develop into more specified tissues. 
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Figure 1.2 Gastrulation. Gastrulation i initiated at stage 10 (A). It is 
characteri ed by a migration of marginal zone cells positioned animally 
into the bla tocoel cavity and hence the centre of the embryo. A to F 
show the cell movements during gastrulation over time. At the end of 
gastrulation (F) the embryo is divided into endoderm (yellow cells), 
mesoderm (red cells) and ectoderm (blue cell s) all located in their 
correct places. (Taken from Development seventh edition, Scott F. 
Gilbert, 2003) 
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1.3.6 Bmp4 signals 
It has been known for a long time that diffusible signals are involved in inducing 
neural structures in the ectoderm (Saxen, 1961; Toivonen et aI, 1975). However, it 
took several decades to discover what these factors where. It would seem from 
earlier experiments that the ectoderm is induced to form neural structures by signals 
from the endoderm but later data showed that the ectoderm is induced to become 
epidermal (Hemmati-Brivanlou and Melton, 1997). Without any signalling factors 
the ectoderm will become neural tissue. The ectoderm is induced by bone 
morphogenetic proteins (bmps) and the nervous system is formed from the region of 
the ectoderm protected from these signals (Wilson and Hemmati-Brivanlou, 1995). 
So the organiser acts by secreting molecules that block bmps and this region of 
ectoderm is able to become neural tissue. cDNA libraries were formed to try and 
find candidate genes that would inhibit bmps and allow neural formation. The 
candidate genes that were found are noggin, chordin and Xnr3. All of these factors 
induce a neural fate, by inhibiting bmp4 and bmp2 (Piccolo et aI., 1996; Smith and 
Harland, 1992; Zimmerman et aI., 1996). 
If bmp4, a member of the TGFt3 family, is expressed in Xenopus embryos all the 
mesoderm becomes ventrolateral, conversly depletion of bmp4 results in two axis 
forming (Dale et aI, 1992; Suzuki et aI., 1994). Bmp4 has been shown to induce 
ectodermal cells to become epidermal. The candidate factors for inhibiting bmp4 and 
allowing neurulation of the ectodermal tissue, (noggin, chordin and follistation) are 
secreted by the organiser. They prevent bmp4 from inducing epidermal tissue by 
binding to bmp4 and inactivating it (Piccolo et aI., 1996; Wilson and Hemmati-
Brivanlou, 1995; Zimmerman et aI., 1996). Bmp4 is initially expressed through-out 
the ectodermal and mesodermal regions of the late blastula and it is during 
gastrulation that bmp4 becomes restricted to the ventro-Iateral marginal zone. It is 
restricted from the dorsal region by Xiro 1, which inhibits bmp4 at a transcriptional 
level, and is expressed in the organiser region at the beginning of gastrulation 
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(Gomez-Skarmeta et aI., 2001; Hemmati-Brivanlou, 1995). Bmp4 induces different 
tissues at different concentrations and a concentration gradient of bmp4 is set up by 
bmp4 coming from the ventral-lateral mesoderm interacting with bmp4 inhibitors 
secreted by the organiser (figure 1.1). Low doses induce muscle tissue, intermediate 
levels induce kidney formation and high levels induce blood-formation (Gawantka et 
aI., 1995). Bmp4 signalling activates transcription factors that induce epidermal and 
ventral mesoderm differentiation and inhibit genes involved in neural formation, 
some examples of these activated genes are, Xventl, Xvent2 (Vox) and Vom (Suzuki 
et aI., 1997). 
Complex networks of activating and repressing signals as discussed above lead to 
the development and differentiation of many cell lineages and axis specification. 
Once the axial and cell layer specification of the embryo is established, there are a 
series of more restricted patterning events that continue to subdivide the embryo into 
more specific tissues and structures. There needs to be tight regulation of gene 
expression and it is mainly carried out at the transcriptional level. Transcription and 
its regulation will now be discussed. 
1.4 Transcription 
Gene expression needs to be regulated, as different genes need to be spatially and 
temporally active accordingly for correct development of an organism and its 
continued survival. Most regulation is at the transcriptional level, the most energy 
efficient place to halt unnecessary activation. Transcription can be regulated by cis 
acting factors such as chromatin structure and repression or enhancer domains, as 
well as trans acting factors for example specificity factors and co-activators (Orkin, 
1992; Ranjan et aI., 1994; Westerfield et aI., 1992). First the formation of the 
initiation complex will be discussed, then eukaryotic promoters, followed by 
transcription factors and other regulatory molecules. 
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1.4.1 Initiation complex 
Before transcription can begin, the initiation complex must be recruited. One well 
known example of how this is achieved involves the T A TA-binding protein (TBP). 
TBP binds to the TAT A box located at the promoter. In eukaryotes the consensus 
sequence is TATAAA and is located around -30 from the start of transcription 
(Lifton et aI., 1978; Smale and Kadonaga, 2003). Although, not all promoters 
contain a TAT A box, arguing there must be an alternative method for forming the 
initiation complex. After TBP has bound to the DNA it recruits TFIIB, which binds 
to TBP and the flanking regions of DNA either side of TBP. Sometimes another 
factor, TFIIA, binds and stabilises this structure and this is normally found when the 
promoter has a non-consensus TAT A sequence. The TFIIB-TBP complex is then 
bound by TFIIF and Pol II, Pol II is the eukaryotic polymerase that binds to the 
promoters of protein coding genes to produce mRNA. TFIIF targets Pol II to its 
promoters by binding TFlIB, reducing Pol II binding to non specific sites. Finally 
TFIIE and TFIIH bind, one of TFIIH's subunits phosphoryates Pol II, initiating 
transcription (Conaway and Conaway, 1993). During transcription the Pol II is 
inhibited from pausing and falling off the DNA, stopping transcription, by 
elongation factors. At the termination site Pol II is dephosphorylated and recycled. 
The transcription factors described here are the general transcription factors and are 
essential for transcription. There are also other transcription factors that are more 
specific and can bind to several or only a few promoters. These specificity factors 
are normally involved in activation of transcription, often by enhancing the 
recruitment of the Initiation complex (Conaway and Conaway, 1993). 
1.4.2 Gene-specificity transcription factors 
Gene specific transcription factors, referred to just as transcription factors now on in 
this thesis, generally bind to specific DNA sequences. Their affinity for these 
sequences is roughly 100 fold higher than their affinity for other DNA sequences. 
These transcription factors contain DNA-binding domains that target them to the 
genes they control. These domains fall into several characteristic structural motifs. 
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To bind to DNA sequences these structures must recognise surface features on the 
DNA, most protein-DNA contacts involved in specificity are hydrogen-bonds that 
are made through the major groove of the DNA. The bases can be recognised by the 
hydrogen-bond donor and acceptor groups of the four nucleotides, as the groups 
involved in this interaction differ among the four bases. Protein-DNA contacts are 
also possible in the minor groove of the DNA, but the hydrogen-bonding patterns 
generally do not allow ready discrimination between base pairs. 
Within these transcription factors residues in amino acid side chains involved in 
making hydrogen-bonds with DNA tend to be Asn, Gin, Glu, Lys and Arg. For a 
protein to interact with the major groove of DNA these residues need to be presented 
on a small structure that protrudes from the protein surface and so the DNA-binding 
domains tend to be small (60 to 90 residues). The DNA binding sites on promoters 
for regulatory proteins are often inverted repeats of a short DNA sequence (a 
palindrome) and multiple subunits of a regulatory protein can bind cooperatively. 
Promoters are discussed in more detail in section 1.5.4 below. 
There are estimated to be between 1500-2000 transcription factors in the Xenopus 
genome (Mike Gilchrist, personal communication). Many are members of multi-
protein families, for example the CTFINF-l family which results from alternative 
RNA splicing of a transcript from a single locus (Santoro et aI., 1988). The Sp 
family, where Sp 1 is a member (Suske, 1999), the homeodomains, which bind to 
homeoboxes and are involved in development (Gehring et aI., 1994) and the GATA 
family, of which gata2 is a member (Patient and McGhee, 2002). Within each 
family, the members often have similar or essentially identical DNA binding 
properties but distinct activation functions. Individual eukaryotic sequence-specific 
factors generally bind to DNA with relatively low specificity (Walter et aI., 1994). 
However, their binding affinity is greatly enhanced when in the correct complex. 
Therefore, normally more than one factor is recruited and this is achieved by several 
recognition sequences located in the promoter or enhancer regions. Within these 
families dimers can form either between two identical proteins (a homodimer) or 
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between two different members of the family (a heterodimer). This allows many 
combinations of subunits to form different complexes and in many cases these 
different combinations appear to have distinct regulatory and functional properties. 
First the different DNA-binding domains of these transcription factors and some 
examples are discussed. 
1.4.2.1 Helix-turn-helix 
The helix-turn-helix is a DNA-binding motif crucial in the interaction of many 
prokaryotic regulatory proteins with DNA and a similar motif is present in some 
eukaryotic regulatory proteins. This motif contains about 20 residues in two short (X-
helices, each around 7 to 9 residues long, separated by a (3 tum. One of the helices 
contains many of the residues that are involved with sequence-specific DNA 
interactions and this helix is referred to as the recognition helix. This helix protrudes 
from the protein surface and when bound to DNA it is positioned in, or nearly in, the 
major groove (Harrison and Aggarwal, 1990). 
1.4.2.2 Zinc finger 
The zinc finger motif is about 30 amino acid residues that form an elongated loop 
held together at the base by a single Zn2+ ion, it is held in place by four residues, 
either four Cysteine or two Cysteines and two histidines. The zinc ion plays no part 
in interaction with the DNA, its role is to stabilise the structure of this small DNA-
binding motif. There are also several hydrophobic side chains in the core of the 
structure that add to stability. This is a common motif found in several transcription 
factors in eukaryotes and many DNA-binding proteins have multiple zinc fingers 
(Laity et al., 200 I). This is because the interaction of one zinc finger with DNA is 
typically weak and so multiple zinc fingers acting simultaneously enhances binding 
(Laity et al., 2001). How these zinc finger proteins interact with DNA differs from 
one protein to the next. For example some zinc fingers contain residues that are 
important in sequence discrimination and others appear to bind DNA with no 
sequence specificity and the residues involved in sequence specificity are located 
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elsewhere in the protein (Wolfe et aI., 2000). It is worth noting that zinc fingers can 
also function as RNA-binding motifs (Laity et aI., 2001) and also in protein-protein 
interactions (Brayer and Segal, 2008). 
1.4.2.3 Homeodomain 
The homeodomain is around 60 amino acids long, highly conserved and has been 
found in a range of proteins (Gehring et aI., 1994). The motif involved in binding to 
DNA is related to the helix-turn-helix motif and the sequence that encodes this 
domain is called the homeobox. These transcription factors are involved in complex 
development of higher eukaryotes (Gehring, 1992; Gehring et aI., 1994) . 
1.4.2.4 Leucine zipper 
The leucine zipper motif is involved in allowing transcription factors to make 
protein-protein interactions and is often separate from the DNA-binding domain. 
The leucine zipper is an amphipathic ex. helix with a series of hydrophobic residues 
concentrated on one side, with the hydrophobic surface forming the area of contact 
between the two polypeptides of a dimer. At every seventh position there is a leucine 
residue which forms a straight line along the hydrophobic surface. These leucine 
residues line up side by side as the interacting ex. helices coil around each other. Most 
regulatory proteins with leucine zippers have a separate DNA-binding domain with a 
high concentration of lysine or arginine residues, and these can interact with the 
negatively charged phosphates of the DNA backbone. These leucine zippers have 
been found in many eukaryotic proteins. 
1.4.2.5 Other DNA and protein-binding domains 
There are several DNA-binding motifs, too many to discuss all in detail. Some 
others include the Glutamine-rich activation motif, first found in Sp 1. Sp 1 contains 
two of these domains (Courey and Tjian, 1988) and the Proline-rich region (Mermod 
et aI., 1989). Deletion of a glutamine rich domain in CREB indicated its presence 
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was critical for stable binding of CREB to chromatin, although not strictly related to 
glutamine content, which has been shown before (Gill et aI., 1994; Mayr et aI., 
2005). A proline-rich domain in human p53, alterations of which are found in tumor 
cells, has been shown to be involved in its binding to other proteins (Golubovskaya 
et aI., 2008). It has been reported that both proline-rich and glutamine-rich activation 
domains function at multiple steps of preinitiation complex assembly, although 
exactly how this is achieved is still to be defined (Choy and Green, 1993; Gill et aI., 
1994; Mayr et aI., 2005). 
1.4.3 Other factors involved in regulation 
1.4.3.1 Chromatin remodelling 
Transcriptionally active chromatin is structurally distinct from inactive chromatin. In 
eukaryotes 10% of chromatin is highly condensed and transcriptionally inactive, this 
is referred to as heterochromatin. The less condensed chromatin making up the rest, 
is referred to as euchromatin. Genes located in the heterochromatin are strongly 
repressed, it is thought that chromatin is prepared for transcription by being "opened 
up" so that regulatory proteins and the basal transcription machinery can access the 
promoter site. Heterochromatin is far less accessible, experiments involving adding 
DNase I to heterochromatin and euchromatin found heterochromatin to be more 
resistant to digestion (Stalder et aI, 1980). For this reason heterochromatin is often 
referred to as "closed" and euchromatin "open". 
The acetylation and deacetylation of histones playa significant role in the processes 
that prepare chromatin for transcription. The amino-terminal domains of the core 
histones are generally rich in lysine residues and particular lysine residues are 
acetylated by histone acetyltransferases (HATs). Newly synthesised histones are 
acetylated before they are imported into the nucleus (Hassig and Schreiber, 1997). 
When chromatin is being activated for transcription, the nucleosomal histones are 
further acetylated (Hebbes et aI., 1988). This acetylation of multiple lysine residues 
in the amino-terminal domains of histones H3 and H4 may possibly reduce the 
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affinity of the entire nucleosome for DNA. When transcription of a gene is finished 
the histones are deacetylased by deacetylaes, helping to restore chromatin to a 
transcriptionally inactive state (Hassig and Schreiber, 1997). 
Some protein complexes are also involved in chromatin remodelling such as 
SWIISNF which can create nuclease hypersensitive sites in the chromatin, 
presumably stimulating the binding of transcription factors (Peterson and Workman, 
2000). SWIISNF is not required for the transcription of all genes and another 
complex involved in remodelling chromatin has been found that complements and 
overlaps SWIISNF activity, called NURF (Hamiche et aI., 1999; Peterson and 
Workman, 2000). 
1.4.3.2 Co-activators 
Co-activators act indirectly, they do not bind to the DNA and are involved in 
interactions between the sequence specific transcription factors and the complex 
composed of Pol II and the general transcription factors (initiation complex). There 
are also repressor proteins that can inhibit contacts between RNA Pol II and 
sequence specific transcription factors, resulting in repression of transcription. 
Examples of this are histone acetlytransferases (HATs) and histone 
deacetlytransferases complexes (HDACs), that influence transcription by modifying 
the acetlylation state of the chromatin (Clayton et aI., 1993). 
1.4.4 Promoters 
1.4.4.1 Core promoter 
The core promoter includes DNA elements that can extend around 35 bp upstream 
or downstream of the transcription initiation site. Most core promoter elements 
appear to interact directly with components of the basal transcription machinery. 
Core promoters have been found to possess considerable structural and functional 
diversity (Butler and Kadonaga, 2002). The TAT A box was the first core promoter 
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element identified in eukaryotic protein-coding genes. In eukaryotes the TAT A box 
sequence TAT AAA is found around -25 to -30 bp from the start of transcription. It 
was thought that the T A TA box was critical for transcription initiation and present in 
all promoters of transcribed genes, however this is now known to be incorrect as not 
all promoters contain a TAT A box. In human genes TAT A boxes have only been 
found in 32% of potential core promoters (Suzuki et aI., 2001). This shows there 
must be other regulatory sequences in this core promoter region involved in 
recruitment of the initiation complex and activation of transcription. The TAT A box 
recruits the T ATA-binding protein (TBP) (Buratowski et aI., 1988), which in tum 
recruits the initiation complex. Other closely related factors that can bind the TAT A 
box have also been identified in several species, TBP-related factor (TRF) or TBP-
like factor (TLF) (Berk, 2000). 
Most protein-coding genes contain an adenosine at the transcription start site (+ 1), a 
cytosine at the -1 position, with pyrimidines surrounding these two nucleotides 
(Corden et aI., 1980), this is defined as the initiator element (Inr). The initiator 
element (Inr) is defined as a core promoter element that is functionally similar to the 
TAT A box, but can function independently of a TAT A box (Smale and Kadonaga, 
2003; Smale, 1989). The Inr sequence lies between -3 to +5 and when mutated 
transcription is greatly reduced, showing this region is necessary and sufficient for 
accurate transcription (Smade 1989, Javahery, 1994). The Inr sequence in general is 
recognised by TFIIO (Smale, 1997). 
The downstream promoter element (OPE) is a downstream core promoter motif, it is 
required for the binding of purified TFIID to a subset of TAT A-less promoters 
(Kadonaga et aI, 2002). It is highly conserved between species and is typically found 
in TATA-Iess promoters (Kutach and Kadonaga, 2000). The core sequence, 
AGACG can vary; the first nucleotide can also be G, the AC can be substituted for 
TT and the final nucleotide can be A or C. This sequence is located at +28 to +32 
from the start of transcription (Kutach and Kadonaga, 2000). Typical OPE-
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dependent promoters contain an Inr and a DPE and mutation of either results in the 
loss of transcriptional activity (Burke and Kadonaga, 1996). 
The TFIIB recognition element (BRE) is recognised by TFIIB. This region is found 
just upstream of the T A TA box (Reiter et al., 1990). The sequence is GGG or 
CCAlCGCC, and is located around -3 to -6 from the TAT A box. In the C-terminus 
of TFIIB there is a helix-turn-helix motif which was found to be involved in the 
recognition of the BRE element (Nikolov et al., 1995). There are many other core 
promoter elements not discussed and likely to be many more yet to be discovered. 
The diverse range of core promoter elements and their presence in different 
promoters is likely to aid in regulation. 
1.4.4.2 Proximal control elements 
The core promoter alone is only capable of supporting a basal level of transcription. 
There are other sequences upstream of the core promoter that are involved in 
enhancing transcriptional levels, these include the CAA T box, the consensus 
sequence in eukarcoytes is GCCCAA TCT, and the GC box, consensus sequence 
GGGCCc. These elements can be located next to the core promoter or far upstream 
from the core promoter. Elements close to the core promoter, -100 to -200 bp from 
start of transcription, are often referred to as proximal control elements. Elements 
located further away either upstream, or even within the gene itself, are referred to as 
enhancers or silencers (see below). First a few examples of proximal control 
elements will be discussed. 
CAA T box transcription factors (CTF) can bind to CAA T box sequences to activate 
or enhance transcription, they are abundant and found in many genes of different 
species (Prinzen et al., 2005). Another proximal control element is the GC box 
which is bound by Sp 1 to enhance expression, it is also found in many genes (Swick 
et aI., 1989). The octamer control element is another sequence found close to the 
start of transcription in several genes, its consensus sequence is, A TTTGCA T and it 
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is bound by Oct proteins (Scholer et aI., 1989). A CpG island is a CG-rich region 
around 20-50 base pairs long within 100 base pairs of the start of transcription. The 
presence of a high level of CG is unusual and this in conjunction with its location 
suggests that it may be a transcription-initiation region. Many genes that are 
transcribed at low rates, such as housekeeping genes do not contain a T A TA-box, 
but do contain these CpG islands. Methylation of these islands has been shown to 
lead to transcriptional repression from downstream genes (Gardiner-Garden and 
Frommer, 1987). 
1.4.4.3 Enhancers and Silencers 
Enhancers are cis-acting DNA sequences that can elevate transcription levels 
independent of its orientation or distance from the transcription start site 
(Blackwood and Kadonaga, 1998). Many promoter regions have been found to 
contain multiple enhancer regions that can vary in size from 50 bp to 1.5 kbp, and 
each enhancer region appears to be designed to perform a specific function, such as 
activation of its associated gene in either a specific cell type or at a particular stage 
in development (Blackwood and Kadonaga, 1998; Zhongan et aI, 2007). These 
enhancer regions therefore are likely to control spatial and temporal regulation of the 
gene and evidence for this has been shown. Silencers on the other hand are very 
similar to enhancers apart from inhibiting transcription and not activating it. For 
example a functional silencer element in the human synapsin I gene that selectively 
represses its transcription in non-neuronal cells has been identified (Li et a1., 1993). 
1.4.5 Transcription factor families and their mechanisms of regulation 
1.4.5.1 Nuclear receptors 
Retinoic acid plays an important role in development and its receptors belong to a 
superfamily of transcription factors, the nuclear receptors. Intracellular receptors for 
most soluble hormones are nuclear receptors, that make up the nuclear-receptor 
superfamily. These transcription factors function as transcription activators when 
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bound to their ligand. All nuclear receptors have a unique N-terminal region of 
variable length (100-500 amino acids). Parts of this variable region can function as 
activation domains in some nuclear receptors. The DNA-binding domain is highly 
conserved, located in the centre region of the protein and has two C4 zinc-finger 
motifs. There is a hormone-binding domain, located near the C-terminal end 
containing a hormone dependent activation domain. This region in some nuclear 
receptors acts as a repression domain when not bound to a ligand. There are different 
DNA response elements for different nuclear receptors, however these nuclear-
receptor response elements always contain inverted or direct repeats. Examples of 
direct repeats are such as for glucocorticoid and estrogen receptors, while indirect 
repeats are exemplified by 03, thyroid hormone and retinoic acid (RA). Both can 
bind several nuclear receptors (NRs). NRs involved in binding to inverted repeats 
bind as homodimers, have an inverted orientation and x-ray crystallography has 
shown them to bind symmetrically. Those NRs involved in binding to direct repeats 
do so as heterodimers with a common NR monomer RXR. For example the retinoic 
acid response element is bound by RXR-RAR (de The et aI., 1990). 
Heterodimeric and homodimeric NRs are regulated differently by the ligands that 
bind to them. Heterodimeric NRs are located in the nucleus. When they are not 
bound to their hormone ligand, these NRs such as RXR-RAR are bound to their 
target DNA element repressing transcription by directing histone deacetylation to 
nearby nucleosomes. When bound to the ligand the heterodimeric nuclear receptors 
containing RXR can now direct hyperacetylation of histones of nearby nucleosomes, 
allowing the recruitment of coactivators and initiation factors leading to transcription 
of the gene (Dilworth et aI., 2000). One example of this is RXR-RAR and its 
retinotic acid (RA) ligand, when RA ligand is bound to the RXR-RAR complex at 
its DNA response element the RXR-RAR co-repressor SMRT is released leading to 
the activation of transcription (de The et aI., 1990). 
Homodimeric receptors are found in the cytoplasm in the absence of their ligands 
and when bound by the hormone ligands they translocate to the nucleus. They are 
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often held to the cytoplasm by inhibitor proteins and when hormone ligand binds 
this inhibitor is released allowing the NR to trans locate to the nucleus and activate 
transcription. A good example of this is the homodimeric glucocorticoid receptor 
(GR). It was shown in transfection experiments that when GR is not bound to its 
target ligand it is anchored in the cytoplasm as a large protein aggregate complexed 
with inhibitor proteins. When the hormone ligand binds to the NR, the inhibitor 
proteins are released and GR can translocate to the nucleus and bind to its response 
element and then interact with chromatin-remodeling and histone acetyltransferase 
complexes (Chalepakis et al., 1990). 
1.4.5.2 NFKb 
NFKb is thought to be the main transcriptional regulator of the immune system in 
mammals. In response to infection, inflammation and other stressful situations in 
mammalian immune-system cells NFKb is rapidly activated. There have been several 
studies into the operation of the NFKb signalling pathway and they have revealed its 
detailed mechanism. Two heterodimeric subunits of NFKb (p65 and p50) have a 
region of homology in their N-terminus that allows them to dimerize and bind to 
DNA. When a cell is not in a stressed state NFKb is kept inactive in the cytosol by 
direct binding of an inhibitor molecule called I-KB (Baeuerle and Baltimore, 1988). 
A single I-KB molecule binds the N-terminus of both NFKb dimer subunits masking 
the nuclear localisation signals (Beg et al., 1992). When the cell is stressed, e.g by 
ionizing radiation, I-KB kinase is activated and phosphorylates two N-terminal serine 
residues on I-KB. An E3 ubiquition ligase can then bind to these phospho-serines, 
polyubiquitinating I-KB, marking it for degradation by a proteasome. If these serines 
are mutated to alanines, thus can not be phosphorylated, NFKb is permanently 
repressed showing phosphorylation is essential for pathway activation (Ghosh and 
Baltimore, 1990). Once I-KB is degradated the nuclear localisation signals on NFKb 
are exposed and NFKb translocates to the nucleus and activates transcription of 
several genes. NFKb signalling is controlled by a negative feedback loop. NFKb 
activates transcription of the gene encoding I-KB, which results in increased levels of 
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I-KB, which bind active NFKb in the nucleus and translocate it back to the cytoplasm 
(Beg et al., 1992). 
1.4.5.3 Smads and their interactions 
Bone morphogenetic protein 4 (bmp4) shown to be involved in haematopoiesis 
(Sadlon et al., 2004) is a member of a large superfamily, the transforming growth 
factor {3 (TGF{3) superfamily. The TGF{3 molecules activate the transcription factor 
family called Smads. There are three types of Smad proteins, receptor-regulated 
Smads (R-Smads), co-Smads and inhibitory or antagonistic Smads (I-Smads). R-
smads contain two domains, the N-terminal domain contains the DNA-binding 
segment and the nuclear localization signal (NLS). When inactive the regions 
involved in activation are hidden by the two domains associating with each other. 
When bmp4 binds its receptor, R-Smads become phosphorylated separating the 
domains and the NLS becomes bound by Importin {3 (Imp-{3). The R-Smads 
simultaneously form a complex with co-Smads in the cytosol. The bound Imp-{3 then 
mediates translocation of the heteromeric R-Smadlco-Smad complex into the 
nucleus. The R-Smads can then associate with other transcription factors to activate 
or repress transcription of target genes. The R-Smads are then dephosphorylated, 
which results in the dissociation of the R-Smadlco-Smad complex. The Smads are 
then exported out of the nucleus to the cytoplasm, where they can be phosphorylated 
again (Heldin et al., 1997). 
1.4.5.4 MRFs/MEF 
The four myogenic proteins (MyoD, Myf5, myogenin and MRF4) are members of 
the basic helix-loop-helix (bHLH) family of transcription factors. These four 
myogenic bHLH proteins are referred to as muscle regulatory factors (MRFs). In the 
centre of these proteins is the DNA-binding basic region adjacent to the HLH 
domain, which is involved in dimer formation. Flanking this central DNA-
binding/dimerisation region are two activation domains. These proteins can form 
homo or heterodimers that bind to a recognition site of six base pairs. This 
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recognition site has a consensus sequence CANNTG, called the E box and is 
abundant within the genome. For this reason there must be control mechanisms to 
ensure that MRFs specifically regulate muscle-specific genes only. A clue in how 
this is accomplished was discovered by studying the binding affinity of MyoD, when 
MyoD is a heterodimer with E2A its DNA-binding affinity is ten times higher than 
when it is complexed as a homodimer (Murre et aI., 1989). The DNA-binding 
domains of MyoD and E2A are similar and both recognise E box sequences. More 
evidence for E2A playing a role in targeting MyoD to the correct E box, was from 
an experiment using azacytidine-treated C3H 10TY' cells; MyoD was found 
complexed with E2A and both were required for myogenesis. Other MRFs have also 
been shown to form heterodimers with E2A and these heterodimers have similar 
properties to the MyoD-E2A heterodimer, suggesting this heterodimerisation is 
involved in regulation of all MRFs and restricts activity of MRFs to genes with 
closely linked E boxes. 
This mechanism can not function alone to control myogenic regulation, since E2A is 
expressed in many tissues. Further studies have shown that this heterodimer 
complex, MyoD-E2A, can bind specifically to another family of DNA-binding 
proteins called myocyte enhancing factors (MEFs) .. MEFs have been shown to 
enhance the ability of MRFs to induce myogenic conversion of azacytidine-treated 
C3H 10TY' cells, although MEFs alone can not induce it (Molkentin et ai, 1995). 
MEFs need to complex with the heterodimer MyoD-E2A to facilitate the 
enhancement of myogenesis and this synergistic action is thought to drive high-level 
expression of muscle-specific genes. The MEFs belong to the MADS family of 
transcription factors and contain a MEF domain next to the MADS domain, which 
mediates interaction with myogenin (Perry et ai, 2001). 
1.4.6 The GAT A family of transcription factors 
The vertebrate GATA family consists of zinc finger transcnptlOn factors that 
recognise the core sequence (A/T)GATA(NG) (Laverriere et aI., 1994). So far six 
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GATA transcription factors have been found, these are GATAl, 2, 3, 4, 5 and 6. The 
GAT A family has two subclasses and are separated according to their sequence 
homology, expression domains and the genes they target. The first group contains 
GAT A 1, 2 and 3 and these are expressed in the ventral mesoderm and neural 
ectoderm and are involved in neural, facio-cranial, urogential and haematopoietic 
development (Pevny et aI., 1991; Tsai et aI., 1994; Walmsley et aI., 1994; Weiss et 
aI., 1994). GATA4, 5 and 6 are expressed in the endoderm and mesoderm and are 
involved in the formation of cardiac and gut tissues (Gove et aI., 1997; Laverriere et 
aI., 1994; Patient and McGhee, 2002; Yamamoto et aI., 1990). The minimal 
promoters for GA TA genes typically contain either conserved CCAA T boxes 
(MacNeill et aI., 1997; Nony et aI., 1998) or CACCC sites (Tsai et aI., 1991). 
GAT A4, 5 and 6 are expressed in overlapping patterns and share domain structure 
and most of their biochemical activities, including DNA binding site preference, 
raising a possibility of redundant function in vivo (Molkentin et aI, 2000). Murine 
gata4 initially plays an essential role in endodermal development and indirectly in 
early heart morphogenesis (Nony et aI., 1998). In Xenopus, gata4 is important for 
development of heart and liver primordia following their specification, and in this 
role it might interact with gata6 (Haworth et aI, 2008). In zebrafish gata5 mutants 
were found to affect heart and endoderm development (Reiter et aI., 1999) but does 
not have these effects in mice, suggesting a role for gata5 in mammals may not be 
conserved with other vertebrates (Molkentin et aI, 2000). In Xenopus embryos gata5 
is essential for early development of heart and liver precursors. It acts earlier than 
gata4, indicating that one early direct target of gata5 is the homeobox gene hex 
(Haworth, 2008). In mouse, zebrafish and Xenopus, gata6 has been shown to have 
roles in the developing liver and heart (Peterkin et aI, 2003). 
Gatal is perhaps the best characterised of the GATA family. The gatal gene 
displays the most restricted expression pattern of any of the six vertebrate GAT A 
genes (Yamamoto et aI., 1997). In mammals the gata 1 gene has two promoter 
regions, one (IE for erythroid) directs expression in erythroid cells, megakarocytes, 
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mast cells and eosinophils, whereas the other promoter, more upstream, (IT for 
testis) directs expression in sertoli cells of the testis (Yomogida et aI., 1994). 
Xenopus gatal expression during development is localised to the ventral region of 
the embryo (Kelley et aI., 1994). It is critical for haematopoiesis and has been shown 
to have a repressive effect on gata2 (Grass et aI., 2003). 
The Murine gata2 transcripton factor has been shown to be involved in 
haematopoiesis, the development of erythocytes (Tsai and Orkin, 1997), 10 
urogenital development (Zhou et aI., 1998b), pituitary cell fate assignments (Dasen 
et aI., 1999) and the generation of a specific class of (V2 interneuronal) cells in the 
spinal cord (Zhou et aI., 2000). The gata2 gene haematopoietic precursor enhancer 
region has been shown to be the target for gata 1 mediated repression of the 
endogenous gata2 gene in an erythroblast cell line induced to differentiate in 
response to gatal (Grass et aI., 2003). A study using cell culture revealed that gata2 
is a direct target of bmp4 and that enforced gata2 expression up-regulated bmp4, 
Flkl and scl (Lugus et aI., 2007). Recently gata2 expression has been shown to be 
up-regulated by fli 1, suggesting fli 1 must act upstream of gata2 in haematopoiesis 
development (Liu et aI., 2008). It has been shown that acetylation of gata2 is 
required for its function in primitive blood formation in vivo (Dalgin et aI., 2007). 
Under normal conditions, gata2 is acetylated by CBP and this enables it to regulate 
transcription of target genes, including those that are required for normal primitive 
haematopoiesis. When CaM Kl V is hyperactivated, it phosphorylates excessive 
amounts of a substrate which can then recruit limiting amounts of CBP away from 
gata2. Under these conditions, gata2 is hypoacetylated and can no longer activate 
transcription of target genes (Dalgin et aI., 2007). The gata3 gene is expressed in a 
diverse set of tissues in mouse embryos, most prominently in the placenta, branchial 
arches, central and peripheral nervous system, adrenal gland and thymus (George et 
aI., 1994). 
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1.4.7 Regulation of the GA TA2 promoter 
Like most other GATA genes, mammalian and chicken GATA2 genes are expressed 
from two alternative promoters (Minegishi et aI., 1998; Nony et aI., 1998; Pan et aI., 
2000). The IS (selective) promoter is used in haematopoietic precursor cells whereas 
the downstream IG (general) promoter is used for all tissues in which gata2 is 
expressed (Minegishi et aI., 1998). The latter promoter is conserved in chicken and 
Xenopus (Nony et aI., 1998). 
The Xenopus gala2 promoter is remarkable in that it alone is sufficient for 
expression in oocytes and embryos (Brewer et aI., 1995). Deletion mapping of the 
gala2 promoter showed that a 66 bp promoter fragment, -66 to -31, was sufficient to 
direct expression in early stage embryos. A resident inverted CCAA T site was 
required for expression, even when assayed in the context of a 1.65 kb fragment. 
This large promoter fragment was inactivated by a single mutation within the 
CCAA T box region (Brewer et al., 1995). The factor, CBTF, that binds this CCAA T 
site moves from the cytoplasm to the nucleus just prior to the onset of gala2 gene 
expression in a restricted, but broad, region of the embryo (Brewer et al., 1995; 
Orford et al., 1998). CCAAT sites are conserved in the promoter regions of many 
gata2 genes (Orford et aI., 1998). The gata2 inverted CCAAT box and surrounding 
bases have been shown to be conserved in humans (Fleenor et al., 1996), mice 
(Minegishi et al., 1998) and chickens (Nony et aI., 1998). Interestingly deletion 
mapping of the chicken gala2 promoter led to similar results as the Xenopus deletion 
(Nony et aI., 1998). This shows that the sequences flanking the inverted CCAA T 
box and surrounding critical bases are essentially functionally conserved between 
species as well. 
In zebrafish regions at approximately 3,500 bp upstream of the gene have been 
shown to be involved in spatial regulation of gala2 expression (Meng et aI., 1997). 
The authors also showed that three distinct tissue-specific enhancer elements act 
independently to enhance gene expression in blood precursors or the CNS. The 
gala2 promoter in fugu, mice, rat and human genomes has been shown to have 
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several conserved regions, three enhancers, two upstream and one downstream from 
the core gata2 promoter (Zhongan et aI, 2007). The two upstream elements are up 1 
and up2. Up2 has been shown to be required for haematopoietic regulation of gata2 
shown using trans genetic zebrafish (Zhongan et aI, 2007), although this element has 
not been shown to be present in Xenopus yet. 
Bmp4 signalling has been implicated in activating expression of gala2, an important 
regulator of multi potent haematopoietic precursor cells. Studies, using Xenopus 
animal caps, showed injection of bmp4 mRNA directly activated gata2 gene 
transcription (Maeno et aI., 1996). The identification of a bmp4 response element in 
the 5' promoter region of zebrafish gala2 that binds Smad 1 and Oct-l provides 
further evidence for bmp4 mediated activation of gala2 (Oren et aI., 2005). A study 
using cell culture revealed that gala2 is a direct target of bmp4 and that enforced 
gata2 expression up-regulated bmp4, flkl and sci (Lugus et aI., 2007). Bmps are 
required to signal to ectodermal cells to generate secondary non-ceIl-autonomous 
signals necessary for primitive erythropoiesis, and that calmodulin-dependent 
protein kinase IV (CaM KIV) antagonises bmp signalling (Walters et aI., 2002). 
Recently it has been shown that gata2 functions downstream of bmp in the same 
cells, and is a direct target for antagonism by CaM KIV (Dalgin et aI., 2007). 
1.4.8 CBTF 
An inverted CCAA T box was identified at the gata2 promoter and was shown to be 
critical for transcription of the gata2 gene (Brewer et aI., 1995). A maternally 
derived CCAA T factor was isolated on its ability to recognise this CCAA T sequence 
and direct correct transcriptional initiation in oocytes and appropriate activation of 
expression in early embryos (Brewer et aI., 1995). This factor, CBTF, is a multi 
subunit complex and was first described in unfertilised eggs and early Xenopus 
embryos and has been shown to be required for transcriptional activation shortly 
after the MBT of the human HSP70 gene, when injected into embryos (Ovsenek et 
aI., 1991). The inverted CCAAT box within the gala2 promoter shares a 10/10 bp 
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homology with the inverted CCAA T box located within HSP70 promoter (Brewer et 
al., 1995). Another promoter has been described to be regulated in a similar way; 
myoD contains an inverted CCAA T box and also shares a 10/10 bp homology with 
the gala2 CCAA T box and competes successfully for binding of CBTF in 
competition EMSAs (Leibham et al., 1994). This suggests that CBTF may also be 
involved in the regulation of other genes (Brewer et al., 1995). CBTF is found in the 
cytoplasm and translocates to the nucleus at the onset of the MBT, when zygotic 
gala2 transcription is initiated (Brewer et al., 1995). This is due to a critical subunit 
of the CBTF complex, ilo, which anchors the protein in the cytoplasm by binding to 
RNA (Orford et al., 1998; Scarlett et al., 2004). This subunit and its interactions are 
discussed below. 
1.4.9 CBTF subunit iln 
In Xenopus a subunit of CBTF is ilo which has been shown to be critical in the 
activation of gala2 (Orford et al., 1998; Scarlett et al., 2004). Originally the human 
orthologue of ilo, interleukin enhancer binding factor 3 (ILF3), was identified as a 
component of a dimeric transcription factor that bound to the interleukin 2 (lL2) 
enhancer and regulated transcription of the gene in vivo (Corthesy and Kao, 1994; 
Kao et al., 1994). ILF3 has been shown to have a number of different roles within 
different species in transcriptional (Orford et al., 1998; Reichman et al., 2002; 
Reichman and Mathews, 2003; Scarlett et al., 2004) and post transcriptional (Xu and 
Grabowski, 1999) regulation. It is possible that these diverse functions, with ILF3 at 
least, are due to alternative splicing of the ILF3 locus resulting in protein diversity 
(Duchange et al., 2000). ILF3 has two dsRNA binding domains (dsRBDs), a nuclear 
localisation signal, and two regions that may be involved in nucleic acid binding at 
its C-terminus, an ROO motif and a OQSY domain are all conserved between 
Xenopus and human ilf3 (Orford et al., 1998). The RGG domain is found in several 
RNA-binding proteins where it binds avidly to single-stranded nucleic acids (Darnell 
et aI, 2001). The OQSY region is an RNA-binding module and a similar domain in 
RHA has a strong preference for binding to ssRNAs (Zhang and Grosse, 1997). 
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IlO is anchored in the cytoplasm until the mid blastula transition (MBT) when it is 
translocated to the nucleus and can activate gata2 transcription (Orford et al., 1998). 
IlO is a phosphoprotein, and mimicking phosphorylation of specific residues can 
affect its nuclear translocation, suggesting that phosphorylation is involved in its 
nuclear translocation (Cazanove, 2006; Elgar, 2001). It has been shown that 
mutations inhibiting RNA binding by the dsRBDs of ilO or injection of RNase into 
the embryo cause ilO to become nuclear before the MBT, suggesting that RNA 
binding anchors ilO in the cytoplasm before the onset of the MBT (Brzostowski et 
al., 2000). At the MBT zygotic transcription begins and there is mass degradation of 
maternal RNA transcripts, it is quite likely that this releases the previously bound 
ilO to translocate to the nucleus. 
Like several RNA binding proteins ILF3 is also methylated (Araya et aI, 2005; Li et 
al., 2002; Tang et al., 2000). The known methyltransferase PRMTI has been shown 
to be associated with ILF3, anti-ILF3 pulled down PRMTI activity and a PRMT1-
GST fusion protein also bound ILF3 (Tang et a1., 2000). PRMTI methyltransferase 
activity has also been shown to be regulated by a number of PRMT 1 binding 
proteins, including ILF3 in a feedback loop (Tang et al., 2000). This has been shown 
to be conserved in Xenopus where prmtIb methylates iIO in vitro (Cazanove et a1., 
2008). The dsRBDs of iIO have been shown to bind to DNA, especially when DNA 
is in an A-form helix structure (Scarlett et al., 2004). Methylation inhibits the DNA 
binding ability of iIO, but not its RNA binding ability, although changing degree of 
methylation does not alter the subcellular localisation of ilO (Cazanove et aI, 2008). 
This is unlike other methylated RNA binding proteins such as Staufen (Ramos et al., 
2000). 
The dsRBDs of ilO have been shown to be critical for gata2 activation (Scarlett et 
al., 2004). When mutant forms of the protein with the dsRBDs inactivated were 
injected into Xenopus embryos no phenotype was observed whereas when embryos 
were injected with active ilOEN or ilOVP16 defects in dorsal-ventral patterning 
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were observed, indicative of reduced gata2 (G. Scarlett personal communication) 
and mRNA levels of gata2 were also shown to be greatly reduced (Scarlett et al., 
2004). It has been suggested that the dsRBDs of ilf3 can bind the gata2 promoter, 
which is partially A-form, to regulate transcription (Scarlett et al., 2004). Recently 
more evidence for this interaction has been found, methylation of ilf3 by prmtlb 
inhibits its ability to bind DNA but not RNA. When pnntl b is over-expressed the 
DNA-binding activity of CBTF and transcription from the gata2 promoter are 
decreased (Cazanove et al., 2008). This suggests that the DNA-binding activity of 
CBTF directly affects transcription from the gata2 promoter. 
1.5 Double stranded RNA binding domains (dsRBDs) 
Double stranded RNA binding domains (dsRBDs) are approximately 70 amino acids 
long and were first found in the Xenopus laevis RNA-binding protein A (XlrbpA) 
and the Drosophila maternal protein staufen. They have now been identified in a 
range of proteins from many organisms, from bacteria such as E.coli to humans (St. 
Johnston and Nusslein-Volhard, 1992). The only homology between these proteins 
is the presence of dsRBDs, although the sequence and structure of dsRBDs is 
conserved (Krovat and Jantsch, 1996). Proteins can contain several dsRBDs, 
although some do only have one (Bernstein et al., 2001). The main activity of 
dsRBDs is to bind dsRNA, however they have been shown to be able to bind RNA-
DNA hybrids and DNA when these structures are in an A-form helix (Bass et al., 
1994; Scarlett et al., 2004; St. Johnston and Nusslein-Volhard, 1992). Surprisingly 
they have also exhibited a protein-protein interaction role (Doyle and Jantsch, 2002). 
However some dsRBDs seem incapable of binding dsRNA but are still critical for 
correct biological function (Krovat and Jantsch, 1996). DsRBDs are divided into two 
groups, type A and B, depending on their homology to the consensus sequence. 
Type A dsRBDs have strong homology though their entire length to the consensus 
sequence, whereas type B dsRBDs are highly conserved at their C-tennini but not at 
their N-termini. Type B dsRBDs tend to bind to dsRNA poorly or not at all, when 
compared to type A dsRBDs (Doyle and Jantsch, 2002). 
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The structure of several dsRBDs has been solved by NMR and x-ray crystalography, 
they revealed a common ex-{3-{3-{3-ex structure where the two ex-helices lie on the face 
of a three-stranded antiparallel (3 sheet (Bycroft et aI., 1995; Ryter and Schultz, 
1998))figure 1~ In 1998 the 1.9A resolution crystal structure for the second 
dsRBD of XlrpbA complexed to dsRNA was solved (Ryter and Schultz, 1998). A 
self-complementary 10-mer RNA that formed several double stranded helices was 
used as the ligand. The structure revealed that the dsRBD made contacts with the 
sugar-phosphate backbone with no direct contacts to the bases, suggesting the 
dsRBDs do not recognise their binding site via sequence specificity (Ryter and 
Schultz, 1998). However, most dsRBDs investigated have been shown to be 
sequence specific and only bind certain dsRNA in vivo. One example of this is the 
RNA-editing deaminases ADARI and ADAR2 which both recognise the glutamate 
receptor B subunit (GluRB) but they deaminate different adenosines within it (Bass, 
1997; Keegan et aI, 2001). However structural studies are revealing it is most likely 
that dsRBDs target RNA by recognition of the RNA's secondary and tertiary 
structure (Ramos et aI., 2000; Ryter and Schultz, 1998). The Ramos study showed 
the third dsRBD of Drosophila Staufen complexed with an RNA stem loop 
containing' an optimal Staufen-binding site reflecting the 3 'UTR of the bicoid RNA. 
The dsRBD made contacts with the sugar-phosphate backbone, the same as Ryter 
and Schultz observed, however there were additional contacts within the tetraloop 
made by the first ex-helix (Ramos et aI., 2000). Sequences within tetraloops are 
constrained with only a few of the 256 possible sequence combinations occurring 
naturally and have been suggested as a mode by which dsRBDs could specifically 
discriminate between individual RNAs (Doyle and Jantsch, 2002). 
When looking at the consensus sequence, residues critical for contacting the sugar-
phosphate backbone are highly conserved between dsRBDs (Ramos et aI., 2000) and 
some of these bases, mainly lysine and glutamine residues, have been shown to be 
critical for dsRNA binding (Bycroft et aI., 1995). Other key residues may be critical 
for sequence specific recognition, for example the residues in the first ex-helix of 
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staufen's third dsRBD (which are important for tetraloop interaction) are highly 
conserved between different species. When comparing this dsRBD to other dsRBDs 
within staufen, or dsRBDs of other proteins the homology is greatly reduced, this 
suggests that individual dsRBDs within a protein may be capable of specifically 
recognising particular RNAs (Ramos et aI., 2000). 
So far all the high-resolution structures of dsRBDs complexed with dsRNA have 
been of one dsRBD and only a low-resolution for multi-dsRBD containing protein is 
available (Nanduri et aI., 1998). This meanS that how dsRBDs interact with dsRNA 
in the context of each other and the importance of multiple dsRBDs is still relatively 
unclear. A study On staufen looked at the importance of multiple dsRBDs, staufen 
contains five dsRBDs and is involved in several biological processes, such as the 
localisation of oskar mRNA to the posterior of the oocyte and in regulating the 
expression of oskar. It was found that dsRBD2 was responsible for localisation of 
oskar, whereas dsRBD5 was needed for translational control of oskar. dsRBD5 has 
also been shown to be responsible for actin-dependent localisation of prospero 
mRNA. Oddly these two dsRBDs of staufen can not bind dsRNA in vitro, 
suggesting a non RNA binding role for dsRBDs (Micklem et aI., 2000; Schuldt et 
aI., 1998). DsRBDs have functions other than just binding to RNA and One of these 
functions is acting as a nuclear localisation signal (NLS). It has been shown that the 
third dsRBD of the human RNA-editing enzyme ADARI acts as a NLS (Eckmann 
et aI., 2001). In the protein ilf3 it has been shown that the dsRBDs anchor the protein 
in the cytoplasm by binding to RNA transcripts until the start of the MBT 
(Brzostowski et aI., 2000). 
The dsRBDs of ilf3 have also recently been shown to be able to bind DNA, 
specifically when it is in an A-form helix. It was also shown that the dsRBDs of ilf3 
were critical for activation of the gala2 promoter (Scarlett et aI., 2004). It was 
hypothesised that due to the partial A-form structure of the critical region of the 
gata2 promoter the dsRBDs could bind directly to the promoter and initiate 
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Figure 1.3 NMR Structure of a double stranded RNA-binding domain 
(dsRBD). The NMR solution structure of a Spennatid Perinuclear Rna-Bind 
Protein found in humans is shown here to illustrate the structure of dsRBDs. 
(Kadirvel s et aI, unpublished, deposited 2006 to pubmed Accession number 
2dmy). DsRBDs generally contain approximately 65 amino acids and fonn a 
structure containing two a-helices and three ~-sheets in a confonnation of a-~­
~-~-a. Image displayed using PyMol (Delano, 2002). 
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transcription. This suggests another functional role that dsRBDs might possess and 
this interaction is investigated in this thesis (Scarlett et aI., 2004). 
1.6 DNA structure 
1.6.1 A-form 
A-form DNA has an A-form helix, as observed for dsRNA, it was first discovered 
by Franklin in 1953 (Franklin and Gosling, 1953). A-form DNA, like B-form DNA 
has a right handed helix. The A-form helix is wider and shorter than the B-form 
helix and the base pairs are tilted rather than perpendicular to the helix axis (Figure 
1.4). B and A-form DNA have different puckerings of their ribose units, in A-form 
DNA, C-3' lies out of plane (C-3' endo) and B-form DNA it is the C-2' that is 
puckered and this lies out of plane also (C-2' endo). This difference in puckering 
affects the helix structure and leads to many of the structural differences between A 
and B-form DNA. A-form C-3'-endo puckering leads to an II-degree tilting of the 
base pairs away from the B-form which is perpendicular towards the helix. A B-
form DNA molecule can be pushed to the A-fonn by dehydration, this may be due to 
the fact that phosphates and other groups of an A-form structure bind fewer water 
molecules. For each helix turn in A-form DNA there are II base pairs. The major 
groove is narrower and deeper than B-form and the minor groove is very broad and 
shallower when compared to B-form. Although A-form structure can be induced by 
dehydration, it can occur under physiological conditions (Basham et aI., 1995). This 
suggests that A-form DNA may be present in the genomes of organisms and CD 
analysis of the gala2 promoter sequence revealed it to be partially A-form in vitro 
(Scarlett et aI., 2004). This suggests that A-form DNA structure may have a role in 
biological functions and this is investigated in this thesis. 
1.6.2 B-form 
The first DNA structure to be discovered was B-form by Watson and Crick (Watson 
and Crick, 1953). The double helix is a right-handed spiral with the DNA bases 
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wound around each other keeping the bases inside and helix and the sugar-phosphate 
backbone on the outside. The helix creates two grooves in one whole tum, these are 
tenned the major groove, which is 22A wide and the minor groove which is 12A 
wide, both are quite deep (Wing et aI., 1980). There are 10 base pairs per tum of the 
helix. Transcription factors and other proteins that bind DNA, tend to bind though 
the more accessible major groove (Pabo and Sauer, 1984). Most DNA under nonnal 
biological conditions is B-fonn (Leslie et aI, 1980). However DNA can fonn other 
structures (Figure 1.5). 
1.6.3 Z-form 
Z-fonn DNA is different from Band A-fonn in that it has a left-handed helix. It was 
discovered by Andrew Wang, Alexander Rich and co-workers in 1979 (Wang et aI., 
1979). The phosphates in the backbone were seen to zigzag which lead to the name 
Z-fonn (Wang et a!., 1979). It has 12 base pairs per helix tum, has a flat major 
groove and a very narrow and deep minor groove (Figure 1.5). Z-fonn DNA does 
seem to have functions in cells and one of these is to reduce supercoiling while DNA 
transcription occurs (Herbert and Rich, 1999; Kim et aI., 2003), it has also been 
identified at a number of promoter elements by a bioinfonnatics approach (Champ et 
aI.,2004). 
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Figure 1.4 Alternative DNA structures. A and B-form DNA are both 
right-handed helices. A-form DNA has more base pairs per tum and a 
shallower major groove than B-form. Z-form DNA is different from A and 
B-form structures in that it is left handed and a shallower major groove 
than either A or B-form, it also has less base pairs per tum. This makes it 
more elongated than either A or B-form. (Taken from Lehninger Principles 
of Biochemistry, Fourth Edition 2004). 
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1.7 Aims 
The objective of this thesis was to investigate a proposed interaction involving the 
two dsRBDs of ilD binding to a partially A-fonn critical region of the gala2 
promoter and hence activating transcription. First the importance of an A-fonn 
element at the gala2 promoter was investigated followed by a study of the relative 
contribution of the A-fonn element and an inverted CCAAT box to transcriptional 
and CBTF binding. These interactions were analysed using EMSA, to assess 
binding. Then luciferase assays were conducted with the wild-type and mutant gala2 
promoters. First temporal expression of this region with the wild-type promoter was 
investigated, to see if it was similar to endogenous gala2. Secondly the relative 
transcriptional activation of mutant promoters compared to the wild-type was 
assayed. After these investigations the region of the gala2 promoter used in the 
luciferase assays was assayed for its spatial activity and whether it was similar to 
that of endogenous gata2. Lastly, we tested the hypothesis that the dsRBDs would 
bind to DNA the same way they bind to dsRNA, i.e using the same residues. To 
investigate this some of the critical residues involved in RNA binding were mutated 
to test if they would also affect DNA binding. 
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Chapter 2: Materials and methods 
2.1 Nucleic acid methods 
2.1.1 Small scale preparation of plasmid DNA (mini-prep) 
5 ml of Luria broth (L-broth) containing ampicillin (50 J..lg/ml) was inoculated with a 
single colony of bacteria that contained the plasmid to be purified and the culture 
grown at 37 °e for 16 hours with shaking. 1 ml of saturated culture was taken and 
placed in a microcentrifuge tube and the cells centrifuged for 10 minutes at 4 °e, 
800 g. The supernatant was discarded and the cell pellet was resuspended in 100 J..lI 
of ice cold solution I (appendix I). 200 J..lI of freshly made solution II (appendix I) 
was added and the sample was mixed by repeated inversion. The sample was left at 
room temperature for 5 minutes to allow cell lysis before adding 150 J..lI of ice cold 
solution III (appendix I) and mixed by repeated inversion. The cells were then left 
on ice for 30 minutes, after which they were centrifuged for 10 minutes at full speed 
in a microfuge (16,000 g). The supernatant was then transferred to a fresh 
microcentrifuge tube, and 10 1-11 of NEB buffer 2 (appendix I) and 3 J..ll of a 10 mg/ml 
RNAse A stock added. The samples were then left at 37 °e for 2 hours to allow the 
RNA to be digested. The sample was further purified by phenol/chloroform 
extraction (see 2.1.4). Following phenol/chloroform extraction 1 ml of absolute 
ethanol and 40 J..ll of 3 M sodium acetate were added prior to centrifugation to 
precipitate the DNA because of the high volume of the solution. The supernatant 
was removed from the pellet and 500 J..ll of 70 % ethanol was added as a wash. The 
sample was then centrifuged for 5 minutes at full speed in a microfuge (16,000 g). 
The supernatant was removed and the DNA pellet was air dried before being 
resuspended in high purity H20 (Sigma). The plasmid DNA was assayed by 1 % 
agarose gel electrophoresis. 
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2.1.2 Purification of plasmid DNA using Qiagen midi and maxi kits 
Larger scale plasmid preparations to produce DNA of sufficient quality for injection 
and transcription were purified using the Qiagen midi (-100 J..lg) and maxi (-1 mg) 
purification kits according to the manufacturer's instructions. 5 ml of L-broth 
containing 50 J..lg/J..lI ampicillin was inoculated with a single colony of bacteria 
containing plasmid of interest and grown over night with shaking. 100 ml of fresh L-
broth containing 50 J..lg/J..lI ampicillin was inoculated with 100 J..lI of the saturated 
culture and again grown over night. The cells were then pelleted at 6000 g for 15 
minutes at 4 0c. The pellet was then resuspended in 4 ml of pre-chilled buffer PI 
(see manufacturer handbook). The cells were lysed by the addition of 4 ml buffer P2 
which was mixed thoroughly by repeated inversion. The cells were incubated at 
room temperature for 5 minutes and 4 ml of buffer P3 was added and mixed by 
repeated inversion before incubating on ice for 15 minutes. To remove cell debris 
the sample was centrifuged at 20,000 g for 30 minutes at 4 0c. The supernatant was 
removed and re-centrifuged at 20,000 g for 15 minutes at 4 °e. A QIAGEN-tip 100 
(midi) or QIAGEN-tip 500 (maxi) was equilibrated by applying 4 ml of buffer QBT, 
the column was allowed to empty by gravity flow. The supernatant containing 
plasmid of interest was applied to the column and again allowed to empty by gravity 
flow. The QIAGEN-tip was washed twice with 10 ml buffer QC. The plasmid was 
eluted with 5 ml buffer QF into a clean 30 ml vessel. The plasmid was then 
precipitated by adding 3.5 ml of 70 % room temperature isopropanol and mixed. The 
sample was centrifuged at 15,000 g for 30 minutes at 4 °e and the supernatant 
carefully decanted. The DNA pellet was washed with 2 ml of room temperature 70 
% ethanol and centrifuged at 15,000 g for 10 minutes. The supernatant again 
decanted and the pellet was air-dried for 5-10 minutes. The plasmid was finally re-
dissolved in 100 J..lI high purity H20 (Sigma) and assayed by agarose gel 
electrophoresis. 
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2.1.3 Restriction enzyme digest of DNA 
Restriction enzyme digests were used for cloning inserts into vectors and to screen 
for putative clones. A restriction digest was carried out by mixing the DNA that was 
to be digested with 0.5 ).11 of the appropriate restriction endonuclease (NEB), 1 X the 
appropriate restriction buffer (NEB) and where required 10 ).1g1).11 bovine serum 
albumin (BSA) solution (NEB). All restriction digests were made up to a final 
volume of 20 ).11 or 50 ).11 for easier handling. The mixture was then placed at the 
appropriate temperature for optimum activity of the restriction endonuclease being 
used for 1-2 hours. Conditions for all restriction endonucleases were as per the 
catalogue. Some restriction endonucleases digests were carried out simultaneously 
(see the NEB catalogue). 
2.1.4 DNA purification by phenol/chloroform extraction 
The sample was made up to 100 ).11 using high purity water (Sigma), to improve 
handling. An equal volume of equilibrated Phenol:Chloroform:lsoamyl alcohol at a 
ratio of (25 :24: 1) was added to the sample. The lid was firmly shut and the sample 
was vortexed for one minute. The sample was then centrifuged for three minutes at 
16,000 g. After the spin the top layer containing the DNA was carefully pipetted off 
and placed in a clean microcentrifuge tube. An equal volume of chloroform was 
added, the lid firmly shut and the sample vortexed for a further one minute. The 
sample was then centrifuged for three minutes at 16,000 g and the top layer carefully 
pipetted off and placed in a new tube. 
2.1.5 Ethanol precipitation of DNA 
In general 3 times the sample volume of absolute ethanol was added to the sample 
and 0.1 volumes of 3M sodium acetate. This was then placed at -20°C for 30 
minutes, after which the sample was centrifuged for 15 minutes at 16,000 g and 4 
0c. The supernatant was then carefully removed from the DNA pellet and replaced 
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with 500 III of 70 % ethanol. This was then centrifuged for 5 minutes at 16,000 g. 
The supernatant was then discarded; this was done carefully so as to not disturb the 
DNA pellet. The pellet was then dried for 1 minute under a lamp prior to 
resuspending the pellet in the required volume. 
2.1.6 Polymerase chain reaction (PCR) 
To perform a standard PCR amplification of DNA 1 X Thermopol buffer, provided 
as a 10 times stock (NEB) was mixed with 5 units Vent DNA polymerase 
(Promega), 10 mM dNTPs (Invitrogen), 100 ng template, 50 pmol (forward) primer, 
50 pmol (reverse) primer and made up to 50 J.lI using high purity H20 (Sigma). 
Samples were then placed in the thermocycler (Gstorm GRI). The template DNA 
was amplified using 30 cycles of: 
Melt: 95 DC, 30 secs. 
Anneal: 55-65 DC 30 secs. 
Extend: 72 DC, 60 secs/1 kb of template sequence. 
When using a new template-primer combination a range of annealing temperatures 
were tested to determine the optimal conditions to maximise product formation 
whilst minimising non-specific background products, this was done using the 
gradient block which allowed different annealing temperatures on the same PCR 
protocol. 
2.1. 7 PCR based site directed mutagenesis 
To perform site directed mutagenesis of a target site, four oligonucleotides were 
required. The first pair were 5' (forward) and 3' (reverse) of the mutation target site 
and contained restriction sites for subsequent sub-cloning. The second pair were 
complementary to the + and - strands at the target site for the mutation and included 
the specific base changes required for the mutation. First the upstream and 
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downstream sequences around the target site were amplified by performing PCR 
under standard conditions using the 5'(forward)/target site (- strand) and 
3'(reverse)/target site (+ strand) as primer pairs. The products of these reactions 
were gel purified (see 2.1.12) and the concentration estimated using small volume 
UV spectroscopy (Nanodrop). To join the two PCR products 100 ng of combined 
upstream and downstream product at equimolar concentrations was mixed with 2.5 
units of Taq DNA polymerase, 1 X Taq buffer, 2.5 mM dNTPs and high purity H20 
(Sigma) was used to make up to 50 Ill. This mixture was cycled ten times through: 
Melt: 95°C: 2.5 minutes 
Anneal: 62 °C: 45 minutes 
Extension: 72°C: 45 minutes. 
10 III of this Taq reaction containing the combined upstream and downstream 
sequence was then amplified by performing PCR under standard conditions using 
the 5' (forward) and 3' (reverse) primer pair. The PCR product was then assayed by 
agarose gel electrophoresis to confirm the PCR product was the right size. The PCR 
product was then purified using phenol/chloroform extraction (2.1.4) and ethanol 
precipitation (2.1.5), prior to digestion with the appropriate restriction endonucleases 
(2.1.3). The digested PCR product was then ligated into the plasmid of choice. 
Putative clones were sent for sequencing (MWG) to check for the presence of the 
specific base change and the absence of non-specific mutations that would affect the 
amino acid sequence. 
2.1.8 DNA Ligation 
To ligate DNA fragments insert and vector were added at a ratio of insert:vector 5: 1 
and no more than 1 Ilg total DNA was added. 1 X ligase buffer (NEB), 100 units T4 
DNA ligase (NEB) was added and the reaction was then made up to 15 III with high 
purity H20 (Sigma). The reaction was mixed and placed at 18°C overnight. 1 III of 
ligation mix was then used for subsequent transformations. No more than 100 ng 
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DNA should be transformed, as higher DNA concentration reduces transformation 
efficiency. 
2.1.9 Caesium chloride gradient DNA purification 
500 ml of L-broth was inoculated with 5 ml of saturated overnight cells containing 
the plasmid of interest and grown overnight. The cells were then centrifuged down at 
6000 g, at 4 °C for 15 minutes in two 250 ml bottles. The supernatant was removed 
and the pellets were resuspended in 40 ml solution I (appendix I). Then 80 ml of 
fresh solution II was added and mixed by repeated inversion. The samples were then 
left on ice for 5 minutes. After which 40 ml of cold solution III was added and 
sample was mixed by inversion and left on ice for a further 15 minutes. The cell 
debris was removed by centrifugation at 10,000 g for 5 minutes. The supernatant 
was poured though a funnel with plastic wool into a measuring cylinder. 0.6 
volumes of propan-2-01 was added and mixed well and the resulting solution was 
centrifuged at 10,000 g for 5 minutes. The pellet was drained and dried under a 
lamp. The pellet was then resuspended in 9 ml T.E., 9.2 g CsCI, 0.46 ml ethidium 
bromide (10 mg/ml stock), prior to prespin at 15,000 g for 10 minutes. The 
supernatant was then transferred into two Beckman tubes making sure there were no 
air bubbles present and were balanced. The samples were then centrifuged overnight 
at 54,000 rpm in a Beckman ultracentrifuge (50,000 g). The tubes were carefully 
removed the next morning and secured on a clamp stand. The top of the tube was 
gently pierced to let air in. A UV transmitter was used to visualise the plasmid band 
and it was extracted with a second needle into 1 ml syringe. The extracted solution 
containing the plasmid of interest was placed in a microcentrifuge tube and an equal 
volume of Isoamyl alcohol was added. The solution was mixed and allowed to settle. 
The top layer was removed and the extraction was repeated until no ethidium 
bromide was visible in the top layer. The caesium chloride was then removed by 
dialysis against 1 litre TE overnight. After ethanol precipitation the plasmid was 
assayed by agarose gel electrophoresis. 
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2.1.10 Obtaining oligonucleotides 
Synthetic oligonucleotides were supplied by Invitrogen, MWG or A TDbio. 
Oligonucleotides destined for electrophoretic mobility shift assay (EMSA) or 
circular dichroism (CD) were HPLC purified whereas oligonucleotides for PCR 
were supplied only desalted. 
2.1.11 Annealing oligonucleotides 
Single stranded oligonucleotides were made up to 2 ~glJ..tl with high purity H20 
(Sigma). To anneal complementary strands equal amounts of +/- strands were added 
together and made up to 100 ~l with 1 X TNE (appendix I). Enough single stranded 
oligonucleotide was added to give a 1 ~g/~l final concentration. The mix was then 
heated to 95°C for 5 minutes and then the heat block turned off and the samples 
were allowed to cool slowly to room temperature. The samples were briefly 
centrifuged and assayed by native acrylamide gel electrophoresis. 
2.1.12 Eluting DNA from agarose gels 
A 0.6 % agarose gel was made using 1 X TAE (appendix I) and the DNA to be 
eluted electrophoresed on the gel (2.3.1). The DNA was visualised by long wave UV 
and the band to be eluted identified using an appropriate size marker. The band was 
then cut out using a scalpel blade. The agarose gel slice was placed into p~e.wetted 
dialysis tubing that was clipped at one end. 200 ~l of 1 X TAE was then placed in 
the dialysis tubing and the other end was clipped, care was taken to make sure there 
were no air bubbles. The tubing with the agarose slice was then placed on a gel tray 
and the tray placed back into the gel tank and run at 100 volts for 1 hour. The current 
was then reversed for 30 seconds. The migrated DNA was visualised on a long wave 
transilluminator and sucked up using a syringe and needle. This solution containing 
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DNA was placed into a microcentrifuge tube, prior to phenol/chloroform extraction 
(2.1.4) and ethanol precipitation (2.1.5). 
2.1.13 Phosphatase reaction 
500 ng of digested PCR product was mixed with 1 X buffer 3 (NEB) and 0.5 units 
(0.5 unit per Ilg of DNA) of Alkaline Phosphatase (NEB). This was then made up to 
50 III with high purity water. The mix was then placed at 37 DC for 60 minutes. After 
which the PCR product was purified by a phenol/chloroform extraction (2.1.4) and 
ethanol precipitation (2.1.5). 
2.1.14 Phosphodiesterase I (Snake venom digest) 
50 ng of annealed oligonucleotide was dissolved in 100 mM Tris pH8, 1 mM Mg2+ 
solution. The O.D at 260 nm of the oligonucleotide was measured by UV 
Spectroscopy (2.3.5). The UV spectrophotometer was set up to run at 37 DC,S III of 
phosphodiesterase I at a concentration of 1 unit/f..ll was added to the cuvette and then 
placed back into the UV spectrophotometer and a time course was set up to follow 
the OD change of the oligonucleotide at 260 nm. When the reaction was finished the 
absorbance of the oligonucleotide was measured over a range of 330-220 and the 
OD was taken at 260. The measurement before the phosphodiesterase was subtracted 
from the measurement after and the percentage difference calculated. This gave the 
observed hyperchromicity of the oligonucleotide. 
2.1.15 Radioactive labelling of nucleic acid probes 
The end-labelling protocol that was followed varied according to the ultimate use of 
the probe. The annealed probe was characterised by running down a 10 % 
acrylamide gel and the concentration determined by absorbance at 260 nm. For 
EMSA a final probe concentration of 40 fmol/1l1 was required so 20 III 200 fmol/1l1 
of annealed oligonucleotide stock solution was mixed with 1 X T4 PNK buffer 
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(NEB), 0.5 J.lI end-labeling grade 'Y_[P33]ATP (Perkin Elmer) and made up to 30 J.lI 
with high purity H20 (Sigma) finally 10 units T4 polynucleotide kinase (NEB) was 
added. The reaction was mixed, centrifuged and incubated at 37°C for 30 minutes. 
Unincorporated 'Y_[P33]ATP was removed using G50 spin columns from GE 
healthcare according to manufactures instructions. 
2.2 Protein methods 
2.2.1 Expression of proteins 
A colony with the plasmid of interest was taken and added to 5 ml L-broth 
containing 50 J.lg/ml ampicillin. This was then grown for 16 hours at 37°C with 
shaking. 1 ml of this saturated broth was taken and added to 100 ml of fresh L-broth 
containing 50 J.lg/ml ampicillin, this was grown for a further 3 hours at 37°C with 
shaking. When the culture reached 0.7 O.Ds a 100 J.lI sample was taken and pelleted 
at 1000 g for 10 minutes to run on a SDS-page gel as an uninduced control, this was 
run alongside samples taken post induction by 1 mM Isopropyl iJ-D-l-
thiogalactopyranoside (lPTG). The culture was then grown for three hours at 37°C 
with shaking. Each hour a 100 J.lI sample was taken and collected by centrifugation 
for 10 minutes at 1000 g for analysis by SDS-PAGE. This was to show how well the 
protein was expressed and how long the culture needed to be left for optimum 
expression after addition of IPTG. All proteins showed maximum expression after 
three hours. The culture was pelleted at 6000 g for 10 minutes. Extraction of the 
protein of interest from the E. coli BL21 bacteria was then performed (2.2.2). 
2.2.2 Sonication 
Pelleted cells containing the protein of interest were resuspended in 10 ml Yang 
lysis buffer (appendix I). 100 J.lI of the sample was taken and centrifuged for 10 
minutes at 1000 g prior to electrophoresis by SDS-PAGE, this sample was labelled 
as total sample. The resuspended pellet was transferred to a 10 ml tube and placed in 
a 100 ml beaker of ice. Sonication was performed using a sonicator (Vibra-cell 
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Model CV33) with an exponential probe. The sonicator was programmed to sonicate 
for 10 seconds and then stop for 10 seconds, for a total sonication time of two 
minutes. A temperature probe ensured the temperature of the protein solution did not 
rise above 10 DC. The sample was then returned to ice for 2 minutes to keep the 
protein temperature low. When processing multiple samples another sample was 
sonicated during this time the sonication program was then repeated on the first 
sample. After the sonication the sample was centrifuged for 15 minutes at 16,000 g, 
the supernatant was taken off and put in to a new tube labelled soluble, while the 
pellet was resuspended in 10 ml and labelled insoluble. 10 J.lI of the soluble and 10 
J.lI of the insoluble fractions were taken for SDS-PAGE electrophoresis alongside the 
total sample taken before sonication. 
2.2.3 Protamine sulphate treatment and purification of proteins 
The supernatant from the sonication was decanted into 15 ml Falcon tubes and the 
protein dissociated from the nucleic acid by adding solid NaCI (Sigma) to a final 
concentration of 2 M. At room temperature 0.5 volumes of 20 mg/ml protamine 
sulphate solution was added and mixed thoroughly. The cell lysates and protamine 
sulphate mix was then transferred into spectropore dialysis tubing (Spectropore) and 
dialysed against 2 litres of 300TWB (appendix I) buffer at 4 DC, after 2-3 hours the 
buffer was replaced and the dialysis continued overnight. As the NaCl concentration 
dropped the protamine sulphate bound the nucleic acids within the solution and the 
protamine-DNA complex precipitated from the solution. The following day the 
dialysed sample was transferred into 30 ml tubes and centrifuged (8,000 g 4 DC) for 
10 minutes to remove the precipitate. The soluble fraction containing the protein of 
interest was then further purified by affinity chromatography using glutathione 
sepharose (GST) spintrap purification modules (GE healthcare). The resin in each 
glutathione sepharose 4B microspin column was resuspended by vortexing gently. 
The caps on the microspin column were then loosened and the bottom of the column 
was snapped off and saved (bottom cap). Each column was placed into a clean 1.5 
ml micro centrifuge tube and were centrifuged for 1 minute at 735 g and the buffer 
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from each column was discarded. The bottom caps were placed back on and 600 J.ll 
of the supernatant containing protein to be purified was loaded onto the column. The 
top caps were screwed securely and the column was the mixed at room temperature 
for 5-10 minutes. The top and bottom caps were removed and the column was then 
placed into a clean 1.5 ml microcentrifuge tube and centrifuged for one minute at 
735 g to collect flow-through, this step was repeated until half of the supernatant 
containing protein had been though the GST spintrap purification module. The 
column was then placed into a clean 1.5 ml microcentrifuge tube and washed twice 
by applying 600 J.ll of 1 X PBS. After the washes 150 J.ll of glutathione elution 
buffer was added to column. The top and bottom caps were replaced and the column 
was incubated at room temperature for 10 minutes. The top and bottom caps were 
removed and the column was placed into a clean 1.5 ml microcentrifuge tube and 
centrifuged at 735g to collect eluant. The eluant was then analysed by SDS-PAGE 
electrophoresis (2.3.3). 
2.2.4 Filter binding assay 
Annealed DNA and RNA oligonucleotide duplexes were labelled with -Y-[P33]ATP 
(2.1.16). Enough DNA was labelled to give a 25 nM concentration per reaction at 
roughly 20 kcpm. A nitrocellulose filter (hybond-C, GE healthcare) was carefully 
pre-soaked in filter binding buffer (FB) (appendix I) for 2-3 hours to ensure the filter 
was completely wetted. A stock solution of labelled DNA and RNA oligonucleotide 
duplex was diluted to 25 nM per reaction and 20 kcpm per reaction using FB 
(appendix I). This was conducted in larger volumes of 100 J.lI per reaction to reduce 
error. Purified protein was then diluted in binding buffer (BB) (appendix I). A serial 
dilution was performed to give a range of concentrations between 25-300 nM. 100 
J.lI of each protein concentration was added to appropriately labelled microcentrifuge 
tubes. Labelled DNA and RNA was then aliquoted to the appropriate protein stock 
tubes. Two controls were prepared without protein, one was filtered to give 
background retention and was considered as 0 % bound. The other control was not 
filtered and was directly added to a pre-soaked filter in a scintillation vial and dried. 
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This gives total retention and was treated as 100 % bound. The reactions were then 
centrifuged briefly to mix and incubated at 4 °C for 15-30 minutes. Once 
equilibrium was reached the pre-soaked filter was placed carefully on the filtration 
manifold ensuring that excess FB was removed and filter not damaged. As the 
manifold used had 5 by 12 cell loading, thus all samples could be loaded at the same 
time. The reactions were applied to the filter and were held in place by surface 
tension, the vacuum was then applied and a wash with 200 III FB performed. The 
filter was then cut and each reaction filter was placed in a scintillation vial, the filters 
were dried in an oven at 60°C for 20-30 minutes until thoroughly dry. The samples 
were then allowed to cool to room temperature and 3 ml of scintillation fluid, 
(Optiphase Supermix PerkinElmer) added to each sample. The radioactivity was 
then measured in a scintillation counter and the results corrected for background. 
2.3 Electrophoresis and Spectroscopy 
2.3.1 Agarose gel electrophoresis 
The gel tray and well-forming comb were first cleaned with distilled H20 followed 
by 100 % ethanol. To make a reservoir, the ends of the gel tray were sealed using 
waterproof tape. To make a 1 X TBE 1 % agarose gel, 1 g routine use agarose 
(Bioline) was mixed with 100 ml 1 X TBE (National Diagnostics) and microwaved 
on full power for two minutes until the solution was totally dissolved and started to 
boil. Once cooled 5 ).11 of 10 mg/ml ethidium bromide (Sigma) was added to enable 
visualisation of nucleic acids. After mixing thoroughly the molten gel was 
immediately poured into the taped gel tray and the well-forming comb placed into 
the slots in the side of the gel tray. Once the gel had set the tape was removed and 
the gel placed into the buffer tank and covered with enough 1 X TBE poured in to 
cover the gel. At this point the comb was withdrawn from the gel. Samples were 
prepared in a volume of less than 20 ).11 and mixed with 1 X DNA loading buffer 
orange G (appendix I). As little as 25 ng DNA can be visualised in a single band 
using ethidium bromide, band concentrations of greater than 250 ng should be 
avoided as this overloads the gel making accurate estimations of size and quantity 
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difficult. The gel was electrophoresed at 100 V and the loading buffer orange G was 
used to estimate the position of the DNA. Following separation the bands were 
visualised using an UV transilluminator to detect the ethidium bromide fluorescence. 
For RNA samples a separate gel tank, gel tray and well-forming comb were used to 
avoid degradation by RNA nucleases. 
2.3.2 Native polyacrylamide gel electrophoresis 
To run a native polyacrylamide gel glass plates, a rubber gasket, and a well forming 
comb designated for this use only were first cleaned with purite H20 followed by 
100 % ethanol. Once dry the gel plates were assembled, ensuring that the gasket was 
seated correctly to prevent leakage of the acrylamide solution. Next the plates were 
clamped together using bulldog clips and stood on a bench ensuring that the gel 
plates were perfectly level. To mix a native 1 X TBE 10 % polyacrylamide gel, 12.5 
ml 40 % polyacrylamide stock (29: 1 National Diagnostics) solution was mixed with 
5 ml of 10 X TBE and made up to 50 ml distilled H20. The polymerisation reaction 
was started by adding 400 III 10 % (w/v) ammonium persulphate (Sigma) and 50 III 
TEMED (Sigma). The gel was then mixed thoroughly and poured immediately into 
the prepared gel plates. Taking care to avoid trapping bubbles, the comb was 
inserted into the liquid gel and pushed fully home. Once the gel had polymerised the 
comb was removed and the pockets rinsed with 1 X TBE, the gel was stable for 
several weeks, if stored in this state at 4 0c. To run the gel, the gaskets were 
removed and the gel assembled into the gel tank. The upper and lower reservoirs 
were filled with 1 X TBE ensuring that bubbles did not become trapped below the 
gel between the two plates. The gel was pre-run at the intended running voltage for 
at least one hour and the pockets rinsed prior to loading. The sample was loaded 
onto the gel in 1 X DNA loading buffer orange G (appendix I) and run at up to 200 
V for the appropriate period using orange G (where applicable) as a marker. No 
loading buffer was used on an electrophoretic mobility shift assay (EMS A) gel, as 
this may interfere with protein-DNA interactions. A sample of orange G was loaded 
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in a separate lane to identify migration distance. Gels to be used for EMSA were 
made to be 4 % polyacrylamide (29: 1) and made with 0.25 X TBE. 
2.3.3 SDS gel electrophoresis 
To assemble the sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) apparatus the glass gel plates, rubber gasket and well forming comb were 
first cleaned with purite H20 and 100 % ethanol. Once dry the gel plates were 
assembled, ensuring that the gasket was seated correctly to prevent leakage of the 
acrylamide solution. Finally, the plates were clamped together using bulldog clips 
and stood upright ensuring that the gel plates were perfectly level. To make a 10 % 
SDS-PAGE, 3.3 ml 30 % acrylamide to bisacrylamide (37.5:1) stabilized solution 
stock (National Diagnostics) was mixed with 2.6 ml Protogel resolving buffer 
(National Diagnostics) and made up to 9.8 ml with distilled H20. The liquid gel was 
polymerised by adding 100 / ..Ll 10 % APS, 20 III TEMED absolute (made up to a 
total volume 10 ml), and mixed well. To ensure an even interface between the gels 
the liquid gel was immediately overlaid with - 2 ml isopropanol. Once the gel had 
set the isopropanol was removed by inversion and the gel washed repeatedly with 
distilled H20, the gel was then left upside-down to allow the residual water to drain 
away. The gel can be stored in this state with a purite H20 overlay for several days 
at 4 °C but should be used within 12 hours once the stacking gel is poured. The 4 % 
stacking gel was prepared by mixing 1.3 ml 30 % acrylamide to bisacrylamide 
(37.5: 1) stabilized solution stock (National Diagnostics) and 2.5 ml Protogel 
stacking buffer (National Diagnostics) and made up to 9.9 ml with distilled H20. To 
polymerise the liquid gel 40 III 10 % APS and 10 III TEMED was added, the 
solution mixed and immediately poured between the gel plates overlaying the 
stacking gel and the comb was inserted fully into the top of the gel. To assemble the 
gel plates for electrophoresis the gasket was removed from the gel plates and the gel 
placed into the tank. The upper and lower reservoirs were filled with 1 X Tris-
glycine running buffer (National Diagnostics), ensuring that bubbles were not 
trapped under the gel between the 2 gel plates. Once the upper reservoir was filled, 
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the comb was removed allowing the buffer to support the fragile well pockets. To 
apply a sample to the gel, a 20 ~l sample in 1 X SDS-PAGE (appendix I) loading 
dye was heated to 95°C for 5 minutes to denature the protein sample and then 
centrifuged briefly to collect any condensation on the roof of the microcentrifuge 
tube. Finally the samples were loaded onto the gel along with 2 ~g of a suitable 
marker. Approximately 100 ng protein can be visualised in a single band, band 
concentrations above I ~g overload the gel, and made accurate estimation of size 
difficult. The gel was run at 250 V until the bromophenol blue dye front left the gel, 
(on a 10 % gel the dye-front migrated at a rate equivalent to a protein of 10-20 kDa). 
To visualise the protein the gel was disassembled, the stacking gel removed and the 
running gel submerged in Coomassie brilliant blue (Sigma) staining solution 
(appendix I). Excess Coomassie brilliant blue was removed by placing the gel in 
destain solution (appendix I) overnight with shaking. The destaining process was 
accelerated by changing the de stain solution frequently and adding a piece of sponge 
to act as a sink for liberated stain. 
2.3.4 Electrophoretic mobility shift assay (EMSA) analysis of embryo extracts 
To analyse embryo extracts using EMSA 10 embryos were homogenised in IX EB 
(appendix I), containing one mini-complete™ protease inhibitor tablet (Roche) per 
10 ml of IX EB. Homogenised embryos were then extracted with an equal volume 
of freon (Sigma) to remove the yolk proteins. Extract was mixed with 40 fmol 
dsDNA probe and 100 ng poly dI-dC (Amersham Pharmacia Biotech) as a non-
specific competitor in IX EMSA buffer to a final volume of 20 ~l. Binding was 
conducted at 4 °C for 30 minutes before loading the samples directly onto a pre-
electrophoresed 0.25 X TBE 4 % polyacrylamide gel, pre-electrophoresis was at 200 
V for 2 hours and gel running was 200 V for 95 minutes. The gel was prepared the 
night before the EMSA was conducted. Following electrophoresis the back plate was 
removed and the gel lifted off with 3 mm paper, doubled over. The gel was then 
covered with plastic wrap and placed on another sheet of 3 mm paper to avoid 
contamination of the vacuum drier. The gel was dried on a vacuum drier for 1 hour 
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at 70-80 °C and placed against a phosphorimager screen in a phosphorimager case 
and left overnight to expose. The next day the phosphorimager screen was scanned 
in the phosphorimager (Fujifilm FLA-SOOO). The phosphorimager software (Fujifilm 
FLA-SOOO) was then used to quantify the bands. 
2.3.5 Ultraviolet (UV) spectroscopy 
A quartz cuvette was cleaned and 500 III purite H20 was added. This was then 
placed in an ultraviolet (UV) spectrophotometer to blank against background. The 
purite H20 was removed and 49S l.tI purite H20 and S III of sample DNA was added. 
For less concentrated samples more can be added in place ofpurite H20. The sample 
was then placed into the UV spectrophotometer and the absorbance scanned from 
360 nm to 220 nm and the appropriate wavelength absorbance of DNA (260 nm), or 
protein (280 nm), used to calculate the concentration in sample of interest. For 
plasmids 1 OD was treated as SO Ilg/Ill for dsDNA. For oligonucleotides and small 
DNA and RNA fragments < 100 base pairs the calculated extinction coefficient was 
used. For unpurified proteins a rough estimate of 1 OD as 1 mg/ml was used and for 
a measurement of purified proteins the calculated extinction coefficient was used. 
2.3.6 Circular Dichroism (CD) spectroscopy 
To prevent damage to the optics the instrument was flushed with nitrogen for 10-15 
minutes before switching the lamp on, the instrument was purged for the duration of 
the experiment. The lamp was switched on and the instrument allowed to stabilise 
for 30 minutes before making any measurements. The UV spectrum of the DNA 
sample was taken and concentration of stock solution calculated from their 
extinction coefficients. Once the CD instrument had warmed up the spectrum of a 1 
cm cell filled with water was taken to determine the baseline between 250 nm and 
320 nm. The instrument was calibrated by replacing the water with a previously 
prepared solution of camphor sulfonic acid and the CD was measured between 250 
nm and 320 nm where a O.S mg/ml solution in a 1 cm path length cell had ellipticity 
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of 168 millidegrees at 290.5 nm. Next the cell was filled with phosphate buffer 
(appendix I). The cell was placed in the instrument taking care to note the 
orientation of its faces in the beam; a baseline was run between 250 and 320 nm. 
The buffer was replaced with the DNA solution and the spectrum taken under the 
same conditions. 
2.4 Bacterial and embryological methods 
2.4.1 Growth and maintenance of bacterial strains 
Bacterial cells were grown in L-broth (Sigma) with ampicillin (Sigma) as a selector, 
at a final concentration of 50 J,lg/ml. Permanent cultures were created by mixing 1 
ml of mid-log phase bacterial cultures with 70 J,ll of filter sterile 100 % DMSO 
(Sigma) and flash freezing in liquid nitrogen. Escherischia coli strain BL21 pLysS 
(Promega) was used for induction of recombinant proteins and the E. coli strain 
DH5a was used for the production and maintenance of plasmid DNA. 
2.4.2 Competent cell preparation 
10 ml of L-broth was inoculated with a single colony of a specific strain of bacteria 
and grown overnight at 37°C with shaking. The next day 5 ml of the overnight 
culture was used to inoculate 500 ml of L-broth. This was then incubated at 37°C 
for 3 hours with shaking, until the cells reached ODsoo = 0.48. The culture was then 
transferred to a sterile Beckman centrifuge tube. The cells were then centrifuged at 
6,000 g for 30 minutes at 4°C. The pellet was resuspended in 166 ml of chilled FBI 
(appendix I) and the cells were incubated on ice for 15 minutes. They were then 
transferred to a sterile 250 ml Beckman bottle and centrifuged at 6,000 g for 30 
minutes at 4 0C. The pellet was resuspended this time in 40 ml of cold FB2 
(appendix I) and incubated on ice for 15 minutes. The cells were then transferred to 
microcentrifuge tubes in 300 J,ll aliquots and snap frozen in liquid nitrogen and then 
stored at -70°C. The competent cells were tested by a trial transformation; good 
cells gave 105 to 106 colonies per 1 J,lg plasmid DNA. 
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150 JlI of competent cells were pi petted into a pre-chilled microcentrifuge tube and 
-50 ng of DNA added in a volume of no more than 10 JlI of high purity H20 
(Sigma). The cells were chilled on ice for 30 minutes, heat shocked at 42°C for 45 
seconds, and then cooled rapidly on ice. Once cool, 900 JlI L-broth was added to the 
microcentrifuge tube and the cells incubated at 37°C for 30 minutes. To plate the 
transformation reaction the cells were pelleted by centrifugation (6,000 g, 4°C) for 1 
minute in a microcentrifuge, 900 JlI L-broth removed and the cell pellet resuspended 
in the remaining broth. Finally all 100 JlI of cells and broth mix was plated onto 
Luria agar plates, containing 50 Jlglml ampicillin, using a sterile spreader. Colonies 
appeared within 12-16 hours at 37°C. 
2.4.3 Care and maintenance of Xenopus laevis embryos 
A female frog was injected with Human Chonionic gonadatrophin hormone the 
previous day and the eggs were fertilised by pipetting sperm over them. The 
embryos were then de-jellied with 2 % cysteine (appendix I). This was done by 
mixing the embryos with 2 % cysteine gently in a 50 ml falcon tube until all the 
embryos grouped together at the bottom with no "gaps" between them. Gaps 
between embryos indicate that the jelly coat had not been completely removed. The 
embryos were then washed with 0.1 X Modified Barth's saline (MBS) (appendix I) 
to remove all cysteine, and finally left in 0.1 X MBS to develop. The embryos were 
kept between 14-22 °C and were checked regularly to remove unfertilised and dying 
embryos, (which if left, release toxins that caused the healthy embryos to die). 
Embryos were then harvested at the developmental stage required and either stored 
at -70°C or used immediately. Embryos that were to be used for injections after 
being de-jellied and washed with 0.1 X MBS they were placed in 1 X MBS, 3 % 
ficoll (appendix I), to prevent blebbing from the injection wound. 
72 
2.4.4 Micro-injections of Xenopus laevis embryos 
The injection apparatus was regulated to an injection pressure of 9.8 bars and a clear 
pressure of >100 bars. A pre-pulled glass injection needle (Clark Electromedical 
GClOO-I0 needle) was prepared using a Sutter p-97 puller and assembled into the 
needle holder apparatus with the retaining collar tightened finger tight. To calibrate 
the needle a binocular microscope was focused onto the tip of the needle at 1 X 
magnification and the tip of the needle broken using fine watchmakers forceps until 
the ejected droplets measured 0.2 eyepiece units across (equivalent to 4 nl volume), 
using an injection time of 0.5 seconds. Next an aliquot of the sample was centrifuged 
(14,000 g) for at least 5 minutes in a cooled centrifuge to pellet particulate matter 
which blocks the narrow needle aperture. Once centrifuged, 5 J.11 of the sample was 
applied to a fresh piece of parafilm and the needle tip positioned within the sample 
and the solution drawn into the needle using the load function of the injector. 
Embryos were injected at the one cell stage with injections targeted to the desired 
region by using the pigmented animal pole as a marker. The embryos were left in 3 
% ficoll for one hour after injections to allow the embryos to heal and recover. The 
embryos were then placed into 0.1 X MBS and allowed to develop at 14-22 °C and 
were checked regularly to remove unfertilised and dying embryos, (which if left 
release toxins that caused the healthy embryos to die). Embryos were harvested at 
stage 14 for dual-Iuciferase reporter assay. They could be stored at -70°C or used 
directly. 
2.4.5 Dual-Luciferase reporter assay 
Plasmids containing the gata2 promoter wild type or mutants and luciferase gene 
were digested with BamHI (2.1.5), purified (2.1.6) and diluted for a final 
concentration of 50 ng per embryo. The TKJRenilla plasmid was treated similarly. 
The TKJRenilla plasmid was then mixed with each of the gata2 promoter plasmids 
for a final concentration of each plasmid to be 50 ng per embryo. The mixes were 
then injected (2.4.3). Injected embryos that survived were taken at stage 14 and 10-
20 embryos lysed in 100 J.11-200 J.11 (10 J.11 per embryo) 1 X passive lysis buffer from 
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the dual-luciferase assay (Promega). The dual-luciferase reporter assay was then 
performed on the embryo lysate. The lysed embryos could also be stored at -70°C 
and the dual luciferase assay carried out at a later date. Preparation of luciferase 
assay reagent II (larII) and stop and glo® reagent was conducted according to 
manufactures instructions (Promega). A 10 second measurement period for each 
assay was set up on the luminometer (1450 Mircobeta Wallac, Trilux). 50 I.ll of pre-
lysed. with 1 X passive lysis buffer. embryo extract was placed into a 9 by 12 cell 
cassette reader. 50 ~l of larI! was added to the embryo extract and mixed by 
pipetting three times. The cassette was then placed into the luminometer, reading 
initiated and activity measurements recorded. The cassette was removed and 50 ~l of 
stop and glo® reagent was added to each well and mixed by pipetting three times. 
The cassette was then placed back into the luminometer and reading was reinitiated. 
The Renilla luciferase activity was then measured and recorded. 
2.4.6 Transgenesis in Xenopus laevis 
An I-SceI restriction enzyme digest (see 2.1.3 and NEB catalogue for conditions) 
was carried out on plasmids that were created to contain the gala2 promoter or 
mutant promoter and gene GFP for 45 minutes. As the I-SceI restriction digest was 
started a female frog (induced the previous day) was squeezed and sperm was added 
to the unfertilized embryos. The embryos were then left until fertilized. This takes 
around 45 minutes. Injection equipment was set up and made ready in this time. This 
is so when embryos are fertilized, and the digest of plasmid complete, injections can 
be done straight away to avoid mosaics. After injections embryos were cared for as 
previously described (see 2.4.3). Embryos were checked every few stages for signs 
of incorporation of the plasmid DNA into the genome by looking at the embryos 
under a blue light on a fluorescence microscope (lumor.VI2 steREO Zeiss). At later 
stages the embryos were checked at every stage. 
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Chapter 3: The effects of A and B form DNA structure 
on transcriptional activity at the Xenopus gata2 
promoter 
3.1 Introduction 
GA T A2 is an important transcription factor involved in haematopoiesis and 
neurogenesis (Nardelli et aI., 1999; Sykes et aI., 1998; Tsai et aI., 1994). The critical 
region of the Xenopus laevis gata2 promoter, -61 to -27 base pairs upstream from 
the start of transcription, is conserved between many vertebrate species including 
humans (Figure 3.1), so understanding how the Xenopus laevis gata2 promoter is 
activated could help understand how other gata2 promoters are controlled. It has 
previously been suggested that the critical region of the gata2 promoter has an A-
form structure, and that this structure acts as a binding site for the a subunit of the 
transcription factor CBTF called ilO (Scarlett et aI., 2004). This interaction was 
proposed to be via the dsRBDs of ilO that normally recognise A-form dsRNA 
(Scarlett et aI., 2004). 
Although there is currently little evidence of A-form dsDNA in vivo or that it is 
involved in any regulatory mechanisms, such as transcriptional control, previous in 
vitro work has suggested that the dsRBDs of ilf3 can bind to the critical region of the 
gata2 promoter. In support of this, a protein containing point mutations that knock-
out the activity of the dsRBDs no longer binds the gala2 promoter region in vitro 
and transcriptional activity in vivo is reduced (Scarlett et aI., 2004). The gata2 
promoter structure at this critical region is partially A-form, as observed in vitro by 
circular dichroism (CD) (Scarlett et aI., 2004). Therefore a model was proposed 
whereby the A-form structure could allow the dsRBDs of ilf3 to bind to the 
promoter region (Scarlett et aI., 2004). In this chapter the previous in vitro 
experiments are expanded and the importance of this possible interaction in vivo is 
also investigated. 
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a 
b 
Xenopus 
GGCTGGCGxxGAGGCTxxxxxTGXTGATTGGCTGGCCCGGGGTT 
Human 
CGGAGGCTGGGAGGCGCGCGGCGTTGATTGGCTGGCTTGGGCTT 
Mouse 
CGGAGGCTGGGCGGCGCGCGGCGCTGATTGGCTGGCGCCGGCTT 
Chicken 
GGCGxGTGTGGx GGCGxGCGGxxxxGATTGGCTGGCCCGGCCGC 
Xenopus Human 
6 
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Figure 3.1 Sequence and structure homology of gata2 promoters. (a) Mouse, 
human and chicken gata2 promoters compared to the critical bases of the Xenopus 
version (-61 to -27). Sequences are highlighted corresponding to conserved regions. 
(b) Structure prediction of the sequences shown above. APE values for each base 
were taken from the tables of Basham et al. and summed to provide a value for a 
given base pair and plotted. The conserved sequences are marked in different 
colours on the graphs to allow comparison. 
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First, structure homology of this critical region was assessed in other gala2 
promoters, Human, Mouse and Chicken along with there sequence homology and 
the results can be seen in figure 3.1. In all four species the sequence and structure of 
the inverted CCAA T box and surrounding bases is highly conserved. A region 
several bases upstream, indicated in red on figure 3.1, shows sequence homology 
between the promoters and more interestingly a conserved negative A-form peak. In 
these experiments the critical region, -61 to -27 of the gala2 promoter, was mutated 
to have a more A or B form structure when compared to the wild-type sequence. The 
structure of oligonucleotide duplexes corresponding to these sequences were then 
probed by CD. Competition electrophoretic mobility shift assays (EMSAs) with 
Xenopus laevis whole cell extract were then conducted on these oligonucleotide 
duplexes to investigate how well they bound to the CBTF complex relative to the 
wild-type gata2 promoter sequence. The mutations were then incorporated in to a 
larger fragment of the gata2 promoter, -417 to + 192, and the amount of transcription 
from these mutant promoters was then assessed using a reporter gene assay in 
Xenopus laevis embryos. In this chapter we show in vivo evidence that the A-form 
structure at the gata2 promoter is involved in transcriptional regulation, presumably 
by allowing enhanced DNA binding by the dsRBDs of ilD. 
3.1.1 Experimental strategy 
To investigate if an A-form DNA structure at the gala2 promoter plays a role in 
regulation of transcription by allowing the dsRBDs of ilf3 to bind to its target 
sequence, two experiments were designed (figure 3.2). The first was to design 
oligonucleotides based on the critical region of the gata2 promoter, -61 to -27, 
which were more A or B form than the wild type, the oligonucleotides were then 
checked by circular dichroism (CD) to ensure the presence of the expected structure. 
The binding of these oligonucleotide duplexes was then investigated to see if they 
bound CBTF (the ilf3 containing complex) better or worse than the wild-type 
sequence using competition EMS A on Xenopus laevis whole embryo extract. 
Competition EMSA on whole embryo extract was chosen to test the binding of these 
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Design of mutant gata2 promoter sequences to 
be more A or B-form using prediction table 
(Basham et aI, 1995) 
~ 
Oligonucleotides containing chosen 
mutations were ordered 
~ 
True extinction coefficients of oligonucleotides 
were calculated and circular dichorism carried out 
to test if oligonucleotides contained the predicted 
structure 
Competition EMSAs with Xenopus laevis whole cell 
extract were carried out on the mutant promoters to 
determine relative binding compared to gata2 wild 
type promoter 
These designed mutations were incorporated into a larger section of 
the gata2 promoter sequence, -417 to + 191 , by peR. These sequences 
were then sub-cloned into the pLUC plasmid driving the firefly 
luciferase reporter gene 
Luciferase assays were carried out to 
investigate the in vivo effect of these mutant 
promoters upon levels of transcription 
Figure 3.2 Flow diagram of experimental strategy. Outline of the 
strategy followed and the experiments designed to investigate the 
hypothesis that the critical region of the Xenopus gata2 promoter is partially 
A-form in structure and this allows the dsRBDs of ilf3 to bind and activate 
transcription. Red boxes indicate steps involved in the first experiment. 
Blue boxes indicate steps involved in the second experiment. 
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sequences since it is quick, reproducible and has been used in past experiments to 
give reliable binding data (Orford and Guille, 1999). It is also 'partially' in vivo as 
whole cell extract is used, therefore proteins are presumably in their correct 
complexes and possess their correct post-translational modification(s). 
The second experiment was designed to assay levels of transcription from mutant 
promoters containing these mutations in a truly in vivo assay. A reporter gene assay, 
the Promega dual-Iuciferase assay, was chosen for this because the assay has been 
used previously to give reliable data and is robust (Latinkic et aI., 1997; Sherf et aI., 
1996). It also allows the study of the effects from the A-form element in isolation 
from long-range chromatin mediated influences and allows relatively easy screening 
of a large number of promoter constructs. Xenopus laevis embryos were used since 
they are available all year round, have a high fecundity, are easy to work with and 
are hardy and it is the Xenopus laevis CBTF and gata2 promoter interaction being 
studied. 
3.2 Design and validation of DNA structure variants 
3.2.1 Mutant design 
The B-form structure is adopted by most DNA under physiological conditions and is 
the common DNA structure found in biological systems (section 1.6.2). However B-
form DNA is not the only structure dsDNA that can form, there is also A-form and 
Z-form. A-form DNA is a right-handed helix like B-form DNA and in vitro B-form 
DNA can be forced to an A-form structure by de-hydration of the DNA molecule 
(Franklin and Gosling, 1953). A-form DNA can be adopted under standard 
conditions by some sequences and algorithm to predict A or B form propensity has 
been described (Basham et aI., 1995). A-form DNA structure has a shorter and wider 
helix than B-form DNA. For more information on the differences between the DNA 
structures see section 1.6 and figure 1.4. Mutant promoters based on the critical 
region of the gala2 promoter, -62 to -27, were designed to be more A or B form 
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form when compared to the wild-type sequence using the method of Basham et al 
(Basham et aI., 1995). 
Basham et aI, showed that by comparing the free energy required to hydrate the 
exposed DNA surfaces of A and B-form DNA it can be predicted whether a 
sequence will form A or B-form DNA under standard conditions. From this an A-
form DNA propensity energy (APE) was derived to describe the thermodynamic 
propensity of a sequence to adopt the A-form DNA conformation (Basham et aI., 
1995). The A or B-form preference was predicted for each base pair in the context 
of its neighbouring bases as a 3 bp travelling window. The base in the middle has the 
preference but flanking bases one either side affect the base in question (Basham et 
aI., 1995). A triplet code table was produced and can be used to accurately predict 
the A-form propensity of a base (Appendix VI) (Basham et aI., 1995). A positive 
APE indicates more B-form preference and a negative APE indicates more A-form 
preference. The A or B form preference for each base of a base pair is calculated 
and then the average for the base pair taken. 
Oligonucleotides were designed to be 36 base pairs long, based on the critical region 
of the gala2 promoter (Brewer et aI., 1995). Dimethylsulphate (DMS) protection and 
interference footprinting showed that CBTF makes critical contacts with a 12 bp 
region surrounding the inverted CCAAT box (the critical region) (Figure 3.3a). This 
region of the Xenopus laevis gata2 promoter has identical sequence to the human, 
mouse and chicken gala2 promoter orthologs (figure 3.3b) (Brewer et aI., 1995; 
Fleenor et aI., 1996; Minegishi et aI., 1998; Nony et aI., 1998). This strongly 
suggests that these interactions are important and disruption of the sequence 
involved in possible direct contacts may affect binding of CBTF and transcriptional 
levels of the gala2 promoter. These sequences were avoided to ensure that only the 
effect of DNA structure was being tested in downstream assays. 
One B-form and three A-form mutants were designed with varying propensities. 
Graphs showing A or B form preference of the single bases, of each base pair, for 
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(a) 
++ ++ 
+ strand 5' 3' CGGAGGCTTGTGATTGGCTGGCCC 
- strand 3' GCCTCCGAACACTAACCGACCGGG 5' 
+++ + ++ ++ 
+ DMS protection and interference 
(b) 
+5' 
+5' 
+5' 
+5' 
CGG AGG CTT GT ATT GGC TGG CC 3' Xenopus 
CGG AGG CTT xT ATT GGC TGG CC 3' Human 
CGC GCG GCG CT ATT GGC TGG CC 3' Mouse 
TGG GGG CGG C 3' Chicken 
Conserved region 
Figure 3.3 Footprinting summary of CBTF. (a) Summary of DMS 
protection and interference footprinting of the CBTF complex bound to 
part of the critical region of the Xenopus gala2 promoter (-58 to -37). 
Bases identified by DMS protection and interference are indicated with a 
+. (b) The critical inverted CCAA T box is high-lighted in red. Part of the 
critical region containing the inverted CCAA T box is conserved, this 
conserved region is found in human, mouse and chicken. (Reproduced 
from Orford 2000). 
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the wild type and all mutant oligonucleotides are shown in figure 3.4. All 
oligonucleotide sequence designs and an average APE per base for the 
oligonucleotide as a whole are shown in table 3.1. After the design of these 
oligonucleotides was complete, they were ordered (Invitrogen) and the 
oligonucleotides were annealed into duplexes. They were then assayed for 
successful annealing and the absence of residual single stranded oligonucleotide 
(figure 3.5). 
3.2.2 Calculation of extinction coefficients of DNA duplexes 
The true extinction coefficients, as opposed to the calculated extinction coefficient, 
of the oligonucleotide duplexes were determined by observing the hyperchromicity 
effect of each oligonucleotide by carrying out a phosphodiesterase I digest. The 
molar extinction coefficient is a measurement of how strongly a molecule absorbs 
light at a given wavelength; it is calculated for DNA and RNA as the sum of the 
extinction coefficients for the bases. It is an inherent property of a molecule and the 
actual absorbance (A) is affected by the concentration of the sample and the path 
length used. The beer-lambert law, Absorbance/optical density (OD) = Extinction 
coefficient (E) X concentration (C) X pathlength (L) OD = E.C.L, can be used to 
calculate the concentration of a sample. 
The molar extinction coefficient of double-stranded DNA (dsDNA) and double-
stranded RNA (dsRNA) is affected by the hyperchromicity effect. The 
hyperchromicity effect is an increase in absorbance of DNA or dsRNA when DNA 
or dsRNA is denatured. DNA or dsRNA is held together by the hydrogen bonds 
between complementary bases, these hydrogen bonds limit the resonance of the 
aromatic ring by holding the bases in place, and therefore the absorbance by the 
DNA or dsRNA is lowered. When the bases become unstacked, absorbance 
increases on average by 30-40 %. The hyperchromicity effect means that the 
observed absorbance for dsDNA or dsRNA leads to concentration predictions that 
are greatly underestimated. The hyperchromicity effect varies for different DNA or 
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Name Sequence APE 
WT GGCTGGCGGAGGCTTGTGATTGGCTGGCCCGGGGTT -0.2 
CCGACCGCCTCCGAACACTAACCGACCGGGCCCCAA 
AFI GGCTGCCGGAGCCTTGTGATTGGCTGAGCCGGGGTT -0.3 
CCGACGGCCTCGGAACACTAACCGACTCGGCCCCAA 
AF2 GGCGAGCCCTCACTTGTGATTGGCTGAGTGGGGGTT -0.5 
CCGCTCGGGAGTGAACACTAACCGACTCACCCCCAA 
AF3 GTGCATGCATGCCTTGTGATTGGCTCAATGGGGGTT -0.49 
CACGTACGTACGGAACACTAACCGAGTTACCCCCAA 
BF GGCTGACGGAAACTTGTGATTGGCTTTAAAGGGGTT 0.1 
CCGACTGCCTTTGAACACTAACCGAAATTTCCCCAA 
Table 3.1 Wild type oligonucleotide design and all mutants. The critical bases 
including the inverted CCAA T box are highlighted in red. Base changes from the 
wild type to make the mutants more A or B form are highlighted in blue. The average 
A-form DNA propensity energy (APE) of each 36 bp oligonucleotide duplex was 
predicted using table from Basham et aI , 1995 and is shown here. A positive APE 
indicated a B-form preference and a negative APE indicated an A-form preference. 
The more negative or positive the APE is it assumed the more affinity for A or B 
form structure. AF I, AF2 and AF3 were designed to be more A-form relative to WT 
and BF was designed to be more B-form relative to WT. 
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Figure 3.4 Prediction graphs of A-form and B-form preference. The method 
of Basham et ai, 1995 involved a triplet code table (Appendix VI) that can 
predict the A or B-form propensity (APE) of a base in relation to its 
neighbouring bases from 5' to 3'. Mutant oligonucleotides that were 36 base 
pairs long were designed to favour an A or B-form structure, using the triplet 
code table. The footprint from Scarlett et ai, 2004 provided information on 
which bases made a major contacts so that mutations could be designed to avoid 
these bases. APEs of bases that could be predicted are shown here. Positive 
APEs indicate a more B-form preference and negative APEs indicate more A-
form preference. (a) Shows the predicted APE for each base, -61 to -27, of the 
wild-type gata2 promoter. This region contains an inverted CCAAT box located 
within the critical bases (Orford, 2000). (b) Mutant AFl, this is one of the 
mutants designed to be more A-form than the wild-type sequence. (c) Mutant 
AF2, this is the second of the mutants designed to be more A-form than the 
wild-type sequence. (d) Mutant AF3, this is the third of the mutants designed to 
be more A-form than the wi ld-type sequence. (e) Mutant BF, this is the mutant 
designed to be more B-form than the wild-type sequence. 
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40 base pairs ---+ 
30 base pairs --+ 
36 base pairs 
Figure 3.5 10% polyacrylamide gel showing annealed duplex 
oligonucleotides. Five sets of complementary thirty six base pair 
oligonucleotides corresponding to mutant designs AF, AF2, AF3, BF and 36 
bp of wild-type promoter (WT) were annealed and run on a 10% 
polyacrylamide gel. Promega 10 bp ladder was used as a DNA marker; the 40 
and 30 bp marks are indicated with arrows. 
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dsRNA sequences and structures, so an average percentage can not be used to 
completely account for the hyperchromicity effect, if an exact concentration is 
required. 
A sample of the DNA for which the hyperchromicity is required was digested with 
phosphodiesterase I. Phosphodiesterase I is an enzyme found is snake venom that 
breaks phosphodiester bonds as found in the backbone of DNA. The OD of the DNA 
sample was taken before and after the phosphodiesterase I digest and this was used 
to calculate the hyperchromicity effect. A time course was taken over the 
phosphodiesterase I reaction and the reaction was complete once the curve plateaued 
(figure 3.6), this was to ensure the completion of the reaction. The percentage 
difference between the OD before and after the reaction can then be applied to the 
extinction coefficient of the given molecule and the correct concentration calculated. 
The hyperchromicity effects for the duplexes used in this chapter can be found in 
table 3.2, along with calculated and true extinction coefficients. 
3.2.3 Circular Dichroism (CD) 
The oligonucleotides were then tested to see if they were more A or B form when 
compared to the wild type. This was done by Circular Dichorism (CD). CD is a form 
of spectroscopy that involves the use of circularly polarized light (figure 3.7). Light 
is electromagnetic radiation between wavelengths of 400 to 700 nm and is formed 
from two waves, an electric and magnetic field. These oscillating fields together 
form the electromagnetic wave. The electric and magnetic field are perpendicular to 
each other, and there is a phase difference of 90 degrees between them. This means 
that when one wave is at its peak, the other is just crossing the zero line. This forms 
an electromagnetic wave that spirals like a helix. When the difference is 90 degrees 
the electromagnetic wave can be said to be "right handed", when the difference is -
90 degrees the wave can be said to be "left handed". Chiral molecules have no 
reflection plane and so any distortion of their electrons will not have one either. 
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Name Ecale Eobs Hyper (%) 
WT 749100 494406 34 
AF1 742800 497676 33 
AF2 748700 483660 28 
AF3 768800 503564 34.5 
BF 779200 506480 35 
Table 3.2 Observed extinction coefficients for WT and mutant oligonucleotide 
duplexes. The calculated extinction coefficient (Ecalc) and observed extinction 
coefficient (Eobs) are shown, along with hyperchromicity effect % (Hyper) for WT, 
AFt, AF2, AF3 and BF oligonucleotide duplexes. Observed extinction coefficients 
were calculated by taking percentage of hyperchromicity effect from the calculated 
extinction coefficient. Hyperchromicity effect percentages were found by 
phosphodiesterase I digests of the duplexes. 
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Figure 3.6 Phosphodiesterase I digest of the oligonucleotide duplex WT. 
Time courses of ODs for all oligonucleotides, WT, AFl, AF2, AF3 and BF 
were taken over a period of 1-2 hours during the phosphodiesterase I digest. 
The reaction was carried out in 100 mM Tris pH8, 1 mM Mg2+ solution 
with 5 units of phosphodiesterase I. The reactions were not stopped until the 
00 plateaued indicating the reaction was complete. The WT 
oligonucleotide time course is shown here as an example. 
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Circularly polarised light ----1~, 
Electric wave -+ 
+--Magnetic wave 
Figure 3.7 Schematic of circularly polarised light. Circularly polarised 
light (blue) is fonned from two oscillating waves, an electric (red) and 
magnetic field (green) together called an electromagnetic wave. The electric 
and magnetic field are perpendicular to each other, and there is a phase 
difference of 90 degrees between them. This means that when one wave is at 
its peak, the other is just crossing the zero line. This fonns an 
electromagnetic wave that spirals like a helix, this is circularly polarised 
light. When the difference is 90 degrees the electromagnetic wave can be 
said to be "right handed", when the difference is -90 degrees the wave can be 
said to be "left handed". In this diagram the wave is right handed. 
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Therefore the interaction between a chiral molecule and left and right handed 
photons will be different. 
In ultra violet (UV) spectroscopy the amount of UV light absorbed by the molecule 
can be used to estimate the concentration of the molecule. In CD spectroscopy equal 
amounts of left and right circularly polarized light are radiated into a solution 
containing the chiral molecule. One type of circularly polarized light will be 
absorbed more than the other and the difference of absorption is measured and 
plotted against the wavelength this forms the CD spectrum of the sample. The 
amount of absorption of right circularly polarized light (Ar) is taken from the amount 
of absorption of the left circularly polarized light (AI) and this equals the CD signal 
at a given wavelength, the equation is CD= AI - Ar-
CD was used in these experiments to determine the DNA structure of the 
oligonucleotide duplexes and this is one of the applications of CD. CD was chosen, 
instead of NMR for example, because it is relatively quick, easy to set up and 
straight forward to perform. This method has also been used to differentiate between 
A or B form DNA before (Ivanov et aI., 1973). This is possible partially due to the 
CD spectra observed with DNA from 200 to 300 nm this is due to the skewed 
orientation of the DNA bases and a change in the base orientation. A-form DNA 
base pairs are tilted rather than perpendicular to the helix axis and therefore result in 
a change from the typical CD spectrum observed for B-form DNA between 200 to 
300 nm. It has been observed that CD spectra often vary more with changes in base 
orientation than with base composition (Rodger, 1997). 
The typical CD spectrum for a truly B-form DNA structure is observed as a positive 
peak at 275 nm, a negative dip at 240 nm and zero being around 258 nm. The typical 
CD spectrum for a truly A-form DNA structure is observed as a positive peak 260 
nm, which is larger than the corresponding B-form peak, and there is a negative 
band at 210 nm. Sequence can have some effect on these peaks though, for instance 
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the CD spectrum of highly GC-rich sequences that are A-form in structure has a 
strong positive band at 266-268 nm. There is a weaker positive band at 284-286 nm 
and a strong negative band at 237-244 nm. B-form DNA with a highly GC-rich 
sequence produces a strong positive band at around 277-282 nm and a negative band 
around 247-250 nm. Whereas AT-rich sequences in both A or B-form structures 
become visualised as a strong positive band between 273-277 nm, but this band is 
less intense in the A-form. In this case A and B-form can only be distinguished by 
the position of the strong negative band. 
The spectrum for the different mutant oligonucleotides and the wild-type are shown 
in figure 3.8. In this experiment both the positive peak and the negative peak 
between wavelengths 220-320 nm were analysed to define if an oligonucleotide had 
an A or B-form structure. This was because the positive peak in highly AT -rich 
sequences is centred in the same place for both A or B-form, therefore the negative 
peak was analysed as well. Positive peaks towards 260 nm indicate a more A-form 
structure and towards the 280 nm indicate a more B-form structure. Looking at the 
spectrum for the wild-type gala2 promoter oligonucleotide it can be seen that it has a 
partial A-form structure, which has been shown by previous experiments (Scarlett et 
al.,2004). 
The mutant AFl has a similar CD spectrum to the wild type. This shows that AFl at 
least shares the wild-type's strong A-form structure, although any increase in A-
form achieved is barely detectable by CD. Unexpectedly the mutant AF2 appears to 
have a more B-form spectrum, despite it's design as A-form; with a predicted APE 
of -0.5. The positive band falls between 277 to 282 nm indicative of B-form. The 
negative band is unchanged, suggesting there may be some A-forming potential still 
present. Looking at the prediction graph for AF2 (figure 3.4) it can be seen that this 
mutant has bases of high A-form preference surrounded by areas of B-form 
preference. By contrast the mutant AFI prediction graph (figure 3.4) shows A-form 
preference spread over the oligonucleotide and not in isolated regions. This result 
suggests that to make DNA more A-form in structure extended areas of A-form 
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Figure 3.8 Circular dichorism of duplex oligonucleotides WT, AFl, 
AF2, AF3 and BF. Circular dichorism spectra are shown for 36 bp duplex 
oligonucleotides AFI , AF2, AF3 , BF and WT, Oligonucleotide duplexes 
were dissolved in 5 mM Phosphate buffer and 100 mM potassium fluoride. 
Absorbance of polarized light was recorded from 220 nm to 360 nm. 
Positive bands towards 260 nm indicate a more A-form structure and 
towards 280 nm indicate a more B-form structure. Negative bands towards 
240 nm indicate preference for A-form structure and towards 250 nm a B-
form preference. 
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preference are required. High local regions of A-form preference may be swamped 
by the surrounding B-form propensity (Peter Cary, unpublished data). The AF2 
mutant was discarded from future experiments as it was not A-form. Looking at the 
spectrum for AF3 (figure 3.8) it is similar to the wild-type spectrum and AFI. This 
apparent lack of change in the CD is at least partly due to the replacement of GC 
base pairs by AT base pairs, resulting in a wavelength shift towards 273- 277 nm of 
the strong positive band and so AF3 is at least as A-form as the wild-type. 
In general the CD spectra for AFl and AF3 do not appear much more A-form than 
the wild-type spectrum. A possible explanation for this is that the wild-type is as A-
form as it can be, without changing critical bases. An estimated 56 % of the wild-
type sequence is A-form and 16 % possibly A-form, but this A-form propensity is 
not evenly spread throughout the wild-type oligonucleotide. The inverted CCAA T 
box has one base pair with high of A-form propensity surrounded by bases with a B-
form propensity and an unknown. In the area where critical bases for CBTF 
sequence specific contacts of the gata2 promoter lie there is also a high number of 
unknowns. Unknowns are bases for which the triplet A or B-form propensity has not 
been solved and so cannot be predicted with the method of Basham et al. As 
witnessed with the AF2 mutant, areas of high A-forming propensity when 
surrounded by B-form or unknowns do not appear to change the DNA structure to 
A-form. As a consequence it is difficult to make the oligonucleotide duplex more A-
form when these bases cannot be changed and gives some explanation for the B-
form shoulder that is seen on all the spectra. 
The flanking regions of the inverted CCAAT box and critical bases are predicted to 
have high A-form propensity, the -46 to -55 upstream and the -30 to -34 downstream 
regions have APEs of -0.70 and -0.25 respectively and presumably the bulk of the 
A-form structure detected by the CD results from these flanking regions. Therefore 
increasing the predicted A-form propensity in these flanking sequences may not 
dramatically increase the total A-form content since these regions are already 
strongly A-form. Only by replacing the CCAAT box and the bases indicated in 
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making direct protein contacts could the CD spectrum be made consistent with a 
completely A-form DNA structure. The predictions for AFI and AF3 suggest that 
the areas of existing B-form structure in the wild-type promoter that could be 
changed have been reduced by the introduced mutations and so the mutants are in a 
more stable A-form structure. The mutant BFl spectrum has a classic B-form shape, 
the peak had completely moved to the 280 nm, typical for a B-form structure. These 
oligonucleotides, WT, AFl, AF3 and BF were next used for competition EMSA. 
3.3 Competition EMSA 
A competition electrophoretic mobility shift assay (EMSA) was carried out on 
whole Xenopus laevis embryo extract with all mutant and wild type 
oligonucleotides. EMSA is a common technique used to study interactions between 
protein and DNA and protein and RNA (Orford and Guille, 1999). This technique 
can be used to determine if a protein or proteins are capable of binding a given DNA 
or RNA sequence. It can also be used, as in this case, to see which DNA sequence 
has a higher affinity for a protein or protein complex. EMSA involves 
electrophoretic separation of a protein-DNA or protein-RNA mixture on a 
polyacrylamide or agarose gel. 
On the competition EMSA gels used in this study, there are several lanes. One was a 
control lane and contained labeled DNA probe only. In this case the DNA probe was 
the WT oligonucleotide, radioactively labeled with 1i:P33]ATP. The other lanes 
contained Xenopus laevis embryo extract that was taken at stage 14, DNA probe and 
varying amounts of unlabelled DNA (cold competitor). Cold competitor was either 
one of the mutant oligonucleotides (AF1,AF3 and BF) or the WT oligonucleotide 
itself. They are referred to as cold competitor because they are not radioactively 
labeled and will compete to bind to the target protein complex, CBTF, with the DNA 
probe. In lanes with protein an extra lower mobility band will appear, the "band 
shift". This is the protein and the DNA probe bound together, which is larger and 
less charged than the free DNA and therefore migrates more slowly though the gel. 
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Cold competitor, either a mutant oligonucleotide (AFl, AF3 or BF) or the WT 
oligonucleotide was added to adjacent lanes. If the cold competitor has a higher 
affinity for the complex than the probe, the band will become fainter. If the cold 
competitor has a lower or no affinity for the complex, the band will either not 
become as faint or not be affected at all. Increasing concentrations of cold 
competitor, 4, 40 and 200 fmol, was added over three lanes and the DNA probe 
concentration was kept constant at 40 fmol. If the cold competitor had a higher 
affinity for the protein CBTF than the DNA probe the bands grew fainter with 
increased cold competitor. The wr cold competitor identified specific CBTF shifted 
bands as well as providing a control to compare mutant cold competitor results. 
The ratio of bound to unbound nucleic acid on the gel is a direct reflection of the 
interactions in the binding reaction at equilibrium. This stability is in part due to the 
low ionic strength of the buffer, but also due to a "caging effect", in that the protein 
surrounded by the gel matrix is unable to diffuse away from the probe (Fried and 
Crothers, 1983). This "freezes" the reaction as it enters the gel and once the mix is 
running on the gel, there are no dynamic interactions occurring. Figure 3.9 shows 
example gels for this experiment. All competition EMSAs were conducted in triplet, 
on different batches of stage 14 Xenopus laevis embryos. As the bands disappear this 
indicates higher binding by the unlabeled probe (cold competitor). Figure 3.9 
indicates that the BF mutant binds less well than the wild type oligonucleotide and 
that AFI and AF3 bind a least equally, if not better than the wild type. From figure 
3.9 it can be seen that there are two bands. It is not known why two bands are 
present it is possible that these bands represent the presence of two highly related 
complexes, isoforms of CBTF which could contain different sub-units. There is also 
a non-specific band present in wr, AFI and BF but not AF3 competition gels. It is 
non-specific and this can be seen from the fact it is unchanged in the WT 
competition. The lack of this band in AF3 could be due to embryo variation. 
The CBTF/DNA complex from the highest concentration of cold probe (200 fmol) 
was five fold higher than the radioactive DNA probe (40 fmol). The band intensities 
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Figure 3.9 Competition EMSA with mutant oligonucleotides. WT probe 
was labelled with V[p33]-ATP and mixed with embryo extract containing the 
protein complex CBTF and varying amounts of cold competitor. The mix was 
allowed to reach equilibrium, 15 minutes at 4°C. The sample was then run on 
a native 4% polyacrylamide gel. The two highest bands indicate binding of 
DNA probe (WT) to two CBTF complexes. As increasing amounts of cold 
competitor were added, 4 finol, 40 fino I and 200 fmol, the bands became 
fainter if the cold competitor bound better to CBTF complexes than the DNA 
probe. The cold competitors used in the different competition EMSAs are 
labelled at the top of the lane as WT, API, AF3 and BF. Unbound DNA probe 
migrated the furthest and is labelled as free probe. 
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corresponding to this complex were measured (Fujifilm FLA-5000 phosphoimager) 
and quantified (Image Gauge Software) before plotting. The numbers from the 
mutant oligonucleotides were normalised to the wild-type, taken as l, to give 
relative binding (figure 3.10). 
This figure shows that AFl and AF3 bind CBTF better relative to the wild-type 
oligonucleotide and that the BF mutant binds relativity less well than the wild-type. 
These data show that an A-forming structure at the gala2 promoter has a higher 
binding affinity for the CBTF complex than a B-forming structure, possibly via the 
dsRBDs of ilf3. The next experiment carried out was to assess the levels of 
transcription in vivo from promoters containing these mutant sequences, to test 
whether increased binding affinity has an effect on transcriptional activation. 
3.4 The luciferase assay 
3.4.1 SV 40 promoter driving firefly luciferase 
A reporter gene assay in Xenopus laevis was picked to investigate whether an A-
form DNA structure at the gala2 promoter was involved in transcriptional activity 
for several reasons. The first is that it gives an idea of transcriptional levels in vivo. 
Secondly the assay has been well established in other systems and shown to give 
reliable data (Sherf et al., 1996). The Dual-Glo luciferase assay system (Promega) is 
designed to be used in cell culture, but was chosen here for increased accuracy due 
to the inclusion of a co-reporter plasmid. A co-reporter allows for background 
transcriptional levels, variation in transcription between individuals and injection 
variation. Two luciferase genes are used, firefly luciferase (primary reporter) and 
Renilla luciferase (co-reporter). A plasmid containing the Firefly luciferase gene, 
pLG4.10 (Promega), was used and had either the wild-type gala2 promoter (WT) or 
varying mutants of the promoter (see table 3.1) sub-cloned upstream of the gene. 
A larger section of the gala2 promoter was used for this assay than for the 
competition EMSA experiments discussed above. Previous research has shown that 
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WT SF AF1 AF3 
Oligonucleotide duplex 
Figure 3.10 Graph of competition EMSA data. Oligonucleotide binding for 
AFl, AF3 and BF was quantified and nonnalized to the wild-type, WT. The 
wild-type is considered to be one and numbers lower than one have poorer 
affinity for the CBTF complex while numbers higher than one have better 
affinity for the CBTF complex relative to the wild-type sequence. Data is an 
average of 15 replicates and en'or bars are shown representing maximum and 
minimum variation. 
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a region 66 base pairs upstream of the start of transcription and 192 base pairs of 
exon I (downstream from the start of transcription) is the minimal promoter, the 
smallest region from which measurable transcriptional activity can be achieved 
(Brewer et aI., 1995). The largest fragment used in their study was a 1842 bp 
fragment (1650 base pairs upstream of the start of transcription and 192 base pairs of 
exon I). However, both the 158 and 1842 bp fragments gave lower transcription than 
a 609 bp sequence containing 417 base pairs upstream and 192 base pairs 
downstream of transcription. This 609 bp region was chosen here to increase levels 
of transcription and hence improve the quality of results while at the same time 
mirroring the behaviour of endogenous gata2 and therefore in vivo significance. 
First the system had to be tested and characterised in embryos since it was designed 
for cell culture. A control plasmid with the firefly luciferase gene driven by the 
SV40 enhancer/promoter, pLG4.13, was ordered (Promega). The SV40 promoter is 
a highly active, constitutive promoter and a lack of reliable luciferase signal from 
this promoter might mean experiments would be impossible with the less active 
gata2 promoter. 50 ng of pLG4.13 was injected into single cell Xenopus laevis 
embryos and the embryos were left until stage 14 and harvested. Stage 14 was 
chosen as it is when zygotic gata2 transcription is active. Embryos were lysed in 1 X 
PLB (Promega, Dual-Glo kit), 20 embryos in 200 J.ll. The equivalent of five 
embryos, 50 ,.tl of extract was taken to be assayed for activity. The cell lysate was 
placed in one well of a 9 by 12 well plate. The luminescence reaction was then 
started by the addition of 50 J.lI of solution lar II (Promega, Dual-Glo kit). The 
sample was then placed in a luminometer to measure the amount luminescence. 
Embryos injected with pLG4.13 plasmid gave significant amounts of luminescence, 
40,000+ candles per second, when compared to five un-injected control embryos, 50 
III of extract in a replicable manner. This showed the system was suitable for use in 
Xenopus embryos (Figure 3.11a). 
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Figure 3.11 Optimisation of the luciferase assay. Luminescence normalised 
by dividing primary reporter (PLUC) candles per second by the co-reporter 
(Renilla) candles per second. (a) Luminescence from SV40.pLUC plasmid 
prepared by Qiagen midi-preparation kit compared to the same plasmid 
provided by Promega. (b) luminescence in candles per second of SV 40.pLUC 
after addition of activator, lar II and quencher, stop and glow. (c) 
Luminescence in candles per second from SV40.pLUC (grey) and TKJRenilla 
(black) over time. (d) Luminescence from SV40.pLUC plasmid prepared 
using Qiagen midi-preparation kit compared to the same plasmid prepared 
with a further a CsCI gradient purification step. 
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Luminescence was normalised by dividing candles per second for the primary 
reporter, in this case firefly luciferase driven by SV 40 enhancer/promoter, by the 
candles per second for the co-reporter. 
Preliminary experiments were conducted with these clones to optimise the assay. 
The luciferase glow for both is a chemical reaction and was started by the addition 
of an activation solution. There are two activation solutions used with the dual 
luciferase assay, these are Lar II, this starts the firefly luciferase reaction and the 
firefly luciferase luminescence was measured first. The second was Stop and Glo® 
this solution was added after the primary reporter, was measured. Stop and Glo® 
solution quenches the firefly luciferase reaction and activates the second luciferase, 
Renilla. The co-reporter is Renilla luciferase and is driven by the Thymidine kinase 
(TK) promoter. This plasmid contains the herpes simplex virus Thymidine kinase 
promoter driving a gene encoding Renilla luciferase. This gene encodes a 36 kDa 
monomeric protein originally cloned from the marine organism Renilla ren iform is. 
The TK promoter was chosen for this co-reporter to provide low to moderate levels 
of Renilla luciferase expression in co-transfected mammalian cells (Promega, dual-
luciferase reporter assay handbook). 
Figure 3.11 a shows relative luminescence for the plasmid pLG4.13, SV 40 promoter, 
when used directly from a sample sent by Promega and the same plasmid prepared 
by a midi-preparation kit (Qiagen). Clones created for this experiment were to be 
prepared using the midi-preparation kit (Qiagen), and the quality of the plasmid 
from this method may be of a lower quality and hence produce lower levels of 
luciferase protein. Figure 3.lla shows this to be true, measurable and reliable 
luminescence can be obtained from the midi-preparation kit although it is 
considerably lower than the plasmid supplied by Promega. In the next experiment 
the co-reporter, TKiRenilla, was not injected, this was to ensure that the Stop and 
Glo® solution does successfully quench the firefly luciferase glow. Figure 3.llb 
shows candles per second for pLG4.13 after the addition of Lar II, the solution that 
initiates the firefly luciferase glow (primary reporter), and after the addition of Stop 
and Glo®. The Stop and Glo® solution does successfully quench firefly luciferase 
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reaction, so all measured luminescence after addition of Stop and Glo® originates 
from Renilla luciferase. 
Next the durability of the luminescence signal from the two luciferases was 
considered, luminescence over a period of 180 seconds was measured for Firefly 
luciferase glow (pLG4.13) and Renilla luciferase glow (TKIRenilla) and results 
shown in Figure 3.l1c. This was conducted to measure the signal decay over time, it 
was important to know this as the length of time taken to measure the luminescence 
could have great effects on results if the signal persistance is short. The Firefly 
luciferase glow does decay more quickly than the Renilla luciferase glow, although 
both are stable for the first 30 seconds of measurement. All measurements were 
therefore taken in the first 30 seconds to avoid this decay affecting the results. 
Figure 3.11d Shows relative luminescence from plasmid prepared either by a Qiagen 
midi-preparation kit or the same plasmid but with an extra purification step, a 
Caesium Chloride (CsCI) gradient. This was done to see if we could improve the 
signal from plasmids prepared by the midi-preparation kit. CsCI gradient 
centrifugation can be used to isolate super-coiled DNA removing nicked circle 
DNA, where as Qiagen midi-preparations alone yield nicked circle DNA as well. 
Super-coiled DNA is known to transcribe better than non super-coiled DNA 
(Ogryz'ko et aI., 1986). The CsCI gradient did not improve the signal from the 
plasmid so this extra step was not used in future experiments. To improve reliability 
of the assay plasmids were digested with BamHI enzyme to linearise the plasmid. 
This was to remove variation in transcription as a result of differences in super-
coiling levels between preparations of plasmid. The BamHI site was located just 
after the firefly or Renilla luciferase gene (Appendix IV). The next step was to get 
measurable luciferase activity from the gata2 promoter driving the firefly luciferase 
gene. 
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3.5 Luciferase assay with gata2 promoter 
The gata2 promoter used in these assays, 417 base pairs upstream on the start of 
transcription and 192 base pairs of exon I (figure 3.12), was cloned into a plasmid 
containing the firefly luciferase gene, pLG4.l0 (Promega). The 417 region was 
chosen over a smaller and more active region, 241 base pairs upstream of the start of 
transcription (Brewer et aI., 1995), to increase mimicing of endogenous gala2 
transcriptional behavior from the injected promoter and improve in vivo significance 
of experiment. A control plasmid was also created with only 31 base pairs upstream 
of the start of transcription and the 192 bases of exon I. This region that does not 
contain the critical inverted CCAA T box, is not sufficient to give normal levels of 
transcription (Brewer et aI., 1995) and was used as a negative control. These regions 
were amplified by PCR from a clone provided by Prof Matt Guille. This clone, 
417CA T, contains the 417 base pairs of the gata2 promoter and 192 base pairs of 
exon I. This promoter was driving the chloramphenicol acetyl transferase (CAT) 
reporter gene in the original clone (Brewer et aI., 1995). The forward PCR primers 
contained a KpnI site and complementary regions to either 417 base pairs or 31 base 
pairs upstream from the start of transcription and the reverse primer, used for both 
clones, contained a BglII site 192 base pairs downstream of the start of transcription 
(Figure 3.12). These incorporated restriction sites were then used to clone the 
promoter into the plasmid pLG4.1O, which contained the synthetic firefly gene luc2, 
this is a modified form of the gene from the organism Photinus pyralis. The clone, 
417WT, was then identified by restriction enzyme digest with KpnI and BglII to 
check correct size of insert and the sequence was confirmed by dideoxy sequencing 
(MWG). 
Once activity of the assay was confirmed in Xenopus laevis embryos with the SV 40 
promoter, preliminary experiments were conducted with the 417WT clone to see if 
this promoter was also active. An assay was also carried out to see if 417WT was 
expressed with the same temporal pattern as the endogenous gala2 promoter. Figure 
3.13a shows luminescence in candles per second from the 417WT and 31 WT 
plasmids, taken from stage 14 Xenopus laevis embryos. Stage 14 was chosen as 
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·417 CTAGATTGTTGGGTG TTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT ·368 
I ·417 primer forward I 
·~7 AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA ·318 
·317 ATTGTGGTG TGTGTGTATTTA TGTCTGATATACAAAAACACAAGCAGAAC ·268 
·267 AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGACA .218 
·217 ATCCCACCCATTAAA TGGACTTTGCTAATAAAG TCCCCCCCCTGCAA TCC ·168 
·167 CCCCACCCA TAGTAA TAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG ·118 
·117 
.fJ7 
·17 
33 
83 
133 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGGG 
CGACTGGC ATTG GGGGTTATTAGCTGT 
I Mutation re gion I I Inverted CCAAT box I I ·31 primer forward I 
GCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCAGT I Exon 1 I 
GCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGTCTG 
CCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCCTC 
AGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCGAT 
I ·417 primer reverse 
183 CTCCAGCT 
-68 
·18 
32 
82 
132 
182 
Figure 3.12 Annotated 417 base pairs of the Xenopus laevis gata2 promoter 
with exon 1. This is the largest section of the gata2 promoter that was cloned in 
to the pLUC plasmid, 417WT. The forward and reverse primers are highlighted 
in blue. A 31 bp section was also cloned using a different forward primer and is 
highlighted in pink. The inverted CCAA T box, -44 to -40, is highlighted in 
green. The region where mutations were designed to make the promoter more A 
or B-form, -59 to -33 , is highlighted in yellow. The inverted CCAA T box 
included in the critical bases was avoided. Specific mutations are not annotated 
(see table 3.1 mutations). Oligonucleotides used in EMSA were based on region -
62 to -27 (not annotated). 
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Figure 3.13 Preliminary luciferase assay experiments with gala2 
promoter 417WT and 31WT Luminescence normalised by dividing 
primary repOlier (PLUC) candles per second by the co-reporter (R enilla) 
candles per second. Either 50 ng 417WI and 50 ng IKJRenilla or 50 ng 
31 WT and 50 ng TKJRenilla were injected into Xenopus laevis embryos at 
the one cell stage. Embryos were harvested and assayed for lwninescence. (a) 
Shows 417WT luminescence compared to 31 WI luminescence from stage 14 
embryos. (b) A time course of 417WI luminescence from embryos taken at 
stages 6 to 24 of development. Luminescence of 31 WI at stage 14 is also 
shown for comparison. 
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previous experiments have shown gala2 transcription to be high at this stage 
(Brewer et aI., 1995). The figure shows that the 417WT is able to give reliable and 
measurable data; the 31 WT gave low signal as was expected. This showed that 
luminescence measured from 417WT clone is from transcription of this plasmid and 
is most likely activated by the same activators as endogenous gala2 because 31 WT, 
missing the critical CCAA T box, is relatively inactive as has been previously 
reported (Brewer et aI., 1995). 
Figure 3 .13b is a time course showing signal from the 417WT construct. This was to 
see if transcription from this promoter mimiced endogenous gala2 expression. The 
signal from the firefly luciferase is very similar to results from a time course 
showing gala2 mRNA levels (Brewer et aI., 1995). The expression peaks here are 
slightly delayed relative to endogenous mRNA expression probably reflecting the 
assay measuring protein expression and the lag during which the mRNA is 
translated. This suggests that transcriptional control of the injected 417WT plasmid 
is the same as transcriptional control of endogenous gala2, at least in terms of stage. 
Transcription in this study seems to start at around stage 10 and increase until stage 
14. There is then a drop in expression at stage 16 and by stage 20 expression is rising 
again. Gala2 has been shown to be active in haematopoiesis and neurogenesis 
(Dalgin et aI., 2007; Zhou et aI., 2000) and possibly the gene is turned on for 
haematopoiesis development around stage 14. Then expression is stopped, 
explaining the dip at stage 16, and the gene is reactivated for neurogenesis at stage 
20. 
The A and B-form mutants containing the same mutations as the oligonucleotides in 
the competition EMSA were introduced into the context of the 417 promoter 
fragment. The mutations were introduced via a PCR based method, involving a long 
PCR tail which contained the base substitutions (table 3.1). The PCR primers 
containing the tail replaced the reverse primer used to create 417WT, 31 WT and was 
designed up to an internal SmaI site, so that the peR product containing the 
mutations could be subsequently sub-cloned into the 417WT plasmid. The SmaI site 
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was chosen as suitable for this method, because there was only one SmaI site in the 
417WT plasmid and as SmaI is a blunt end cutter a digest did not have to be carried 
out on the PCR product prior to cloning. The forward primer used to create 417WT 
was kept the same. The PCR products were then sub-cloned using a KpnI digest of 
the 5' end and the blunt end at the 3' end, into a 417WT plasmid similarly digested. 
Possible clones were screened with a SmaI digest which should be destroyed or a 
KpnI and BglII digest to check for a correct size insert. The clones were then 
confirmed by DNA sequencing. 
Oligonucleotides used in the CD and competition EMSA were named WT, AFl, 
AF2, AF3 and BF. The -417 to 192 promoter regions used in luciferase assays were 
named 417WT, 417AFl, 417AF3 and 417BF. There was no 417AF2 because AF2 
was removed from study after CD showed it did not have an A-form structure. The 
WT oligonucleotide was represented in luciferase assays by 417WT. This is the 
wild-type with no added mutations. 417 AFI has the same mutations as AF1; the 
difference is 417 AFI is longer, -417 to 192, compared with AF1, -62 to -27, and 
cloned into the pLUC plasmid. This also applies to 417 AF3 and AF3, 417BF and 
BF. 
Luciferase assays were then carried out using the clones and repeated in triplet with 
different embryo batches on different days (figure 3.14). This figure shows that 
transcription from the A-form mutants is higher and from the B-form mutant lower, 
relative to 417WT. The results from the competition EMSA (figure 3.10) and the 
luciferase assay (figure 3.14) agree well with each other and the graphs look very 
similar. This suggests that binding of CBTF to the gala2 does directly affect 
transcriptional activation. 417 AFI transcriptional levels from the luciferase assay are 
almost doubled when compared to the wild-type plasmid, 417WT. showing that 
mutations introduced to the 417WT promoter to produce 417 AF1 increased 
transcriptional activity. 
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Figure 3.14 Transcriptional from gata2 mutant promoters. Relative 
expression was calculated by first calculating the relative luminescence for 
each mutant clone, 417AFl , 417AF3, 417BF, 417WT and 31WT. 
luminescence of the mutants was then normalized to the luminescence of 
417WT, considered to be one. All experiments were done in triplicate. 
Embryos were injected at 1 cell stage with 50 ng of 417WT, 31 WT, 417 AFl, 
417 AF3 or 417BF plasmid and 50 ng control plasmid TKJRenilla. Embryos 
were then harvested at stage 14 and assayed for luminescence. A line is 
placed at one, all mutants lower than one give less transcription compared to 
417WT and mutants higher give more transcription compared to 417WT. 
Error bars show maximum and minimum variation. 
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The results from the EMSA for AFI show that this mutant has higher binding when 
compared to the wild-type (WT), suggesting that binding of CBTF to the gala2 
promoter leads to transcriptional activity. The results for AFI and 417AFl suggest 
that these mutations that made the promoter more A-form have increased its affinity 
to bind to the dsRBDs of ilO, when ilO is in the CBTF complex, and thus lead to 
increased transcription. Binding of AFl relative to WT was increased but not as 
much as transcriptional levels of 417 AF 1 relative to 4t7WT. The reasons for this are 
not clear but it is possible that these base substitutions in the form of an 
oligonucleotide do affect binding and the effects on transcription of this small 
binding effect is magnified. This theory is supported by the fact that this is true for 
most of the clones used in this experiment; again offering support that CBTF 
binding to gala2 promoter directly affects its activation. The CD for AFt showed 
that this mutant promoter was at least as A-form as the wild-type (WT) promoter. It 
is unlikely that these base substitutions would increase transcription by chance, but 
to help reduce this possibility three A-form mutants were designed, to strengthen the 
evidence that mutant A-form structure has led to the increase in CBTF binding and 
transcription. 
AF2 was discarded from experiments after CD, because it did not have an A-form 
spectrum and therefore any results from this mutant would be unclear. AF3 had 
more mutations than AFt, this was to try and increase the amount of A-form 
propensity in this mutant. Changing more bases did not make AF3 more A-form 
than AFt. From the CD it can be said that AF3 is only as A-form as the wild-type 
(Wf). The positive peak on the CD for AF3 has moved towards the B-form. This is 
probably due to the mutant being AT -rich. In AT-rich sequences the positive band 
on the CD spectra around 260 nm to 280 nm is the same for A and B-form structures 
(section 3.2.3 and figure 3.8). The AF3/417AF3 constructs had higher levels of 
binding and transcriptional activity than the WT 1417WT sequences. The binding and 
transcriptional levels of AF1I417AFI were even higher than those observed for 
AF3/417AF3. The enhanced activity of AF1I417AFI compared to AF3/417AF3 
may be that AF1I417AFI is more A-form than AF3/417AF3, as suggested by the 
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CD data. The importance of an A-form element at this position in the promoter is 
supported by the BF/417BF assays, the BF mutant had a typical B-form CD 
spectrum and had lower binding and transcriptional levels than any of the other test 
sequences. 
3.6 Summary 
The experiments in this chapter ultimately aimed to test if an A-form structure at the 
gata2 promoter is important in activation of transcription. Thirty-six base pair 
oligonucleotides were designed using A-form prediction tables (Basham et al., 1995) 
and these mutants were tested using CD. The CD showed that the mutations 
succeeded in changing the structure to more A or B-form relative to the wild-type, 
with the exception of AF2. Competition EMSA was then carried out using these 
mutant duplex oligonucleotides. The competition EMSAs showed that mutations 
that made the promoter more A-form increased CBTF binding and B-form structures 
reduced binding, again normalised to the wild type. The next step was to move in 
vivo and to investigate transcription from promoters containing these mutant 
sequences. A luciferase assay was chosen to test these mutants in vivo as it is both 
quick and reliable. The assay was optimised and the gata2 promoter, 417 base pairs 
upstream of the start of transcription and 192 base pairs of exon I, had the mutations 
used in oligonucleotides for competition EMSA introduced via a PCR based method. 
The promoters were then sub-cloned into the pLG4.10 plasmid, hence driving the 
firefly luciferase gene. The amount of luminescence from this could then be used to 
assay levels of transcription from these promoters. Mutant promoters were injected 
into Xenopus laevis embryos and harvested at stage 14 for luciferase assay. The 
luciferase assay results reveal that the A-form mutant promoters give more 
transcription and the B-form mutant promoters give less transcription relative to 
wild type. 
Overall this suggests that DNA structure can play a role in regulation of 
transcription and in this case that an A-form element at the gata2 promoter is 
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important in transcriptional control. The importance of A-form DNA has never been 
researched in regulatory mechanisms and there is virtually no research in vivo and so 
evidence represented in this chapter is novel. Although the data shown in this 
chapter suggest an A-form DNA element at the gata2 promoter is important in 
activation, how important is not clear. For instance it does not show if binding and 
transcription would still occur if critical bases including the inverted CCAA T box 
(Brewer et aI., 1995) were removed and replaced with a totally A-form element. In 
the next chapter this will be investigated by studying a totally A-form structure at the 
critical region ofthe gata2 promoter. 
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Chapter 4: Contribution of an A-form element at the 
gala2 promoter to transcriptional activity 
4.1 Introduction 
In chapter 3 the importance of an A-form element at the critical region of the gala2 
promoter in transcriptional regulation was investigated. Previous research had shown 
that the ilO subunit of CBTF contained two double stranded RNA binding domains 
(dsRBDs), and that these dsRBDs are critical in allowing ilO to activate 
transcription (Scarlett et aI., 2004). DsRBDs are primarily involved in binding to 
dsRNA which is typically A-form in structure. DNA is normally found in the B-
form conformation, but can form an A-form helix (Franklin and Gosling, 1953; 
Watson and Crick, 1953). There is evidence that the critical region of the gala2 
promoter (-61 to -27) is partially A-form in structure (Scarlett et aI., 2004). A 
hypothesis was formed that the dsRBDs could bind to the critical region of the gala2 
promoter and activate transcription because of this structure. In chapter 3 this 
hypothesis was investigated by mutating the critical region of the gala2 promoter to 
be more A or B-form in structure. Results from chapter 3 suggest that an A-form 
element at the gala2 promoter is indeed involved in binding of the CBTF complex 
and activation of the gala2 promoter. In this chapter these experiments from chapter 
3 are expanded to test the relative contribution of structure and sequence to 
transcription. 
The critical bases indicated from the footprint of the ilO binding region of the gala2 
promoter (Orford et aI., 1998) (figure 3.3) include an inverted CCAA T box (Brewer 
et aI., 1995). For this reason experiments in chapter 3 avoided these critical bases 
when designing mutant promoter sequences so that the only variable affecting 
binding and transcription would be DNA structure. In this chapter how important the 
critical bases and CCAAT box are when an A-form element is present at the 
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miminal gata2 promoter was studied. A totally A-form element replacing the critical 
region of the gata2 promoter was produced in this chapter to test whether the gata2 
promoter would still be active. The total A-form element (TAF) had no resemblance 
to the wild-type region of the gata2 promoter and was unconstrained by the bases 
indicated to make essential DNA contacts from the footprint. Control sequences 
were also designed, these were a wild-type sequence with the CCAA T box removed 
(NC), the B-form mutant from chapter 3 with CCAAT box removed (BFNC) and a 
randomised sequence with no resemblance to the gata2 promoter and with no 
designed preference for a DNA structure (RAN). 
In this chapter the binding and transcriptional activity of these mutant regions was 
tested using the same methods as chapter 3. First 36 base pair oligonucleotides were 
designed using the algorithm of Basham et al (Basham et aI., 1995). These 
oligonucleotides were then tested by circular dichorism (CD) for the presence of the 
expected structure. Competition EMSA with Xenopus laevis embryo extract was 
then preformed on the oligonucleotides to investigate how well they bound to the 
CBTF protein complex. The oligonucleotide sequences were then incorporated into 
the 417 region of the gata2 promoter, 417 base pairs of the gata2 promoter and 192 
base pairs of exon I. These mutant promoter regions were then cloned into the pLUC 
plasmid driving the firefly luciferase gene. The level of transcription from these 
mutant promoters was then assayed by measuring the amount of firefly luciferase 
protein produced in a luminometer. 
4.2 Design of oligonucleotides 
Four 36 base pair duplex oligonucleotide mutant sequences were designed. Two 
were based on the gata2 promoter with the critical CCAAT box removed, these were 
based on the wild-type oligonucleotide (WT) and the B-form oligonucleotide (BF) 
previously used in chapter 3. With the inverted CCAAT box removed they were 
named NC and BFNC respectively. The other two oligonucleotides designed had no 
resemblance to the gata2 promoter, apart from the last six bases, which encoded a 
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Sma I restriction enzyme site. These bases were retained to allow incorporation of 
the sequence into the 417 gala2 promoter region later on (see chapter 3). All the 
oligonucleotide sequences used in this chapter can be seen in table 4.1 along with 
the WT oligonucleotide from chapter 3. The A-form propensity energy (APE) of all 
the oligonucleotides calculated using the Basham et al method are also shown. 
Positive numbers indicate a B-form preference and negative numbers indicate an A-
form preference (section 3.2.l). The prediction table from Basham et al predicts the 
A-form propensity of a base, in relation to its two surrounding bases (section 3.2.1). 
Prediction graphs showing the distribution of A or B-form preference over the whole 
oligonucleotide are shown in figure 4.1. 
4.3 Formation of duplexes and circular Dichorism (CD) 
Once all oligonucleotides were designed they were ordered (A TDbio) and annealed 
before assaying on a 10 % polyacrylamide gel to check for the absence of residual 
single stranded oligonucleotide (figure 4.2). Once annealing was confirmed the 
concentration of these mutant oligonucleotides was calculated using the Beer-
Lambert law (see chapter 3). The hyperchromicity effect was tested and calculated 
for each oligonucleotide duplex and applied to the extinction coefficients (see 
chapter 3).The calculated extinction coefficients, observed extinction coefficients 
and hyperchromicity effects for all duplexes can be seen in table 4.2. 
After the concentrations of the duplexes were calculated CD was carried out (section 
2.3.6). In figure 4.3 the CD spectra for the four oligonucleotide duplexes used in this 
chapter are shown with the WT oligonucleotide CD spectrum for comparison. The 
typical CD spectrum for a truly B-form DNA structure is observed as a positive peak 
at 275 nm and a negative dip at 250 nm. The typical CD spectrum for a truly A-form 
DNA structure is observed as a positive peak at 260 nm, which is larger than the 
corresponding B-form peak, and there is a fairly intense negative band at 210 nm, 
although the sequence of the oligonucleotide can have an effect on the position and 
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Name Sequence APE 
WT GGCTGGCGGAGGCTTGTGATTGGCTGGCCCGGGGTT 
-0.2 
CCGACCGCCTCCGAACACTAACCGACCGGGCCCCAA 
TAF GGCTGCCGGGGGCCCCCGTGCATGCATGCCGGGGTT -0.19 
CCGACGGCCCCCGGGGGCACGTACGTACGGCCCCAA 
NC GGCTGGCGGAGGCTTGTGTCCATCTGGCCCGGGGTT -0.1 
CCGACCGCCTCCGAACACAGGTAGA CGGGCCCCAA 
BFNC GTGCATGCATGCCTTGTGTCCATCTCAATGGGGGTT 0.2 
CACGTACGTACGGA~CACAGGTAGAGTTACCCCCAA 
RAN CCGCTTAAGATATCTGCGCGCCTTAAGATAGGGGTT 0.2 
GGCGAATTCTATAGACGCGCGGAATTCTATCCCCAA 
Table 4.1 Wild-type and mutant duplexes The critical bases including the inverted 
CCAAT box that have not be changed are highlighted in red. Base changes from the 
wild type to make the mutants more A, B-form or randomly selected (RAN) are 
highlighted in blue. T AF was designed to be totally A-form in structure with no 
resemblance to the gala2 promoter and RAN was designed with no structure 
preference and no resemblance to the Xgala2 promoter as a control. TAF, NC, 
BFNC and RAN have the 3' region highlighted in green as this is the same in all 
oligonucleotides to facilitate cloning. The average A-form DNA propensity energy 
(APE) of each 36 bp oligonucleotide duplex was predicted using the table from 
Basham el ai, 1995 and is shown. A positive APE indicated a B-form preference and 
a negative APE indicates an A-form preference. 
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., -'---------------' 
Figure 4.1 Prediction graphs of A and B-form preference. The method of 
Basham et aI , 1995 involved a triplet code table (Appendix VI) that can 
predict the A or B foml propensity (APE) of a base in the context of its 
neighbouring bases. Mutant 36 bp oligonucleotides were designed to favour an 
A or B-form structure using this method. APEs of bases that could be 
predicted are shown here, positive APEs indicate a more B-form and negative 
APEs a more A-fonn preference. (a) The predicted APE for each base, -61 to -
27, of the wild-type Xgata2 promoter. This region contains the critical bases 
including the inverted CCAAT box (Orford, 2000). (b) Mutant TAF, this 
mutant was designed to be totally A-fonn and have no resemblance to the 
wild-type sequence. (c) Mutant NC, this is the wild-type sequence with the 
CCAAT box removed. (d) Mutant BFNC, this is the B-foml sequence from 
chapter 3 with the CCAAT box removed. (e) Mutant RAN, this mutant was a 
random sequence designed with no structure preference and no resemblance to 
the wild-type sequence. 
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40 base pairs --. 
30 base pairs --. 
Marker T AF NC BFNC RAN 
36 base pairs 
~ oligonucleotide 
Figure 4.2 10% Polyacrylamide gel showing annealed oligonucleotides. 
Four sets of complementary thirty-six base pair duplex oligonucleotides 
corresponding to the mutant designs TAF, NC, BFNC and RAN were 
annealed and run on a 10% polyacrylamide gel. Invitrogen 10 bp ladder was 
used as a DNA marker; the 40 and 30 bp marks are indicated with arrows. 
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Name Beale Eobs Hyper (%) 
WT 749100 494406 34 
TAF 722000 565326 21.7 
NC 737600 494192 33 
BFNC 779200 503363 35 
RAN 774000 504648 35 
Table 4.2 Extinction coefficients for WT and mutant oligonucleotide duplexes 
The calculated extinction coefficient (Ecalc) and observed extinction coefficient 
(Eobs) are shown, along with hyperchromicity effect for WT, TAF, NC, BFNC and 
RAN oligonucleotide duplexes. Observed extinction coefficients were calculated by 
taking percentage of hyperchromicity effect from the calculated extinction 
coefficient. Hyperchromicity effect percentages were found by phosphodiesterase I 
digests of the duplexes. 
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Figure 4.3 Circular dichorism of duplex oligonucleotides WT, TAF, NC, 
BFNC and RAN. Circular dichorism spectra are shown for 36 bp duplex 
oligonucleotides T AF, NC, BFNC, RAN and WT. Oligonucleotide duplexes were 
dissolved in 5 mM Phosphatase buffer and 100 mM potassium fluoride at pH 7.8 
and absorbance of polarized light was taken from 220 run to 360 run. Positive 
bands towards 260 run indicate a more A-form structure and towards 280 run 
indicate a more B-form structure. Negative bands towards 240 run indicate 
preference for A-form structure and towards 250 run a B-form preference. 
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intensity of these bands. The CD spectrum of NC, the wild-type sequence with the 
CCAAT box removed, shows a more A-form structure since the positive band has 
moved more towards 260 nm and the negative band has moved towards 240 nm 
indicative of A-form (section 3.2.3). One of the obstacles observed in chapter 3 was 
trying to make the -61 to -27 region of the gala2 promoter more A-form without 
changing the critical bases from the footprint. The Basham et al prediction table was 
unable to fully assign the critical region since there were six undetermined bases. 
We hypothesised that this region was B-form and the flanking regions where 
mutations could be inserted already had an A-form structure, restricting the 
enhancement of the A-form already present. This NC oligonucleotide supports this 
theory, as removing the CCAA T box constraint has made the oligonucleotide more 
A-form. 
TAF was designed to be totally A-form with no resemblance to the gala2 promoter 
and the CD spectrum shows this sequence to be totally A-form. It has a strong 
positive band at 260 nm and a strong negative band around 240 nm. The B-form 
oligonucleotide from chapter 3 then had the CCAA T box removed to be used as a 
control in this experiment (BFNC), we hypothesised that if the CCAAT box is 
important its removal will lower the already reduced binding and transcription of the 
B-form mutant. The CD spectrum of this mutant looks very similar to the original B-
form (BF) mutant; with a positive band around 280 nm and a negative band around 
250 nm. The last oligonucleotide to be assayed was RAN; it had no resemblance to 
the WT sequence or any A or B-form preference and was a control for the TAF 
oligonucleotide. The RAN CD spectrum fell between an A and B-form signature, the 
positive band was more towards the B-form than the WT oligonucleotide but not as 
B-form as BFNC and the negative band fell in the B-form range. 
4.4 Competition EMSA 
Competition electrophoretic mobility shift assay (EMSA) (Orford and Guille, 1999) 
was carried out on whole Xenopus laevis embryo extract with the new mutant 
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oligonucleotides and the WT from chapter 3. This technique was used to determine 
the affinities of mutant oligonucleotides for the CBTF protein complex. EMSA 
involves electrophoretic separation of a protein-DNA or protein-RNA mixture on a 
polyacrylamide or agarose gel (section 3.3). Figure 4.4 shows typical EMSA gels for 
mutant oligonucleotides used in this chapter compared to the WT oligonucleotide 
EMSA from chapter 3. Cold competitor oligonucleotide was added in increasing 
amounts 4, 40 and 200 finol (indicated above the lanes) with 40 finol WT 
oligonucleotide probe. All oligonucleotides used in this chapter, TAF, NC, BFNC 
and RAN do not bind CBTF as well as the WT oligonucleotide. These competition 
EMSA gels were repeated 15 times and the amount of labelled complex from the 
200 frnol lanes for the mutant oligonucleotides were quantified on imagegauge 
software. The averages were then compared to the WT oligonucleotide average 
again, at 200 fmol. A histogram of the data is shown in figure 4.5. 
Figure 4.5 shows that none of the mutants bind as well as the WT oligonucleotide, 
indicating the importance of the CCAA T box. The control NC, which is the same 
sequence as the WT oligonucleotide but with the CCAA T box removed, binds very 
poorly although the non-CCAA T box critical bases are still present. This confirms 
that the CCAA T box is necessary for binding of the gata2 promoter to CBTF, as 
previously shown (Brewer et al., 1995). 
T AF binding data also supports the importance of the CCAA T box. In chapter 3 it 
was shown that an A-form element at the gala2 promoter contributes to correct 
binding of the gata2 promoter to CBTF and also in activation of gala2 transcription. 
However the experiments in chapter 3 did not answer how important this A-form 
element was for binding and transcriptional regulation with respect to sequence. 
TAF, an A-form sequence with no gala2 promoter resemblance was used in this 
chapter to see if an A-form structure without the critical bases, indicated from the 
footprint, would bind the CBTF complex as well as the WT oligonucleotide. It can 
be seen from figures 4.4 and 4.5 that TAF has reduced binding compared to the WT, 
although the TAF oligonucleotide does have a considerably higher binding affinity 
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WT TAF NC RAN 
CBTF--+ 
--+ 
Free 
--+ 
probe 
Figure 4.4 Competition EMSA with mutant oligonucleotides. WT probe 
was labelled with y[p33]_ATP and mixed with embryo extract containing the 
protein complex CBTF and varying amounts of cold competitor. The mix was 
allowed to reach equilibriwn for 15 minutes at 4 0c. The sample was then run 
on a native 4 % polyacrylamide gel. The two highest bands indicate binding of 
DNA probe (WT) to two CBTF complexes. As increasing amounts of cold 
competitor were added, 4 finol, 40 fmol and 200 fmol, the bands became 
fainter if the cold competitor bound better to CBTF complexes than the DNA 
probe. The cold competitor used in the different competition EMSAs are 
labelled at the top of the lane as WT, T AF, NC, BFNC and RAN. Unbound 
DNA probe ran the furthest and is labelled as free probe. 
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Figure 4.5 Summary graph of competition EMSA results. Oligonucleotide 
binding for T AF, NC, NCBF and RAN was quantified and nonnalized to the 
wild-type (WT). The wild-type is considered to be one, numbers lower than 
one have poorer affinity for the CBTF complex whi le numbers higher than 
one have better affinity for the CBTF complex relative to the wild-type 
sequence. Data is an average of 15 replicates and error bars are shown 
representing maximum and minimum variation. 
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for the CBTF complex than the NC, BFNC and RAN oligonucleotides. This 
confirms that the A-form structure is sufficient to direct binding of the CBTF 
complex to the minimal gala2 promoter region. As expected the BFNC and RAN 
oligonucleotide did not bind well and this again adds support to the role of the 
CCAATbox. 
4.5 Luciferase assays 
The sequences from all mutant oligonucleotides used in this chapter were then 
incorporated into the 417 region (section 3.5), replacing the critical region, -62 to -
27. This was done by a standard PCR reaction with the reverse primer having an 
extended tail containing the required mutations, this is the same method used in 
chapter 3 (section 3.4.2). Once the mutant 417 gala2 promoter regions were 
amplified they were cloned into the pLUC plasmid which contained the firefly 
luciferase gene (section 3.4.1). The luciferase assay was used as a method to 
measure transcriptional activity of these mutant promoters relative to the 417WT 
promoter, again as used in chapter 3. Activity was measured by assessing the level 
of luminescence produced by the firefly luciferase gene (section 3.4.1). The 
luciferase assay had already been optimised (sections 3.4.1 and 3.4.2), so these 
plasmids containing the mutant sequences, 417TAF, 417NC, 417BFNC and 
417RAN, were each co-injected with the control plasmid tkiRenilla, which acted as 
an internal control (section 3.4.1). All luciferase assays were carried out using the 
same method used in chapter 3, section 3.4.2, and carried out in triplet with an 
average for each mutant calculated. The data were normalised to the 417WT results. 
Figure 4.6 shows a histogram of the results from this assay, none of the mutants are 
as transcriptionally active as the 417WT plasmid, confirming again that the CCAA T 
box is also critical for transcriptional activation of the gata2 promoter. The mutant 
417TAF sequence was created to test whether a totally A-form structure at the 
critical region of the gala2 promoter unconstrained by the WT sequence is less 
active when compared to 417WT. The results show that an A-form element at the 
critical region of the gala2 promoter is not enough to produce WT levels of 
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Figure 4.6 Transcriptional levels from mutant gala2 promoters. Relative 
expression was measured by first calculating the relative luminance for each 
mutant clone, 417TAF, 417NC, 417NCBF, 417RAN, 417WT and 31WT. 
Luminance of the mutants was then normalized to the luminance of 417WT, 
which is considered to be one. All experiments were done in triplicate on 
separate embryo batches. Embryos were injected at 1 cell stage with either 50 
ng of 417WT, 31 WT, 417TAF, 417NC, 417NCBF or 417RAN plasmid and 
50 ng of control TKJRenilla plasmid. Embryos were then harvested at stage 
14 and assayed for luminance. A line is placed at one, all mutants giving 
results lower than one give less transcription compared to 417WT and 
mutants higher give more transcription compared to 417WT. Error bars are 
shown representing the maximum and minimum variation. 
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transcription alone, showing that the CCAA T box must be also involved. The 
417NC mutant with just the CCAAT box replaced is also relatively inactive 
compared to 417WT and shows the importance of these five bases. 
Unlike the binding of T AF the transcriptional levels of 417T AF are as low as 
417NC, 417BFNC and 417RAN. This suggests that the CCAAT box and the critical 
bases from the footprint are important in assembling fully active CBTF complex at 
the promoter. It is possible that in the competition EMSA experiment 417T AF binds 
well to the ilB subunit, as a single component separate from the CBTF complex. 
Therefore disassembling the CBTF complex by titrating out the ilB component. This 
would result in reduced visualisation of the CBTF/WT probe complex and therefore 
an apparently high binding for the CBTF complex. This would also explain the 
relatively low transcriptional activation from 417TAF, as although it may bind ilf3 
as a single subunit it can not assemble the full CBTF complex and transcriptional 
activation of gata2. This suggests a role for the critical bases in recruiting non-ilf3 
CBTF subunits. An alternative explanation for the importance of the CCAA T box 
sequence is that it forms an unusual structure or bend allowing the dsRBDs of ilB 
easy access to bind to sequences surrounding the CCAA T sequence. Further 
experiments are required to distinguish between these two possibilities. 
4.6 Summary 
4.6.1 Chapter 4 
The experiments from this chapter were carried out to test if a total A-form element 
with no resemblance to the critical region, -61 to -27, of the gata2 promoter could 
bind CBTF and also activate transcription. It was found that none of the mutants had 
high affinity for CBTF when compared to the WT oligonucleotide. These 
oligonucleotide sequences were then incorporated into the 417 gata2 promoter 
region and cloned into the pLUC plasmid containing the firefly luciferase gene. The 
transcription levels of these mutant promoters were then measured by assaying the 
level of firefly luciferase protein. It was found that none of the mutants created in 
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this chapter were transcriptionally as active as the 417WT promoter. This showed 
that the CCAA T box is critical for activation of the gata2 promoter, in agreement 
with previous data (Brewer et al., 1995). 
4.6.2 A dual-mechanism of gala2 promoter regulation 
Figure 4.7 shows the data for the competition EMSA and luciferase assays from both 
chapters 3 and 4 together. Binding of mutant oligonucleotides largely mirror the 
transcriptional levels of these sequences when placed in the context of the 417 gala2 
promoter region. This supports previous data that binding of the CBTF complex 
directly affects levels of transcription from the gala2 promoter. Putting all the data 
together it can be seen that for the two A-form mutants made and tested in chapter 3, 
AFI and AF3 (417 AFI and 417 AF3 when in the context of the 417 gata2 promoter 
region), both elevate transcriptional levels above that of the WT sequence. Even 
though they are not greatly elevated, the results show a positive contribution of the 
A-form element at the gata2 promoter. This is supported by the activity of the BF 
mutant, designed to be more B-form, this mutant's binding and transcriptional 
activity are greatly reduced from that of the Wf. It is possible that critical bases not 
identified by the footprint were mutated that resulted in this low activity but it is 
unlikely since many of the same bases were mutated in the A-form mutants. All four 
mutants created in chapter 4 are without a CCAA T box and do not produce 
equivalent CBTF binding or transcriptional activity as the Wf, even the total A-
form T AF. These results show that the presence of an A-form element alone is not 
enough to rescue activity from the promoter. The results from chapter 3 and 4 taken 
together suggest that the gata2 promoter is regulated by two important factors, 
structure and sequence. These two regulation mechanisms are sometimes known as 
direct (sequence recognition) and in-direct read-out (structure recognition). 
Proteins involved in binding to DNA are usually involved in direct read-out and 
proteins involved in binding to RNA are usually involved in in-direct read-out. The 
regulation of the gata2 promoter is unusual as it is regulated by a protein that 
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Figure 4.7 Summary EMS A and luciferase data from chapter 3 and 4 
relative to wild-type. A histogram of competition EMSA results of all 
oligonucleotides used in chapters 3 and 4 were normalized to the WT 
oligonucleotide. They are plotted alongside the luciferase results of all pLUC 
plasmids used in chapters 3 and 4. The EMSA and luciferase data for each 
sequence is closely mirrored. 
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contains dsRBDs that bind to dsRNA and these dsRBDs have been shown to be 
critical for binding of CBTF to the gata2 promoter (Scarlett et ai., 2004), possibly 
because of an A-form element at the gata2 promoter (Scarlett et aI., 2004). In 
chapter 3 the importance of this A-form structure was investigated and it was found 
that an A-form structure at the critical region of the gala2 promoter contributed to 
binding of CBTF and transcriptional activity from the 417 gala2 promoter region. 
This A-form element is not the only important region of the gala2 promoter, the 
inverted CCAA T box has been shown to be critical (Brewer et ai., 1995) and in 
chapter 4 this was also confirmed. This research has suggests a dual regulatory 
mechanism is involved in regulation of the gata2 promoter. In this model both the 
CCAAT box and the flanking A-form regions are required for full activity. In 
support of this is the results observed from the TAF/417TAF experiments. The TAF 
oligonucleotide competed better in the competition EMSAs compared to the other 
non-CCAAT box oligonucleotides, NC, BFNC and RAN, although this was not 
reflected in the transcriptional assays. This difference in binding and transcriptional 
data for TAF suggests that it may bind ilO as a single sub-unit, due to its highly A-
form structure, inhibiting its involvement in the formation of the CBTF complex. 
Future work should look at other A-form elements with the CCAAT box present but 
the surronding contact bases indicated from the footprint removed. It is possible that 
these contacts are not critical due to their sequence but to the structure which they 
form, i.e. A-form. 
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Chapter 5: Transgenic gatal Xenopus laevis 
5.1 Introduction 
A transgenic organism or cell is one that has a foreign gene, usually from a different 
species, inserted into its genome. The inserted gene is called a transgene. The term 
transgenic was first used by l.W. Gordon and F.H. Ruddle (1981), when they created 
transgenic mice by micro-injecting DNA into the pronuclei of fertilized eggs. Since 
then the use of transgenic animals has become very popular for incorporating 
transgenes to act as a reporter of promoter activity. Transgenic animals can be used 
as experimental models for phenotypic tests with genes whose function is unknown 
or to generate animals that are susceptible to certain compounds or stresses for 
testing in biomedical research (Merlino, 1991). A promoter or modifying element, 
such as an enhancer, can also be placed in front of a reporter gene and characterised. 
Transgenic Xenopus laevis have been used to locate regulatory regions of genes for 
dissection (Casey et aI., 1999; Knox et aI., 1998), to see where a protein is expressed 
(Kroll and Amaya, 1996) and to misexpress genes during development under 
specific spatial and temporal control (Hartley et aI., 2002). A reporter gene that is 
commonly used for this is green fluorescent protein (GFP) and it has been 
extensively used as an expression reporter in transgenic organisms and has also been 
engineered to give increased fluorescence (Heim et aI., 1995). The GFP protein is 
composed of 238 amino acids (26.9 kDa) and was originally isolated from the 
jellyfish Aequorea victoria that fluoresces green when exposed to ultra violet (UV) 
or blue light (Prendergast and Mann, 1978), there are two main benefits of using 
GFP in transgenic Xenopus; the first is that unlike some other reporter proteins, such 
as firefly luciferase used in chapters 3 and 4, GFP does not need a substrate to start 
the florescent reaction. The second is that GFP is not toxic to the organism. 
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In this chapter transgenic Xenopus laevis were created with the 417WT or 417NC 
promoter from chapters 3 and 4 and GFP as the reporter gene. In chapter 3 it was 
found that 417WT had similar temporal expression as endogenous gata2, here we 
aimed to assay if the 417WT promoter was active enough to give visible 
fluorescence and if it had the same spatial expression as endogenous gata2. The 
417NC transgenic was created to test if this previously characterised weak promoter 
would provide visible expression and if so whether levels would be lower than in the 
417WT transgenic. Previous research (Brewer et aI., 1995) (and in chapter 4 of this 
thesis) it was shown that the inverted CCAAT box of the gata2 promoter is required 
for transcriptional activity and in light of this it might be expected that 417NC will 
not give visible expression of the reporter. A trangenic Xenopus assay was chosen 
for the reasons above and as it also represents a truly in vivo method, since the 
transgene containing the promoter of interest and reporter gene become incorporated 
into the genome of the animal and passed onto any off-spring. Importantly the 
transgene is in a fully chromatinised state and subject to the full range of chromatin 
mediated regulatory mechanisms available to the cell. 
As a first step in generating transgenic Xenopus plasmids were created that 
contained the GFP gene, the promoter of interest (gata2), 5'HS4 chicken insulator 
regions and I-SeeI restriction enzyme sites. The insulators protect the transgene from 
endogenous enhancers, silencers and highly condensed chromatin (Bell et at, 2001). 
The I-SceI restriction enzyme site has an extended recognition site of 18 base pairs 
not found in the Xenopus laevis genome. The whole restriction enzyme digest with 
the I-SeeI enzyme was injected, to stop multimerisation and the plasmid re-ligating. 
This method was chosen because it can be done on high numbers of animals at one 
time, has a high success rate and reduced mosaic expression (Pan et at, 2006) 
compared to other methods such as REMI and transposon mediated integration 
(Kroll and Amaya, 1996; Sinzelle, 2006). 
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5.2 Transgenic methods 
5.2.1 REMI and transposon meditated insertion 
The first attempt at creating transgenic frogs was in 1984 by Etkin et aI. They 
linearised plasmids that contained a gene driven by a promoter; several genes were 
used, such as sea urchin histone genes. Either these linearised plasmids or non-
linearised plasmids were injected into Xenopus embryos. This DNA was found to be 
maintained in the form of long extrachromosomal concatemers during early stages 
of development, the DNA was eventually incorporated into the genome at later 
stages. They found that genes integrated into the frog genome occurred more for the 
linearised DNA approximately 60 %-70 % whereas injected circular DNA was about 
10 %-30 %. The method was fast and easy but the transgene was found to be 
mosaicly expressed in most of the injected animals, i.e. the trans gene had not been 
integrated into every cell, resulting in patchy expression. The injected genes also 
showed incorrect spatial and temporal regulation probably due to chromatin 
mediated effects such as condensed chromatin, silencing and enhancer regions 
(Etkin et aI., 1984). 
Since these early experiments improvements have been made to the transgenesis 
method. Until recently there were two main protocols used for transgenesis; these 
were the use of transposons (Ivics et aI., 1997) and restriction enzyme-mediated 
integration (REMI) (Kroll and Amaya, 1996). Transposons are inverted repeats of 
DNA that flank a central region encoding a transposase. A transposase can remove 
the segment of DNA via the transposons and incorporate the segment into another 
locus. These transposon regions can be used in transgenesis. The central transposase 
encoding region can be removed and replaced with a trans gene as long as 
transposase is still provided either by means of an internal inducible transposase 
source or by co-injection of a transposon containing the transgene and transposase 
mRNA. This has been successfully performed in a variety of different animals such 
as Drosophila (Spradling et aI., 1995), medaka fish (Wadman et aI., 2005) and 
Xenopus iaevis (Sinzelle, 2006). Natural vertebrate transposons are rare and only 
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two are currently used the sleeping beauty (SB) transposon (Ivies et al., 1997) and 
the Frog prince (FB) transposon (Miskey et aI., 2003). A problem with transposon 
transgenics is the size of the fragment used affects transgenesis Efficience (Izsvak et 
al., 2000). Also mRNA has to be co-injected adding complication to the process as 
mRNA is unstable and must be transcribed and injected without degradation to 
provide the transposase. 
The REMI method in Xenopus involves sperm nuclear transplantation. The 
trans gene is linearized and then incubated with decondensed sperm nuclei, a 
restriction enzyme such as BamHI, Xenopus egg extract. This mix is then 
subsequently transplanted into unfertilized eggs (Kroll and Amaya, 1996). The host 
genome is partially digested by the injected enzyme and the linearized transgene 
becomes immediately integrated. Hence, the transgene should show non-mosaic and 
a correct spatial and temporal expression pattern of the trans gene in the transgenic 
animals. This means that these transgenic Xenopus can be used to study gene 
function directly and do not have to rely on a second generation from breeding of 
transgenics (Kroll and Amaya, 1996). There are some problems with the REMI 
method, the sperm nuclear transplantation uses a relatively large needle and reduces 
survival rates. Kroll and Amaya, 1996 found that only 1 % to 16 % of transplanted 
eggs developed normally to tadpole age. Also there is the added problem that sperm 
nuclear transplantation is technically difficult and experience is needed to produce a 
satisfactory level of transgenesis. 
5.2.2 I-sceI restriction site and 5'HS4 chicken insulator transgenic 
methodology 
Recently a new method of transgenesis has been developed that involves using a 
restriction enzyme known as I-SceI and was the method of transgenesis used in 
Xenopus laevis in this chapter (Pan et al., 2006). I-SeeI has an extended recognition 
site of 18 base pairs, which is expected to exist only once in 7 x 1010 base pairs of 
random DNA sequences. This means the chance of there being an internal I-SeeI site 
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in a vertebrate's genome is small and in fact is not found in the Xenopus laevis 
genome. The plasmid containing GFP and the promoter of interest has I-SceI sites 
before the first insulator and after the terminal insulator. The plasmid can be 
digested with I-SceI and the whole digested product, including the I-SeeI injected 
into one cell Xenopus embryos (figure 5.1). This means that although the plasmid 
may be re-ligated once injected the presence of the I-SceI enzyme results in the 
plasmid being continually linearised reducing episomal expression, where the DNA 
is not incorporated into the genome, and also provides more chance of the trans gene 
becoming incorporated. The second benefit of this constant digestion is that it 
reduces the transgene DNA forming concatamers and the trans gene should therefore 
be incorporated as a monomer. 
The method used here also involves insulator regions since they protect a gene from 
chromatin-mediated effects such as a silencing region (Bell et aI., 2001). Where the 
injected transgene becomes incorporated can not be controlled and endogenous 
chromatin domains can have an effect on expression, for example if the trans gene 
was to become incorporated after a silencer the promoter maybe silenced or at least 
down regulated. Alternatively the transgene could become incorporated within 
highly condensed chromatin, where transcription factors and other initiation factors 
could not access the trans gene promoter. The transgene could also become 
incorporated downstream of an activator and become up-regulated. The problem 
with the trans gene becoming incorporated near a silencer or in highly condensed 
chromatin is that there will be very low or no protein production and therefore no 
visible glow from the GFP expressed, this would then result in other methods such 
as RT-PCR, in-situ hybridization, immohistochemisty, or a western-blot to check for 
presence of the reporter mRNA or promoter. Although RT-PCR can detect if the 
GFP transgene is being expressed it would not show spatial expression of the GFP 
protein. However the alternative, in-situ hybridization techinque, whilst sensitive to 
spatial expression limits the stages that can be assessed and is much more difficult to 
quantify. 
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Sub-cloning of transgenic plasmids 
417WT.GFP and 417NC.GFP by 
insertion of the 417 gafa2 promoter 
region and the GFP gene, 5'HS4 
insulator and I-SceI into the context 
of the base plasmid pGEM3Z. 
I-See! restriction digest carried out 
on 417WT.GFP and 417NC.GFP 
plasm ids for 45 minutes . 
1 
Whole I-SceI restriction digest injected 
into one cell stage Xenopus laevis embryo 
Xenopus laevis embryos assayed at various 
stages for transgenesis 
Figure 5.1 Plan for creation of transgenic Xenopus laevis. Schematic 
showing the design and steps involved in creating transgenic Xenopus laevis. 
First a plasmid was sub-cloned with the promoter of interest 417WT or 417NC, 
the GFP gene, insulators and I-sceI digest sites. The I-SceI digest is started at 
the same time as fertilisation of embryos. After 45 minutes the digest is then 
injected into the nucleus of a Xenopus laevis embryo at one cell stage. The 
digested DNA is injected at 75 pg per embryo and the embryos were allowed to 
develop and screened for GFP expression. 
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To help avoid this problem insulator regions were placed in front of the promoter 
and after the GFP gene. The insulator site used here was the t3-globin 5'HS4 chicken 
insulator, this insulator has been studied in detail (Chung et al., 1997) and has been 
used in transgenic fruit flies, mice, and rabbits to reduce endogenous chromatin-
mediated effects on the transgene (Bell et al., 2001). More recently this t3-globin 
5'HS4 chicken insulator has been used in Xenopus embryos to reduce variegation of 
transgenes (Sekkali et al., 2008). An outline of the experimental strategy used to 
produce transgenic Xenopus laevis in this chapter is shown in figure 5.1. 
5.3 Cloning of the GFP gene into the pGEM3Z plasmid 
The first step in creating transgenic Xenopus laevis was to clone plasmids that 
contained the GFP gene driven by the promoter of interest, 417WT or 417NC, 
flanked by 5'HS4 insulators and restriction enzyme I-SceI sites. These plasmids, 
417WT.GFP and 417NC.GFP, were generated by first sub-cloning the GFP gene, 
insulator sites and two flanking I-SceI sites into a base plasmid, pGEM3Z to create a 
plasmid named pGEM3Z.GFP. The promoters 417WT or 417NC were then sub-
cloned into restriction enzyme sites, KpnI and BglII, between the end of the first 
insulator and the beginning of the GFP gene, so that the promoters were driving 
transcription of the GFP gene. First the plasmid pGEM3Z.GFP will be discussed. 
A plasmid (tkeGFP.SceI.CTCF) containing the GFP gene was kindly provided by Dr 
Anna Noble. This plasmid contains the TK promoter, two I-SceI sites and two 5'HS4 
insulators which were repeated twice (before the TK promoter and after the GFP 
gene). The TK promoter region was not required as the 417WT promoter, previously 
described, was to be used to drive expression of the GFP gene. The I-SceI site and 
insulator upstream of the TK promoter could not be easily used because the TK 
promoter was to be removed and there were no restriction enzyme sites in 
appropriate locations to remove the TK promoter and insert the promoter of interest, 
417WT. The GFP gene region with the downstream insulator and I-SeeI site was 
amplified by PCR. 
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A forward PCR primer, 98 bp, was designed to be complementary to the 5' end of 
the GFP gene. Its complementary region to the GFP gene was 28 bp and the forward 
PCR primer had a 70 bp long tail region. This region contained two restriction 
enzyme sites, KpnI and BglII, directly upstream of the GFP gene complementary 
region to facilitate later sub-cloning of the 417WT or 417NC promoter. As 
mentioned above the upstream I-See! site and the insulator from the plasmid 
tkeGFP.SceI.CTCF could not be easily utilized. These regions were recreated using 
the forward PCR primer. Directly upstream of the two restriction enzyme sites, Kpnl 
and BglII, on the forward PCR primer the 5'HS4 chicken insulator was repeated 
twice, to improve insulation of trans gene. Directly upstream of the insulator region 
there was a I-SceI site and upstream of that was a HindIII restriction enzyme site, to 
allow cloning of the PCR product into the plasmid pGEM3Z. The pGEM3Z plasmid 
was used as a base plasmid to store and amplify the transgene. A smaller reverse 
PCR primer was designed to be complementary to the I-SceJ site located 
downstream the GFP gene and insulator present in the plasmid tkeGFP.SceI.CTCF. 
The downstream 5'HS4 chicken insulator and I-SceI site from the GFP gene in the 
plasmid tkeGFP.SceI.CTCF could be utilized as there was no region between the 
end of the GFP gene and start of insulator that needed to be removed. A restriction 
enzyme site, SacI, was created after the reverse PCR primer I-Scel site 
complementary region to allow cloning of the PCR product into the plasmid 
pGEM3Z (figure 5.2). 
peR was performed with these primers using the plasmid, tkeGFP.SceI.CTCF, as a 
template. peR using a primer with a long tail, such as the 98 base pair forward 
primer used here, is often difficult. Therefore the template was linearised with 
EcoRV to improve melting and Platinum® peR SuperMix high fidelity was used 
(Invitrogen). This is an optimised peR mix and has high fidelity to prevent 
misincorporation of nucleotides. The high fidelity is provided by a mixture of Taq 
DNA polymerase and the proofreading Pyrococcus species GB-D polymerase. The 
mixture of the proofreading enzyme with Taq DNA polymerase increased fidelity 
approximately six times over that of Taq DNA polymerase alone (Invitrogen, 
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Figure 5.2 Design of the steps involved in sub-cloning 417WT.GFP and 
417NC.GFP. Schematic showing the steps involved in the design and sub-
cloning of the plasmids to be used in transgenic experiment. A peR product 
encoding the GFP gene flanked by 5'HS4 chicken insulators and an internal 
multiple cloning site (to facilitate later cloning of promoters) was amplified. 
These regions are also flanked by two I-SceI sites and a HindIII (5 ' ) and a Sac! 
(3 '). This peR product was then introduced into pGEM.3Z via the HindIII and 
Sad sites creating pGEM.3Z.GFP. The multiple cloning site within the peR 
product were used to sub-clone in the promoter of interest. 
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Platinum® PCR SuperMix high fidelity manual). Anti-Taq DNA polymerase 
antibody inhibits polymerase activity, allowing an automatic "hot-start" (Chou, 
1992; Sharkey et aI., 1994). Antibody-mediated hot starts improve PCR specificity 
and yield (Westfall, 1997) and allows for room temperature set up of the reaction. 
After the PCR product was produced (figures 5.2 and 5.3) it was cloned into the 
pGEM3Z plasmid via the HindIII and Sad restriction enzyme sites. The presence of 
the PCR product insert was confirmed by a HindIII and Sad restriction enzyme 
digest and analysis of correct insert size, 1267 bp, by 1 % agarose gel 
electrophoresis (figure 5.4). The correct sequence of the insert was confirmed by 
sequencing (MWG). This new plasmid was named pGEM3Z.GFP and provides a 
basis for future transgenic experiments with different promoters. The next step was 
to clone the 417WT and 417NC promoters into this plasmid. 
5.4 Sub-cloning 417WT and 417NC promoters into pGEM2T.GFP 
For this experiment the 417WT promoter and the 417NC promoter were cloned in 
front of the GFP gene in the pGEM3Z.GFP. The 417WT promoter and the 417NC 
promoter were excised using KpnI and BglII from the already existing plasm ids 
417WT.pLUC and 417NC.pLUC, where these promoters were driving the luciferase 
gene (chapters 3 and 4). The excised fragments were then gel-eluted to remove the 
pLUC plasmid and then sub-cloned into pGEM3Z.GFP via the KpnI and BglII 
restriction sites. Presence of the insert was assayed by restriction enzyme digest with 
KpnI and BglII and the correct size of insert, 609 bp, checked by electrophoreses on 
a 1 % agarose gel (figure 5.5). The correct sequences of 417WT.GFP and 
417NC.GFP were confirmed by DNA sequencing (MWG). 
5.5 I-SeeI digest and injection into Xenopus laevis embryos 
An injection amount of between 75 pg to 150 pg per embryo was selected, (personal 
communication A. Noble) and a preliminary experiment was conducted where two 
amounts were injected, 75 pg or 100 pg, into groups of Xenopus laevis embryos. 
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'---1267 bp peR 
1,000bp-.... product 
with GFP gene 
500 bp 
Figure 5.3 1 % agarose gel showing a peR product containing the GFP 
gene. Lane 1 contained NEB 2-log DNA ladder. 1,000 and 500 base pair bands 
from ladder are indicated with arrows. Lane 2 shows a negative control peR 
reaction with no template. Lanes 2 to 6 show the amplified peR product at 
1,267 base pairs (also arrowed). This peR product contains the GFP gene, a 
multiple cloning site containing KpnI and BglII restriction enzyme sites, 5'HS4 
chicken insulator regions and flanking I-Sce! restriction enzyme sites. 
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backbone 
1267 bp peR product 
excised from pGEM.3Z 
Figure 5.4 Restriction enzyme digest confirmation of inserted peR 
product into pGEM3Z creating pGEM3Z.GFP. Lane 1 contains NEB 2-log 
DNA ladder. 1000 and 500 base pair bands are indicated with arrows. Lane 2 
shows the putative clone undigested. Lanes 3 - 5 show possible clones 
digested with, SacI and HindIII, to assay for the presence of the inserted peR 
product. The clone in lane 3 has the correct size, 1268 base pairs excised from 
the pGEM3Z plasmid. This plasmid was later confirmed by DNA sequencing. 
Lane 4 shows a putative clone with the wrong sized insert excised which was 
therefore discarded . 
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Figure 5.5 Restriction enzyme digest confirmation of the pGEM3Z.GFP 
plasmid with inserted 417WT and 417NC promoters. Lane 1 contains the 
NEB 2-1og DNA ladder, 1000 and 500 base pair bands are indicated with 
arrows. Lane 2 shows undigested 417WT.GFP clone. Lanes 3 and 4 show the 
609 base pair 41 7WT or 417NC promoters excised from the plasmid by KpnI 
and BglII restriction enzyme digest. These putative 417WT.GFP and 
417NC.GFP plasmids were then confirmed by DNA sequencing. 
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Amounts above 100 pg per embryo of the 417WT.pLUC plasmid in previous 
experiments gave high mortality rates (data not shown) and so 100 pg was the 
threshold amount of the 417WT.GFP or 417NC.GFP plasmids per embryo to be 
used in this experiment. This experiment was carried out to see whether, 75 pg or 
100 pg provided most transgenic Xenopus. Those injected with 100 pg were found to 
have a low survival rate and this agrees with preliminary experiments in chapter 3, 
where 100 pg or more injected DNA produced a high mortality rate (data not 
shown). Therefore 75 pg was chosen to be the amount of plasmid injected per 
embryo. 
Plasmids were diluted to give 75 pg DNA injected per embryo. Diluted plasmids 
were digested with I-SceI for 45 minutes, the digest was started at the same time as 
fertilization of Xenopus laevis embryos so that embryos can be injected as early as 
possible. Late injections can lead to mosaic patterning (figure 5.7). An aliquot of the 
I-SceI digest was assayed by agarose gel to check for complete digestion (figure 5.6) 
and injections continued until embryos neared the two cell stage and the first divide. 
Embryos were cultured and assayed for GFP expression after stage 10 (when zygotic 
transcription has started) at stages 11, 14, 20, 24, 36 and 46. They were checked for 
GFP expression using a UV light with blue filter (figure 5.7). 
5.6 Assaying 417WT.GFP and 417NC.GFP Transgenic Xenopus 
laevis 
First whether the 417WT promoter would be active enough to give visible glow was 
considered. Although detectable glow in a luminometer from the luciferase assays 
was observed in chapters 3 and 4 it is much more sensitive than looking for a visible 
glow and with the luciferase assays five embryos per well were assayed at a time. 
Figure 5.7 shows expression of GFP in transgenic Xenopus laevis at stages 20, 24 
and 46. One problem with trans genesis is mosaic patterning, where the transgene is 
not incorporated into every cell. Figure 5.7 shows an example of this, the transgenic 
Xenopus laevis only has GFP expression in a small region and is patchy. The 
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3 Kbp 
I Kbp 
Plasmid 
1877 bp insert containing 
417WT promoter and GFP 
Figure 5.6 Restriction enzyme digest confirmation of the I-See! digest of 
the 417WT.GFP plasmid. Lane 1 contains NEB 2-log DNA ladder. 3000 
and 1000 base pair bands are indicated with arrows. Lane 2 shows 
undigested 417WT.GFP plasmid. Lane 3 shows 417WT.GFP digested with 
I-SceI, the excised insert containing the promoter and GFP can be seen 
running below pGEM3Z (2743 base pairs) at 1877 base pairs. The insert is 
composed of the original peR product containing the GFP gene (1268 base 
pairs) and the 417WT promoter (609 base pairs). 
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(b) 
GFP 
(d) 
(f) 
Figure 5.7 Mosaic G FP expression from 417WT transgenic Xenopus laevis. 
Embryos were exposed to UV light with a blue filter. (a) Shows a stage 20 
embryo with mosaic GFP expression, indicated with an arrow. (b) The same 
image as (a) but taken with a standard light microscope. (c) Shows a stage 24 
embryo with mosaic GFP expression, indicated with an arrow. (d) The same 
image as (c) but taken with a standard light microscope. (e) Shows a Stage 46 
embryo with mosaic GFP expression, indicated with an arrow. (f) The same 
picture as ( e) but taken with a standard light microscope. 
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transgene IS incorporated into the genetic material of these cells. The GFP 
expression visualised here is not due to episomal expression from non incorporated 
plasmid because the GFP signal did not fade as the Xenopus laevis aged. If the 
expression was due to episomal plasmid the signal would become weaker as the 
plasmid DNA became degraded. 
From this is can be concluded that GFP glow is visible from the 417WT promoter 
and the injected DNA has become incorporated into the genome, even though it is 
only in some of the cells i.e mosiacly expressed. Mosaic expression is most likely 
due to the timing of the trans gene injection into the Xenopus laevis embryo. With 
late injections sometimes the cells start to divide before the transgene DNA can get 
into every cell. Therefore cells derived from the original cell with inserted transgene 
in its genome will express the GFP protein and the cells derived from the cell that 
did not receive the transgene will not express the GFP protein. GFP images in figure 
5.7 are shown alongside nonnal light images, to help indicate the location of GFP 
expression. 
The 417WT promoter in chapter 3 was shown to have temporal expression similar to 
endogenous gala2, although this does not show if 417WT is expressed spatially 
similar to endogenous gala2. The protein gata2 is known to be involved in 
haematopoiesis and neural development (Kelley et aI., 1994; Nardelli et aI., 1999) so 
it would be expected that expression would be in blood islands and neurons. Figure 
5.8 shows GFP expression in three Xenopus laevis tadpoles, in figure a and c, 
expression can be seen in the somites and in figure e expression is across all visible 
tissues suggesting that 417WT is not tissue specific. Figure 5.9 shows a mosaic 
transgenic, that seems to have the transgene incorporated on one side of the embryo. 
There is expression everywhere on the right side of the tadpole and the glow from 
the right side can be seen coming though on the left, shown in figure 5.9c. Figure 
5.ge is taken looking down at the tadpole and clearly shows the right side is 
expressing GFP in all visible cells and the left side is not. This odd expression was 
probably caused by a late injection where as the embryo divided into two cells, the 
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(d) 
GFP 
(t) 
GFP 
Control 
Figure 5.8 GFP expression is not tissue specific with the 417WT 
promoter. Figure (a) and (c) shows expression of GFP in somites and 
notochord and (b) and (d) are light microscope pictures of the same images. 
(e) Shows a tadpole where GFP expression is in all visible tissues, suggesting 
417WT is not tissue specific. (f) The same image as (e) but taken with a light 
microscope. 
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Figure 5.9 Expression of GFP from 417WT on one side of a Xenopus laevis 
tadpole. (a) OFP expression is visible in all tissues on the right side of the 
tadpole. (b) The same picture as (a) but taken with a standard light microscope. 
(c) The same tadpole from the left side; the left side has no OFP expression 
although some fluoresence is visible coming from the right side. (d) The same 
picture as (c), taken with a standard light microscope. (e) The same tadpole 
looking from the top, visible expression is only on the left side, indicating this 
is a mosaic transgenic tadpole and that OFP expression from 417WT is not 
tissue specific. (f) The same picture as (e) but taken with a standard light 
microscope. 
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trans gene became restricted to one cell; all cells derived from this one would express 
the OFP transgene. This is more evidence for 417WT not being tissue specific. 
The above results suggest that a region located elsewhere of -417 bp of the gala2 
promoter is involved in the regulation of spatial expression. Regions farther 
upstream, approximately -3,500 bp, have been shown to be involved in spatial 
regulation of gala2 expression in zebra fish (Meng et aI., 1997). They showed that 
three distinct tissue-specific enhancer elements act independently to enhance gene 
expression specifically in blood precursors, the EVL or the CNS. The minimal 
promoter region necessary for the maintenance of tissue-specific expression of gata2 
was found to be -1,031 bp, with this region present specifically was still seen in the 
blood precursors (Meng et aI., 1997). Future work could look at larger regions of the 
gala2 promoter to determine sequences involved tissue specifically. 
417WT.OFP was not the only construct made, 417NC.OFP was also created, this 
construct is the same as 417WT.OFP but the critical CCAAT box has been deleted 
(see chapters 1, 3 and 4). This construct has been shown to be largely inactive 
presumably reflecting a reduced binding affinity for CBTF (Brewer et aI., 1995). 
Embryos were injected with the 417NC.OFP plasmid to see if any fluorescence 
could be detected, although it was expected that there would not be any signal as 
transcription from this inactivated promoter is relatively low (chapter 4). 
Surprisingly some embryos did have visible OFP expression, but not as many as 
417WT.OFP injected embryos. From a 417NC.OFP (n= 20) injected batch 38.4 % 
expressed visible OFP, whereas with a 417WT.OFP (n= 20) injected batch 54.8 % 
expressed visible OFP (figure 5.10), suggesting that in 417WT.OFP transgenic 
Xenopus the transgene was more active. 
Although the use of the restriction enzyme I-SceI reduces concatamers of the 
transgene forming, an experiment using this transgenesis method showed that 
between 1 to 8 inserts can become incorporated at one time (Pan et aI., 2006). It is 
also possible that the 417NC.OFP injected embryos had visible OFP expression due 
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Figure 5.10 Table and graph comparing 417WT and 417NC transgenic 
Xenopus laevis with visible GFP expression. (a) Table comparing 
percentages of bright or dim glowing transgenic Xenopus laevis from two 
groups with either the 417WT.GFP or the 417NC.GFP transgene. (b) 
Histogram comparing the percentage of total transgenic Xenopus laevis with 
visible GFP of 417WT.GFP and 417NC.GFP. 
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to several inserts being incorporated into the genome at different sites, giving rise to 
increased signal. The method used to assay expression in this study was visual 
estimation of GFP intensity by eye and does not reveal the number of inserts that 
have become incorporated into the genome. Southern blotting could be conducted to 
assess the number of inserted trans genes in the transgenic Xenopus laevis genome. 
5.7 Summary 
In this chapter transgenic Xenopus laevis were created using the 417WT or 417NC 
promoters from chapters 3 and 4 to drive the GFP reporter gene. These transgenics 
were used to test whether the shortened 417WT promoter would give visible GFP 
expression and whether the expression would be tissue specific. Transgenics were 
chosen because the trans gene becomes incorporated into the genome and hence a 
more in vivo environment. 417NC is a negative control from chapter 4, it has no 
critical inverted CCAA T box and previous experiments have shown it has low 
transcriptional activity, probably due to its inability to bind the transcription factor 
complex CBTF (Brewer et aI., 1995). Here it was used to see if there would be any 
expression from this inactive promoter in the context of a fully chromatinised in vivo 
environment. The Xenopus transgenesis method employed here involved the use of a 
restriction enzyme, I-SceI, which has an 18 bp recognition sequence which does not 
exist within the Xenopus laevis genome. Chicken 5'HS4 Insulators were also used to 
reduce chromatin mediated effects. Insulators have been shown to protect trans genes 
from endogenous silencing elements, inactivity due to incorporation in condensed 
chromatin and over expression from endogenous enhancer elements (Bell et aI., 
2001; Sekkali et aI., 2008).The 417WT promoter proved to be active enough to give 
visible GFP fluorescence, but was not tissue specific. Suggesting other element(s) 
located elsewhere than the -417 base pairs of the gala2 promoter are involved in 
spatial localisation. Future work should focus on finding the part(s) of the gala2 
promoter that would provide spatial expression. 
The 417NC promoter did give some visible GFP expression and this could be due to 
the number of inserts that became incorporated within the genome at different sites, 
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giving rise to intense signal. Although the method used here to create transgenic 
Xenopus laevis reduces greatly the number of concatamers, such concatamers with 
up to 8 transgene copies have been found in transgenic Xenopus made using this 1-
SceI method (Pan et aI., 2006). From the analysis method used in this chapter, 
visualisation of GFP expression by eye, it is not possible to know how many 
trans gene inserts did become inserted into the genome. Further experiments need to 
be performed to investigate this. Also A or B-form mutants could be investigated to 
see if these mutations could increase or decrease expression, although this would be 
difficult to assay using the method of analysis used in this chapter alone, other 
methods such as RT-PCR would have to be used in addition to standard 
visualisation. 
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Chapter 6: Investigation into the amino acids involved 
in binding of the dsRBDs of Uf3 to dsRNA and dsDNA 
6.1 Introduction 
liD is a subunit of the multi-protein complex CBTF. The previous chapters have 
been concerned with the CBTF target in Xenopus laevis, the gala2 promoter. In 
these chapters the hypothesis was that the gala2 promoter was partially A-form in 
structure allowing the double stranded RNA binding domains (dsRBDs) of ilD to 
bind and activate transcription. Evidence supporting this hypothesis was shown in 
chapters 3 and 4. In general dsRBDs are primarily involved in binding to dsRNA, 
which is A-form in structure but the dsRBDs ofilf3 have also been shown to bind to 
DNA (Scarlett et aI., 2004) and have a higher affinity for A-form DNA in particular. 
In this chapter the dsRBDs of ilD are investigated in vitro, do they bind DNA and 
RNA in the same mode? i.e. using the same amino acid residues. 
The two dsRBDs of ilD can bind dsRNA and it has been suggested ilO becomes 
anchored to cytoplasmic RNA preventing nuclear localisation (Brzostowski et a1., 
2000). liD also contains other domains such as a nucleoplasmin type NLS (Robbins 
et aI., 1991), an RGG domain similar to the one found in heterogeneous nuclear 
ribonucleoproteins (hnRNP) Al and U, which have been shown to be involved in 
nucleic acid binding (Cobianchi et aI., 1988; Kiledjian and Dreyfuss, 1992) There is 
also a poly-Q region that has been suggested to be involved in transcriptional 
activation in other proteins (Liberati et aI., 1999). Double stranded RBDs are found 
in a range of different organisms and are conserved relative to the consensus dsRBD 
sequence and their structure (Doyle and Jantsch, 2002). Some examples are the 
Xenopus laevis RNA-binding protein A (Xlrbpa) and Drosophila staufen dsRBDs 
(St. Johnston, 1992). There are two types of dsRBDs, type A and B, both the ilO 
dsRBDs are of type A also found in Staufen and Xlrbpa (Doyle and Jantsch, 2002). 
Type A dsRBDs are highly conserved though-out the whole dsRBD sequence while 
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type B is only highly conserved at the C tenninal (Krovat and Jantsch, 1996). Type 
A dsRBDs have been shown to bind dsRNA in vitro and they exhibit a cooperative 
binding effect when there is more than one present, as with ilf3. Type B dsRBDs 
have been shown to have a low affinity for dsRNA in vitro (Doyle and Jantsch, 
2002; Krovat and Jantsch, 1996). 
We used the crystal structure of the second dsRBD of Xlrbpa complexed with 
dsRNA and the consensus sequence for dsRBDs (figure 6.1 and figure 6.2) (Ryter 
and Schultz, 1998) to investigate if the same amino acids of the dsRBDs of ilf3 are 
involved in binding to dsRNA and DNA. A mutation in the dsRBDs of iIf3, 
F433A1F552A, has been previously described, this mutant effectively ablates 
binding to both dsRNA and DNA. This mutation was based on a conserved 
Phenylalanine residue (Scarlett et aI., 2004). Mutation studies on other dsRBDs, 
Staufen and Xlrbpa, also lead to repression of dsRNA binding when this residue was 
mutated (Bycroft et aI., 1995; Krovat and Jantsch, 1996). The crystal structure of 
Xlrbpa complexed with dsRNA showed that this conserved phenylalanine residue, 
F145 in Xlrbpa dsRBD2, is important in stabilising a lysine side-chain that makes 
important backbone contacts adjacent to the major groove (figure 6.1) (Ryter and 
Schultz, 1998). 
The Xlrbpa crystal structure revealed other critical contacts (Figure 6.1) (Ryter and 
Schultz, 1998) and using the consensus sequence for dsRBDs compared to the 
crystal structure of Xlrbpa more mutations that should reduce dsRNA binding of the 
dsRBDs of ilf3 were designed. It is hypothesised that if the dsRBDs of ilf3 bind to 
dsRNA and DNA in the same way, the same amino acids should be involved and so 
mutations that reduce dsRNA binding should reduce DNA binding. Mutants were 
generated by site directed mutagenesis, purified via a glutathione S transferase 
(OST) tag and then assayed for binding to dsRNA or DNA by filter-binding assays. 
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Figure 6.1 Diagram of XlrbpA dsRBD bound to dsRNA. This diagram 
shows a dsRBD bound to dsRNA with all major contacts indicated from the 
crystal structure. Diagram taken from Ryter and Schultz, 1998. 
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Figure 6.2 The dsRBDs consensus sequence compared with the dsRBDs of itO and Xlrbpa2. The sequence for the first and second 
dsRBD of ilf3 and Xlrbpa-2 compared with the consensus sequence for dsRBDs, their locations within the respective proteins is indicated. 
The dsRBDs of ilf3 are class 2 dsRBDs and have high homology in their C terminus and the middle, they have less homology in their N 
terminus. Xlrbpa-2 has more homology in its N terminus than the ilf3 dsRBDs. The Xlrbpa-2 protein complexed with dsRNA crystal 
structure and the consensus sequence was used to design amino acid mutations within the dsRBDs ofilf3. 
6.2 Design of Mutants ilO(28.5)_GST 
A range of mutations were designed to investigate which amino acids of the ilf3 
dsRBDs are involved in facilitating ilf3 binding to dsRNA and DNA. Mutations of 
amino acids shown to make dsRNA contacts from the Xlrbpa crystal structure (Ryter 
and Schultz, 1998) were chosen. The hypothesis I chose to test is that the dsRBDs of 
ilf3 can bind to DNA in the same way as it binds to dsRNA, using the same or 
conserved amino acids. Previous research has shown that the dsRBDs can bind to 
DNA and have a higher affinity for A-form DNA than B-form (Scarlett et aI., 2004). 
Double stranded RNA under normal conditions forms an A-form structure and the 
more open minor groove of the A-form structure allows the dsRBDs to bind, so it is 
hypothesised that when DNA is in the canonical structure for dsRNA this helps 
facilitate binding. We have shown evidence for the in vivo significance of this 
possible interaction (chapter 3). It is known that the dsRBDs of ilf3 are critical for 
gala2 transcription (Scarlett et aI., 2004) and when the critical region of the gata2 
promoter is in a more A-form state there is increased transcription (chapter 3). 
Previous research has investigated the binding ability of the dsRBDs, and found a 
single point mutant in both dsRBDs (F433A1F552A-GST) successfully reduced 
binding to dsRNA and DNA. In this chapter we extend this study with ten new 
mutants. In figure 6.3 the sequence of ilf3 is shown, with the two dsRBDs, the 
nuclear localisation signal (NLS) and the RGG indicated. The start and end of the 
region used for the previously produced wild-type clone ilf3(28.S)_GST and Ilf3(28.S) 
F433A1F552A-GST (RBD-) both of which have a molecular weight of 28.5 kDa is 
also indicated. These clones were used in this chapter and were provided by Prof 
Matt Guille (Scarlett et aI., 2004). 
6.2.1 Knock-outs of 2'hydroxyl contacts 
The first mutations to be designed were knock-outs of residues involved in making 
2'hydroxyl contacts with dsRNA. DNA does not have a 2'hydroxyl and so residues 
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1 MRPMRIFLND DRHVMAKHSV VYPTQEELEA VQNMVSHTER ALKAVSDWID QQEKDCSGEQ 
61 EQPMAEETET TEEGKDSEMK TGENPTRTLR GVMRVGLVAK GLLLKGDLDL ELVLLCRDKP 
121 TISLLKRVAD NLVLQFETVS EDKYEVIQNI REALIVVKST KEPPLTLNIR LTSPLVREEM 
181 EKLSAGETLT VSDPPDVLDR HKCLAALASL RHAKWFQARA NGLKSCVIVI RVLRDLCTRV 
'-it Start of ilf3(28.5) 
241 PTWEPLRGWP LELLCEKAIG TANRPMGAGE ALRRVLECLS SGILMPDGSG LYDPCEKDAS 
301 DALEHLERQQ REDITQSAQH ALRLAAFGQL HKVLGMDPLP SKMPKKTKVE TPVIDYTVQI 
NLS 
361 PPSTTYAMPP LKRPIEEDGD DKSPSKKKKK IQKKDEKSEP PQvMNALMRL NQLKPGLQYK 
dsRBDl 
421 LISQTGPVHA PVFTMSVEVD DKTFEASGPS KKTAKLHVAV KVLQDMGLPT GMEEKEEGTD 
481 ESEQKPVVQT PAQPDDSAEV DSAALDQAES AKQQGPILTK HGKNPVMELN EKRRGLKYEL 
dsRBD2 
541 ISETGGSHDK RFVMEVEVDG VKFQGSGSNK KVAKAYAALS ALEKLFPDYT MYTEAPKKKR 
tEnd of iID(28.5) ROO 
601 PPMMPRGGPK FAGKHNQGFG MMYSEVPPPQ AMRGRGRGGM NRGRGRGRGG FGGGYMNSGG 
661 YGGGYGGNYN YQTSATAGYS QFYSNGGASG NAGGGGAGTG GYSSYYQGDS YSAPTPPKPF 
PolyQ 
721 VNKKPPPPQQ QQQQQPPPQH ASNPPKPSYN QGYQGHQGGQ QQQQQQQQQQ TYNQNQYSNY 
781 GPPQKQKGGY NQGAQGAGSG GSYNYSNSYT GGTAPGYGSG EGAGGRGGSS YTAPSSGYNT 
841 GAHSGYGGAS STSTYQGYTQ SNYNQGPPGQ NYSGPPNNYQ QPQGGAGSYS RNTEHNMSYQ 
901 YR 
Figure 6.3 Annotated amino acid sequence of ilf3. The full amino acid 
sequence ofilD with the NLS (blue), the two dsRBDs (red) and ROG (purple) 
highlighted is shown. Also indicated is the dsRBD containing region used in 
the binding assays (iID(28.S»). 
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involved in these contacts should be redundant when binding to DNA. The crystal 
structure of Xlrbpa complexed with dsRNA revealed that a histidine, located at 141 
in the Xlrbpa sequence, makes a 2'hydroxyl contact. This histidine is a conserved 
residue and the corresponding histidine was located in the first dsRBD and second 
dsRBD of ilf.3. The consensus sequence compared with the ilf.3 dsRBDs and the 
Xlrbpa dsRBD sequence from the crystal structure can be seen in figure 6.2. Two 
mutants were designed; the first would only contain a mutation in the first dsRBD of 
Ilf.3 where the histidine was replaced with a glycine (H429G). Glycine was chosen 
as a non-polar, neutral aliphatic residue that is not capable of making a 2'hydroxyl 
contact. The second mutant based on H 141 contained the mutation in the first 
dsRBD, H429G and the equivalent mutation in the second dsRBD located at 
position H548G. This mutant was referred to as H429G/H548G. It was expected that 
the double mutation will reduce the binding affinity of the dsRBDs of ilf.3 to dsRNA 
to that observed for DNA. The mutant that contains the mutation only in the first 
dsRBD was expected to reduce binding to dsRNA but not DNA and that binding 
will fall between the binding affinity of the wild-type dsRBDs for dsRNA and DNA. 
Another 2 'hydroxyl contact was indicated by the crystal structure (Ryter and 
Schultz, 1998), located at position Q1l8 in the second Xlrbpa dsRBD. The 
equalivant residue in the consensus sequence and the two dsRBDs of ilf.3 is an 
asparagine. Asparagine is biochemically similar to glutamine and therefore expected 
to behave in similar ways. The residue Ql18 falls in an alpha helix, glycines disrupt 
alpha helices and so the residue was mutated to alanine (Bryson et aI., 1995). 
Alanine is an aliphatic residue, similar to glycine and can not form a 2'hydroxyl 
contact. The mutant created was N530A located in the second dsRBD of ilf.3. It is 
expected that mutant N530A would have a similar binding affinity for dsRNA or 
DNA as mutant H429G, as they both contain one point mutation in one dsRBD that 
reduces 2'hydroxyl binding. 
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6.2.2 Addition of a Proline 
The crystal structure revealed a critical base involved in making a 2 'hydroxyl 
contact that was not a conserved residue, P140 (Ryter and Schultz, 1998). A mutant 
was designed here to change the non-conserved base located at the equivalent 
position in the ilO dsRBD, V 428, to a Proline. Prolines are thought to be involved in 
aiding recognition of a specific sequence by a dsRBD and it was hypothesised that 
by changing this base we could increase the affinity of the dsRBDs of ilO for 
Xlrbpas' target sequence. 
6.2.3 Knock outs of critical lysine contacts 
The crystal structure revealed critical contacts by lysine and glutamine residues 
(KI63, Q164 and K167) to free non-bridging oxygens of the phosphate backbone. 
All of these residues were conserved and could be found in the first and second 
dsRBD of ilO. Mutants were designed at each corresponding critical residue 
indicated by the crystal structure (Ryter and Schultz, 1998). Mutant proteins with a 
mutation in the first dsRBD only and also a second mutant with the residues in both 
dsRBDs knocked-out. Mutants based on the K163 consensus residue in ilO were 
K451A and K451NK570A, those based on Q164 were K452A and K452NK571A 
and those based on K167 were K455A and K455NK574A. The already established 
mutant F433NF552A was shown to be involved in stabilising some of these lysine 
interactions adjacent to the major groove from the crystal structure of Xlrbpa 
complexed with dsRNA (Ryter and Schultz, 1998). All mutants designed along with 
the wild-type and already produced F433NF552A mutant are shown in table 6.1, 
along with the dsRBD the mutation is located in, the mutants Xlrbpa equivalent and 
a description of native residues contact with dsRNA. 
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Name of protein Mutation dsRBD Xlrbpa Description 
with Equivalent 
mutation 
ilf3\Z5·))_GST N/A N/A N/A Wild-type 
ilf3\zs.)) F433NF552A Both F145 Stabi lizes K 163 
F433A1F552A-GST and K 167 side 
(RBD-) chains 
i1f3\lS.)) H429G-GST H429G dsRBDl H141 Makes 2'OH 
ilf3\zs.)) H429GIH548G Both HI41 Makes 2'OH 
H429G1H548G-GST 
ilf3\l8.') N530A-GST N530A dsRBD2 Ql18 Makes2'OH 
ilf3\lS.') V428P-GST V428P dsRBDI Pl40 Makes 2'OH 
ilf3(ls.,) K451 A-GST K451A dsRBDl K163 Backbone 
contact 
ilf3\zs.)) K451A1K570A Both K163 Backbone 
K451A1K570A-GST contact 
ilf3(lS.') K452A-GST K452A dsRBDI QI64 Bridges major 
groove 
ilf3\lB.)) K452A1K57 I A Both Q164 Bridges major 
K452A1K571 A -GST groove 
ilf3(lB.') K455A-GST K455A dsRBDl K167 Backbone 
contact 
i1f3(lB.') K455A1K574A Both K167 Backbone 
K455A1K574A-GST contact 
Table 6.1 List of mutations of the dsRBDs of ilO used in this chapter The mutant 
proteins name is shown along with the Xlrbpa position equivalent. There is also a 
description of where the amino acid mutated makes contact with the dsRNA or 
dsDNA. The mutation name reflects the original amino acid and its location 
followed by the amino acid it has been replaced within relation to the full length ilf3 
sequence. When the amino acid is mutated in both the first dsRBD and second 
dsRBD the amino acid mutated in the first dsRBD is first followed by the second 
separated by a forward slash. 
161 
6.3 Creation of mutant ilf3(2S.S) regions with site directed 
mutagenesis 
Site directed mutagenesis (SDM) is a method of introducing specific DNA base 
changes, possibly resulting in a new codon. The method used here involves four 
primers. Two are designed to be the forward and reverse primers of the total DNA 
region, 777 bp, to be amplified and two are designed, + and -, to be complementary 
to the region where the mutation is to be inserted and contains the necessary DNA 
base changes. Two standard peR reactions were then carried out, one with the 
forward and - primers and one with the reverse and + primers. Two peR products 
were produced, both containing the necessary base changes for the mutant residue. A 
further modified peR step then joined the two half sequences together to form the 
full gene region. This region was then amplified to create a DNA fragment that 
corresponded to the ilf3(28.5) protein with the required mutation. A schematic of the 
SDM peR method is shown in figure 6.4 and a 1 % agarose gel with two halves of 
the ilf3(28.5) for two mutant regions is shown in figure 6.5. 
Once the DNA region corresponding to the ilf3(28.5) protein with the desired residue 
mutation was created it was inserted into the pGEX-2T plasmid. pGEX-2T encodes 
Glutathione S-transferase (GST), proteins of interest can be fused to GST to form a 
chimeric protein. The GST protein can then be used to purify the target protein away 
from contamnants, the GST tag can then be cleaved off after purification and the 
protein of interest purified away from the GST protein. This is necessary for some 
applications such as some structural analysis, but not necessary here. The GST tag 
also helps to stabilise the ilf3(28.5) protein used here and helps it stay soluble (G. 
Scarlett, personal communication). 
The forward and reverse primers contain restriction enzyme sites that become 
incorporated into the DNA region of ilf3(28.5) and are then used to clone the DNA 
into pGEX-2T. The forward primer contained a BamHI site and the reverse primer 
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Figure 6.4 Schematic of SDM procedure used to create insert DNA 
coding mutant i1f3(28.5) proteins. The DNA sequence was mutated to code 
for different amino acid(s) using a peR based site directed mutagenesis 
method (section 2.1. 7). (a) A forward primer and a reverse primer were 
designed for the beginning and end of the sequence encoding a 28.5 kDa 
fragment of the protein ilf3 spanning 777 bp. Two other primers were 
designed (red) that were complementary to the region where the mutation was 
to be inserted. They contained the base changes needed to create mutants of 
ilf3(28.5). One was complementary to the top strand (+) and the other was 
complementary to the bottom strand (-). (b) Two standard peR reactions 
were carried out. One with the forward and (-) primer and the other with the 
reverse and (+) primer. This resulted in two fragments, each one half of the 
ilf3(28.5) sequence, both containing the mutant base change/so (c) These two 
halves were joined via a modified peR step (section 2.1.7). (d) Once joined 
the peR fragment containing DNA coding for ilf3(28.5) mutant protein was 
amplified by a standard peR reaction. 
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(a) 
500bp--. 
(b) 
500bp --+ 
Figure 6.5 peR fragments containing mutant sequences. A peR method 
was used to generate mutant fragments. The method involved the use of fOllr 
primers. Two were designed for the middle of the 28.5 kDa dsRBD fragment 
of ilB. A further two were designed to be the forward and reverse primer of 
the whole fragment. The peR reaction was conducted with a forward and 
bottom mutation primer as a pair and the reverse and top mutation primer as a 
pair. (a) Lane 3 shows one half and lane 5 the other half of the mutant 
(H429G). Lanes 2 and 4 are no template controls. Lane 1 contains 2-long NEB 
marker (NEB). The 500 bp band is indicated. After another peR step was 
carried out to join the two peR products together. (b) Lane 2 is a no template 
control. Lanes 3 and 4 show the final 777 bp peR fragment to be cloned into 
pGEX-2T. Lane 1 contains 2-long NEB marker (NEB). 
164 
contained an EcoRI site. The ilf3(28.5) gene was cloned into the pGEX-2T plasmid 
via the BamHI and EcoRI restriction enzyme sites N-tenninal to the GST tag. The 
GST -ilf3 fusion protein was expressed from the lac promoter which was induced by 
the addition of Isopropyl (j-D-l-thiogalactopyranoside (IPTG), before which, the 
gene is repressed by the internal lacIq protein. The laclq protein binds to the lac 
promoter repressing transcription, IPTG binds to the laclq protein and prevents DNA 
binding. This system allows induction of expression of the protein of interest at will, 
avoiding expressing cells being out-competed by non-expressing cells. 
Once the mutant ilf3(28.5) genes were ligated into the pGEX-2T plasmid, the samples 
were checked for correct incorporation. First, plasmids were screened for expression 
of the correct sized proteins. Figure 6.6 shows an example 10 % SDS-PAGE assay 
for the correct sized recombinant protein. The correct size for the ilf3(28,S)_GST 
fusion is 55.5 kDa, a protein of the correct size insert is indicated with an arrow on 
the gel. If cloning is not successful the GST protein alone runs at 27 kDa and is also 
indicated on the gel. This expression assay was carried out for all clones produced. 
Any putative clones that expressed the correct size protein were also assayed for the 
correct size DNA insert by digestion with BamHI and EcoRI restriction enzymes to 
excise the 777 bp insert. Figure 6.7 shows putative clones for Ilf3(28,5)H428G-GST, 
all contain the correct sized insert. This was carried out for all the mutants, after 
putative clones had gone through this screen they were sent to be completely 
sequenced (MWG) to confinn the correct DNA sequence. It is important to confinn 
the sequence as one single base change could lead to an unwanted amino acid 
mutations. Once all mutant clones were confirmed they were expressed and purified 
for use in the filter-binding assay. 
6.4 Expression and purification of the mutant I10(28.S)_GST 
proteins 
The wild-type and mutant ilf3-GST fusion proteins were grown in E.coli BL21 cells 
for 3 hours until mid log-phase and then expression of the fusion proteins was 
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Figure 6.6 ]0 % SDS-page assaying for correctly expressing putative clones. 
Possible clones that contained the recombinant ilf3 dsRBD-GST fusion (55.5 
kDa) where screened for first by protein expression assays. Correct sized proteins 
of 55.5 kDa were taken for further analysis such as those colonies in lanes 4, 5,6, 
7, 9, II , 12. Lanes 2, 3, 8 and 10 contain non-recombinants most likely withou t 
the ilf3(28.5) region present as the GST tag alone runs at 27 kDa. Lane 1 contains 
benchmark protein ladder (Invitrogen) the 50 kDa band is indicated. 
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1000bp --+ 
777 bp insert 
500 bp 
Figure 6.7 1 % agarose gel assaying for correct size of DNA insert. 
Recombinant pGEX-2T plasmids were checked for the presence of the DNA 
insert encoding the 28.5 kDa ilf3 mutants by restriction enzyme digest with 
EcoRI and BamHI. The digest was then run on a I % agarose gel and the correct 
777 bp insert was located with 2-log NEB ladder. Lane 1 contains the 2-log 
NEB ladder with the 1000 bp and 500 bp bands indicated. Lanes 2 to 5 
contained prospective clones containing the DNA insert coding for ilf3(28.5) kDa 
mutants. This was carried out for all the mutants described in this chapter. 
167 
induced by the addition of ImM IPTG. Previous experiments with ilt3(2t1.5)_GST and 
ilt3(28.5) F433NF552A-GST showed that the optimum growth time after induction 
with IPTG was 3 hours and that the ilf3(28.5)_GST and ilf3(28.5) F433A/F552A-GST 
fusion proteins were soluble. Although it was likely that each mutant in this chapter 
would behave the same way it was not guaranteed so preliminary expression studies 
were carried out for each mutant. Figure 6.8 shows an example 10 % SDS-PAGE for 
the preliminary expression assays of the mutant ilf3(28.5)H429G-GST, optimum 
expression is visible after 3 hours. The cells were then sonicated and collected by 
centrifugation. The supernatant was taken and a sample analysed by SDS-PAGE as 
the soluble fraction. The remaining pellet was resuspended and a fraction taken and 
analysed by SDS-PAGE gel as the insoluble fraction, Figure 6.8b shows that the 
ilf3(28.5)H429G-GST protein is soluble. This procedure was repeated for all mutant 
clones, all were found to behave the same way. This suggested that none of the 
mutations created affected the overall folding of the protein. 
After expression and sonication of the mutant GST fusion proteins and before they 
were purified away from endogenous E.coli proteins, bound nucleic acids were 
removed. To remove these nucleic acids the wild-type ilf3(28.5) and mutant GST 
fusion proteins were placed in a high salt (2 M NaCl) solution to dissociate the 
proteins and nucleic acids. Then protamine sulphate was added and the salt 
concentration slowly dropped by dialysis. Nucleic acids have a high affinity for 
protamine sulphate so become bound to the protamine sulphate which then 
precipitates and can then be pelleted by centrifugation and discarded from the 
protein solution. 
The soluble fraction now contained the protein of interest as a GST fusion and 
contaminating E.coli proteins. To purify the protein of interest spin columns with 
beads coated in glutathione were used. The soluble supernatant is applied to the 
column and the GST fusion becomes bound to the glutathione beads. Three washes 
were then applied and the GST fusion eluted from the column by addition of a 
glutathione solution. At each stage a sample was taken for electrophoresis on a 10 % 
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Figure 6.8 Preliminary expression assays with recombinant iIfJ(211.5LGST 
fusion protein by 10 % SDS-PAGE. All proteins were expre sed in BL21 
E.coli and induced by the addition of 1 mM IPTG after the E.coli culture had 
been grown for 3 hours. An induction time course was taken over the next 3 
hours. (a) Fractions from each sample were run on a 10 % polyacrylamide D -
PAGE. Lane 2 shows the proteins present before IPTG induction. Lane 3 i 
protein expression 1 hour after IPTG induction, a band representing the protein 
of interest is visible. Lane 4 shows expression after 2 hours and Ian 5 shows 
expression after 3 hours, band intensity increases with time. Lane I contains 
benchmark protein ladder and the band corresponding to 50 kDa is indicated. 
(b) A solubility assay was conducted, E.coli expressing the fusion protein were 
grown for 3 hours after induction, a fraction of the sample was taken and 
labelled total sample (lane 2). The rest of the sample was sonicated and spun 
down. The soluble fraction was taken off; this contained the soluble pr tein 
(lane 3). The insoluble fraction was resuspended in an a equivalent volume run 
alongside (lane 4). The protein of interest, iIO-GST fusion (55.5 kDa) i 
soluble. This was true for all mutants from this assay. Lane 1 contains 
benchmark protein ladder and the band corresponding to 50 kDa is indicated 
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SDS-PAGE. Figure 6.9 shows an example of a 10 % SOS-PAGE with all the 
fractions from each purification step with the purified protein in lane 11. The 
example shown here is the wild type ilf3(28.5)_GST fusion protein, there is little 
degradation of the protein. This was repeated for all the mutants described in this 
chapter and all were purified to the same standard. Figure 6.10 shows the purified 
protein for all mutants electrophoresed on a 10 % SOS-PAGE. 
6.S Binding of mutant I1f3(28.StGST proteins to DNA and RNA 
6.5.1 Radio-active labelling of RNA and DNA 
RNA and DNA oligonucleotides corresponding to 36 bps of the critical region of the 
gata2 promoter were annealed in lXTNE and then checked for the absence of 
residual single stranded oligonucleotides by eletrophoresing a sample on a native 10 
% polyarilimide gel. Figure 6.11 shows the RNA and DNA oligonucleotide duplexes 
annealed with no single stranded oligonucleotide present. The oligonucleotides were 
then radioactivity labeled with '){p33]_ATP to be used as probes in filter-binding 
assays. 
6.5.2 The filter binding assay 
The filter binding assay was used to assess how well mutant ilf3(28.S)_GST fusion 
proteins bound to dsRNA or DNA. Double stranded RNA or DNA probes were 
labelled with '){p33]_ATP and then mixed with the protein of interest. The sample 
was then filtered though a nitrocellulose membrane optimized for protein retention. 
Only probe that had not bound to the protein could pass though. The amount of 
labelled probe retained by the protein was then measured by a scintillation counter. 
Filter binding assays were chosen to assess the binding abilities of mutant i1f3 
proteins because they give fast and reproducible data. To screen a number of 
mutants for binding activity such as with this study, a filter binding assay is ideal. 
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Figure 6.9 Purification of ilf'3(28.SLGST protein. A cu lture of E.coli BL21 
expressing the iID(28.5LGST construct was grown to the mid-log phase and 
expression was induced by the addition of 1 mM IPTG. 3 hours after induction 
cells were pelleted and disrupted by sonic.ation, nucleic acid was remov d by 
extraction with protamine sulphate and the protein of interest, ilf3 (28.5L T, 
purified using GST -spin columns (GE healthcare). Samples were taken from 
each stage for anaylsis by 10 % SDS-PAGE. Lane 2, sample after 3 hours 
induction. Lane 3, soluble sample after sonication, protamine ulphat 
extraction was preformed on the soluble fraction. Lane 4, insoluble sampl aftcr 
sonication. Lane 5, soluble sample after protamine sulphate ex traction used in 
further purification. Lane 6, sample taken from the resuspended pell et of the 
protamine sulphate extraction. Lane 7, flow-though from GST-spin columns. 
The spin column was saturated and so some ilf3(28.5LGST protein was n t 
bound. Lane 8, first wash with 1 X PLB of the GST-column, all non-b und 
protein is removed. Lane 9 and 10, samples from the second and third wash r 
the GST -column with 1 X PLB. Lane 1 I, sample taken [Tom thei IfJ (28 .5L T 
purified protein which was eluted with glutathione elution solution. Th result 
show that the sample is purified with little degradation . Lane 1 contained th 
benchmark protein ladder (Invitrogen) the 50 kda band is indicated. 
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Figure 6.1 0 Pur ified 55.5 kDa i1f3(28.5LGST mutants. All proteins w r 
expressed in E. coli BL21. Expression was induced at the mid-log phas by 
addition of 1 mM IPTG. After 3 hrs, celIs were disrupted using sonication, the 
protein-bound DNA was removed by protamine su lphate extraction and then th 
proteins were purified using GST spintrap columns (GE healthcare). ampl s r 
the purified protein for all mutants used in this chapter are shown as assayed by 
10 % SDS-PAGE. All proteins were purified with little degradation and n 
other non-specific proteins. 
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Figure 6.11 Annealed 36 bp DNA and RNA oligonucleotide duplexes 
corresponding to the gala2 promoter. Equimolar quantities of + and - 36 bp 
DNA oligonucleotide strands based on the gata2 promoter were mixed in IX 
TNE and annealed. Two RNA oligonucleotides, + and - , based on the am 
sequence were also mixed at equimolar quantities in IX TNE and annealed. 
The duplexes were then analysed for lack of residual single strands on a 10 % 
native polyacrylamide gel. Lane 1, 10 bp ladder (Invitrogen) the 40 bp band is 
indicated. Lane 2, Annealed DNA oligonucleotide duplex. Lane 3 annealed 
RNA oligonucleotide duplex. 
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6.5.3 Testing the assay with WT and RBD-
Previous binding experiments with the ilf3(28.S)_GST and ilf3(28,S)F433NF552A-GST 
construct showed that ilf3(28,S)_GST bound better to dsRNA and DNA than the 
mutant ilf3(28,S)F433NF552A-GST which effectively ablated binding (Scarlett et aI., 
2004). Here these two constructs were used as controls to show the filter binding 
assay could provide reliable data and provide a comparison. Figure 6.12 shows a 
graph of the percentage binding at varying concentrations, 0 nM, 25 nM, 50 nM, 100 
nM and 300 nM, of ilf3(28,S)-GST and ilf3(28,S)F433NF552A-GST to 25 nM dsRNA 
or DNA (36 bp oligonucleotides based on the critical region of the gata2 promoter). 
As previously reported (Scarlett et aI., 2004) the ilf3(28.5)_GST fusion protein binds 
dsRNA better than dsDNA. The ilf3(28.5)F433NF552A-GST fusion protein reduces 
binding to both dsRNA and DNA by almost 100 % when protein concentration is at 
the inflection point (50 nM) as expected. These results showed that the filter binding 
assay was working and that reliable data could retrieved from it. These results also 
showed the inflection point to be at 50 nM for the protein ilf3(28.S)_GST when bound 
with 25 oM dsRNA. This suggests that there are two protein molecules bound to one 
dsRNA molecule, i.e the stoichiometry of the ilf3(28.5)_GST fusion protein to dsRNA 
is 2: 1. For all the mutant ilf3(28.5)_GST fusion proteins bound with either dsRNA or 
DNA data are shown with the percentage binding curves for ilf3(28.S)_GST and 
ilf3(28.5)F433NF552A-GST and discussed in the following sections. 
6.5.4 Assessing 2'hydroxyl knock-outs 
These mutants were designed to reduce the binding of the dsRBDs of ilf3(28.5) to 
dsRNA to that observed for DNA. It was hypothesised that residues that made a 
2'hydroxyl contact with dsRNA are redundant in binding to DNA and could explain 
the drop in the binding affinity ofilf3 seen between dsRNA and DNA. 
174 
100 
~ 0 
~ 75 
= = 0 
~ 50 
= 
.2 
-(j 25 = .. 
~ 
0 
0 25 50 100 300 
Concentration of protein (nM) 
-+- Ilf3 (28.5)-GST 
DNA 
~ F433A1F552A 
DNA 
--.- I1f3 (28SLGST. 
RNA 
~ F433A1F552A 
RNA 
Figure 6.12 ilf3(28.5tGST or ilf3(28.S)F433A1F552A-GST percentage binding 
with DNA or RNA. Filter binding assays (section 2.2.4) were carried out to 
measure the percentage binding of purified protein to RNA or DNA 36 bp 
duplex oligonucleotides. The RNA or DNA oligonucleotides were labelled 
with y[p33]. Samples containing 25 nM labelled y[p33] DNA or RNA and 
varying amounts of protein 0, 25, 50, 100 and 300 nM were filtered and 
amount of retained nucleic acid measured in a scilliation counter. Percentages 
were calculated using a negative no protein control, (0 nM), that was filtered 
and a positive control that contained no protein but contained 25 nM labelled 
RNA or DNA and was unfiltered (100 %). The graph shows percentage of 
bound nucleic acid for either ilfJ (28.5tGST or ilf3(285)F433A1F552A-GST 
(labelled F433A1F552A). 
175 
Two different residues that made 2'hydroxyl contacts were mutated, the first was 
H429 to glycine, which was changed in one dsRBD only and in a second mutant it 
was changed at both dsRBDs, H429G/H548G. A further mutant was N530, which 
was changed to an alanine in the second dsRBD (N530A). Figure 6.13 shows the 
binding curves of iIO(28.5)H429G-GST and ilO(28.5)H429G/H548G-GST fusion 
proteins at varying concentrations, 0 nM, 25 nM, 50 nM, 100 nM and 300 nM, with 
25 nM DNA or dsRNA. The ilO(28.5)_GST and ilO(28.5)F433A1F552A-GST binding 
curves from figure 6.12 are presented for comparison. The binding curves show that 
the mutant H429G reduces binding of dsRBDs to dsRNA at 50 nM protein 
concentration, but at higher protein concentrations, 100 nM and 300 nM 100 % of 
the protein is bound, indicating that the protein still retains some binding affinity. 
The mutant H429G also surprisingly reduced the binding of the dsRBDs to DNA as 
well. The DNA binding curve of mutant H429G falls between the wild-type ilO(28.5)_ 
GST and the already established mutant ilO(28.5)F433A1F552A-GST. Residues that 
make 2 'hydroxyl contacts with dsRNA would become redundant in DNA binding if 
the dsRBDs of ilO bind dsRNA and DNA in the same way, via the same residue 
interactions. The binding curves for H429G support an alternative hypothesis that 
the dsRBDs of ilO interact with dsRNA and DNA though different binding clefts. 
However it is possible that this residue also makes non-direct or water-meditated 
contacts with base functional groups as well as a 2' hydroxyl contact. Something 
which is observed for some histidine residues in the Xlrbpa crystal structure, these 
base specific contacts would still be present when bound to DNA. Removal of them 
by mutation of the histidine would cause a reduction in the DNA binding affinity 
although the effect on RNA affinity would be much larger as both the 2' hydroxyl 
and base specific contacts will be affected. The mutant H429G/H548G knocks-out 
the dsRBDs binding affinity for dsRNA to almost as low as F433A1F552A, arguing 
that these residues are critical for dsRNA binding for ilO. The mutant 
H429GIH548G does not seem to affect DNA binding affinity anymore than H429G 
when compared to the affect on RNA binding. This suggests that this interaction is 
less important in binding of the dsRBDs of ilO to DNA than binding of the dsRBDs 
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Figure 6.13 Mutant ilf3(28.5)H429G-GST or ilf3(28.5)H429GIH548G-GST 
percentage binding with DNA or RNA Filter binding assays (section 2.2.4) 
were carried out to measure the percentage binding of purified protein to 
RNA or DNA 36 bp duplex oligonucleotides. The RNA or DNA 
oligonucleotides were labelled with y[p33]. Samples containing 25 nM 
labelled y[p33] DNA or RNA and varying amounts of protein 0, 25, 50, 100 
and 300 nM were filtered and amount of retained nucleic acid measured in a 
scilliation counter. Percentages were calculated using a negative no protein 
control that was filtered (0 %), and a positive control that was unfiltered (100 
%). (a) Shows percentage binding of mutant ilf3(28.5)H429G-GST (H429G on 
the graph) or ilf3(28.5)H429G/H548G-GST (H429G1H548G on the graph) to 
36 bp labelled y[p33] DNA oligonucleotide. The binding curves from figure 
6.12 for ilf3(28.5LGST and F433A1F552A to DNA are also shown for 
comparison. (b) Shows percentage binding of mutant ilf3(28.5)H429G-GST 
(H429G on the graph) or ilf3(28.5)H429GfH548G-GST (H429G/H548G on the 
graph) to 36 bp labelled y[p33] RNA oligonucleotide. The binding curves 
from figure 6.11 for ilf3(28.5LGST and F433A1F552A to RNA are also shown 
for comparison. 
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of ilf3 to dsRNA. This was expected due to the lack of a 2'hydroxyl in DNA and 
possible redundancy of this residue in binding to DNA. The results shown here 
suggest that residues H429G/H548G are critical for dsRNA binding and are needed 
for DNA binding but are not as critical. 
6.5.5 Mutant N530A 
The third residue to be mutated was N530, which was mutated to an alanine. This 
residue was shown to make a 2'hydroxyl contact to dsRNA from the crystal 
structure of Xlrbpa (Ryter and Schultz, 1998). In the dsRBD of Xlrbpa the residue 
was glutamine, but glutamine and asparagine are biochemically similar so it was 
assumed they would have similar interactions. The consensus and Xlrbpa sequences 
(Figure 6.2 and Figure 6.1) showed that this residue was conserved in both of ilf3s 
dsRBDs. The previous 2 'hydroxyl mutants were mutated from a histidine to a 
glycine and here the residue asparagine was changed to an alanine. Glycine and 
alanine are closely related small, non-polar, uncharged residues. Both of these 
residues should act in a similar way when used as inactive substitute residues, they 
should remove the original residue's properties that allow it to make contacts but not 
affect the structure of the protein. 
Figure 6.14 shows percentage of retained nucleic acid by the mutant N530A at 
varying protein concentrations, 0, 25, 50, 100 and 300 nM with 25 nM DNA shown 
in figure 6.14a and 25 nM dsRNA shown in figure 6.14b. Both the percentage 
binding of ilf3(28.5)_GST and the mutant F433A1F552A are shown for comparison. 
N530A mutant seems to bind similarly to DNA and dsRNA as does mutant H429G. 
This suggests that the interaction of these different residues with the 2'hydroxyl of 
dsRNA is similar and are equally important in both dsRBDs, because both these 
residues, located on different dsRBDs in IIf3, made 2 'hydroxyl contacts and binding 
seems to be affected similarly for both mutants. If DNA and RNA binding modes 
were the same then residues involved in making 2'hydroxyl contacts to dsRNA 
would become redundant in binding to DNA, as 2'hydroxyl group not present in 
DNA, and should have no affect when mutated on DNA binding. The results here 
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Figure 6.14 Mutant Xilf3(28.5)V428P-GST or Xilf3(28.5)N530A-GST 
percentage binding with DNA or RNA Filter binding assays (section 2.2.4) 
were carried out to measure the percentage binding of purified protein to RNA 
or DNA 36 bp duplex oligonucleotides. The RNA or DNA oligonucleotides 
were labelled with y[p33]. Samples containing 25 nM labelled y[p33] DNA or 
RNA and varying amounts of protein, 0, 25, 50, 100 and 300 nM were filtered 
and amount of retained nucleic acid measured in a scilliation counter. 
Percentages were calculated using a negative no protein control, (0 nM), that 
was filtered and a positive control that was unfiltered (100 %). (a) Shows 
percentage binding of mutant ilf3(28.5)V428P-GST (V428P on the graph) or 
ilf3(28.5)N530A-GST (N530A on the graph) to 36 bp labelled y[p33] DNA 
oligonucleotide. The binding curves from figure 6-12 for ilf3(285LGST and 
F433A1F552A (RBD-) to DNA are also shown for comparison. (b) Shows 
percentage binding of mutant Xilf3(28.5)V 428P-GST (V 428P on the graph) or 
ilf3(28.5)N530A-GST (N530A on the graph) to 36 bp labelled y[p33] RNA 
oligonucleotide. The binding curves from figure 6.12 for ilf3(28.5)-GST and 
F433A1F552A (RBD-) to RNA are also shown for comparison. 
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suggest that is not true, since these two mutations have affected DNA binding as 
well. It is possible these residues are not involved in direct contacts as with dsRNA 
binding but are involved in non-direct water mediated contacts. 
6.5.6 Mutant V 428P 
P140 was also indicated from the crystal structure as making a 2'hydroxyl contact 
(Ryter and Schultz, 1998). This residue was not a conserved residue in the consensus 
sequence although it was shown from the crystal structure to be involved in critical 
interactions of Xlrbpa with dsRNA. This interesting residue was not present in the 
dsRBDs of iiD. Hence we mutated the residue in the first ilf3 dsRBD in the 
corresponding location of P140, V428 to a proline. It was thought that this may 
increase the binding affinity of the dsRBDs of ilf3 to DNA or dsRNA. The 
percentage of retained nucleic acid by this mutant, V 428P, at varying concentrations 
0, 25, 50, 100 and 300 nM with 25 nM DNA can be seen in figure 6.14a and for 
dsRNA in figure 6.14b. This mutant has slightly reduced binding to both DNA and 
dsRNA. It could be that this proline residue in Xlrbpa is involved in sequence 
recognition of a target sequence of Xlrbpa. Although studies have shown that 
binding of the dsRBDs in general appears to be independent of sequence (Ryter and 
Schultz, 1998), it is known that for ilD dsRBDs there is some sequence specificity 
(Scarlett et aI., 2004). It could be that this mutant V 428P has increased the dsRBDs 
of lID's affinity for a different sequence, in the future it would be interesting to 
investigate the binding this mutant to other sequences. 
6.5.7 Assessing lysine mutants 
The crystal structure of Xlrbpa complexed with dsRNA, revealed two lysines, K163 
and K167, and a glutamine, Q164, involved in making critical contacts with non-
bridging oxygens of the phosphodiester backbone. The corresponding residue to 
Q164 in the dsRBDs of ilB is also a lysine and this is true in most dsRBDs. They 
are in the a-helix at the C-terminal of Xlrbpa, and from the crystal structure of 
Xlrbpa it can be seen that the side chain of K163 hydrogen-bonds directly to an 
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adjacent phosphodiester group on this same side of the major groove and amino acid 
side chains further along in the a-helix (Q164 and K167) interact on the other side of 
the major groove (Ryter and Schultz, 1998). These contacts position the a-helix so 
that it bridges the major groove. The lysine side chains are stabilised by aromatic 
side chains of F145 and Y131 which pack against K163 and K167, respectively 
(Ryter and Schultz, 1998). F145 is the residue which the mutant F433NF552A is 
based on, we therefore tested if by mutating the corresponding residues in the ilD 
dsRBDs of K163, Ql64 and K167 DNA and dsRNA binding will be reduced. Six 
mutants were generated based on these residues, they were all changed to an alanine 
because they were present in an a-helix and glycines can disturb a-helices (Bryson 
et aI., 1995). The mutants in the ilD dsRBDs were K451A and K451AJK570A based 
on K163. K451A only had a mutation in the first dsRBD and K451AJK570A had the 
residue mutated in both dsRBDs. Mutant K452A, had this mutation just in the first 
dsRBD and mutant K452NK571A, had these mutations in both dsRBDs and 
mutations were based on the residue Q164. Mutant K455A, had this mutation just in 
the first dsRBD and K455AJK574A, had this mutation in both dsRBDs and 
mutations were based on the residue K167. 
Figure 6.15 shows the percentage of retained nucleic acid over a range of protein 
concentrations 0, 25, 50, 100 and 300 nM of mutant proteins ilD(28.S)K451A-GST 
and iID(28.5)K451AJK570A-GST with 25 nM DNA (figure 6.15a) or dsRNA (figure 
6.15b). DNA binding is affected by these mutants to about the same level at the 
control F433AJF552A mutant. The double mutant, K451AJK570A does not affect 
binding much more than the single mutant, K451 A. The interesting effects of these 
mutants seems to be on dsRNA (figure 6.15b) and both mutants K451 A and 
K451 NK570A completely ablate binding of the dsRBDs of ilD to dsRNA, even at 
highest concentrations of protein. This shows that this residue is more than just 
important it is completely required in the first dsRBD and possibly critical in the 
second dsRBD for binding of ilD to dsRNA. 
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Figure 6.15 Mutants K451A or K451A1K470A percentage binding with 
DNA or RNA Filter binding assays (section 2.2.4) were carried out to measure 
the percentage binding of purified protein to RNA or DNA 36 bp duplex 
oligonucleotides. The RNA or DNA oligonucleotides were labelled with y[p33]. 
Samples containing 25 nM labelled y[p33] DNA or RNA and varying amounts 
of protein, 0, 25, 50, 100 and 300 nM were filtered and amount of retained 
nucleic acid measured in a scilliation counter. Percentages were calculated 
using a negative no protein control, (0 nM), that was filtered and a positive 
control that was unfiltered (100 %). (a) Shows percentage binding of mutant 
ilfJ(2s.5)K451A-GST (K451A on the graph) or ilf3(28.5)K451NK570A-GST 
(K451 AlK570A on the graph) to 36 bp labelled y[p33] DNA oligonucleotide. 
The binding curves from figure 6.12 for ilf3(2S.5LGST and F433NF552A 
(RBD-) to DNA are also shown for comparison. (b) Shows percentage binding 
of mutant ilf3 (28.5)K451 A-GST (K451 A on the graph) or 
ilf3(2s.5)K451A1K570A-GST (K451NK570A on the graph) to 36 bp labelled 
y[p33] RNA oligonucleotide. The binding curves from figure 6.12 for ilf3(2s.5)_ 
GST and F433A1F552A (RBD-) to RNA are also shown for comparison. 
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All these mutants, K451A and K451NK570A (Figure 6.15), K452A and 
K452NK4 71 A (Figure 6.16), K455A and K455NK574A (Figure 6.17) suggest that 
different residues are involved in DNA and dsRNA binding because they all 
completely ablate dsRNA binding and only marginally lower DNA binding. This 
also showed that each individual residue, at least for the first dsRBD is critical as 
when any of these residues is removed binding was almost lowered to 0 %. Another 
investigation into these conserved lysines has shown them to be critical for binding 
to dsRNA (Bycroft et aI., 1995). DNA binding is affected to similar levels of the 
control mutant F455NF552A but not to the extent that dsRNA binding is affected 
and one residue change, K455A seems to have little effect on DNA binding. 
Although this suggests different residues are involved in DNA and dsRNA binding 
by the dsRBDs of ilf3 it is also possible that the same amino acids are involved in 
binding DNA and dsRNA but the importance of each of the residues in binding 
differs between DNA or dsRNA binding. It is also impossible to tell if the second 
dsRBD is critical for dsRNA binding because the mutation in the first dsRBD 
completely reduces binding. Future experiments should look at making these 
mutations solely in the second dsRBD. 
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Figure 6.16 Mutant K452A or K452A1K471A percentage binding with DNA 
or RNA Filter binding assays (section 2.2.4) were carried out to measure the 
percentage binding of purified protein to RNA or DNA 36 bp duplex 
oligonucleotides. The RNA or DNA oligonucleotides were labelled with y[p33]. 
Samples containing 25 nM labelled y[p33] DNA or RNA and varying amounts of 
protein, 0, 25, 50, 100 and 300 nM were filtered and amount of retained nucleic 
acid measured in a scilliation counter. Percentages were calculated using a 
negative no protein control, (0 nM), that was filtered and a positive control that 
was unfiltered (100 %). (a) Shows percentage binding of mutant ilf3(2s.5)K452A-
GST (K452A on the graph) or ilf3(2S.5)K452NK471A-GST (K452NK471A on 
the graph) to 36 bp labelled y[p33] DNA oligonucleotide. The binding curves 
from figure 6.1 2 for ilf3(2s.5)-GST and F433A1F552A (RBD-) to DNA are also 
shown for comparison. (b) Shows percentage binding of mutant ilf3(28.5)K452A-
GST (K452A on the graph) or ilf3(2s.5)K452NK471A-GST (K452NK471A on 
the graph) to 36 bp labelled y[p33] RNA oligonucleotide. The binding curves 
from figure 6.1 2 for ilf3(2S.5LGST and F433A1F552A (RBD-) to RNA are also 
shown for comparison. 
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Figure 6.17 Mutant K455A or K455A1K474A percentage binding with DNA 
or RNA Filter binding assays (section 2.2.4) were carried out to measure the 
percentage binding of purified protein to RNA or DNA 36 bp duplex 
oligonucleotides. The RNA or DNA oligonucleotides were labelled with y[p33]. 
Samples containing 25 nM labelled y[p33] DNA or RNA and varying amounts of 
protein, 0, 25, 50, 100 and 300 nM were filtered and amount of retained nucleic 
acid measured in a scilliation counter. Percentages were calculated using a 
negative no protein control, (0 nM), that was filtered and a positive control that 
contained no protein but contained 25 nM labelled RNA or DNA and was 
unfiltered (100 %). (a) Shows percentage binding of mutant ilf3(28.5)K455A-
GST (K455A on the graph) or ilf3 (28.5)K455A1K474A-GST (K455A1K474A on 
the graph) to 36 bp labelled y[p33] DNA oligonucleotide. The binding curves 
from figure 6.12 for ilf3(28.5LGST and F433A1F552A (RBD-) to DNA are also 
shown for comparison. (b) Shows percentage binding of mutant ilf3(28.5)K455A-
GST (K455A on the graph) or ilf3(28.5)K455A1K474A-GST (K455A1K474A on 
the graph) to 36 bp labelled y[p33] RNA oligonucleotide. The binding curves 
from figure 6.12 for ilf3(28.5LGST and F433A1F552A (RBD-) to RNA are also 
shown for comparison. 185 
6.6 Summary 
A mutant screen was carried out to investigate which residues of the dsRBDs of itf3 
were involved in making contacts to dsRNA, revealed by the crystal structure of 
Xlrbpa (Ryter and Schultz, 1998), are also critical for DNA binding. The crystal 
structure of Xlrbpa complexed with dsRNA and the consensus sequence of dsRBDs 
were used to locate conserved residues in the first and second dsRBD of ilf3. Ten 
new mutants were designed and the previously described wild-type ilf3(28.5)_GST and 
mutant ilf3(28.5)F433A1F552A-GST already produced (Scarlett et aI., 2004) were 
used as positive and negative controls respectively. The mutants chosen were 
residues involved in 2'hydroxyl and critical backbone contacts. 
Figure 6.18 is a summary histogram of the binding percentages for all mutants 
described in this chapter at a concentration of 25 nM protein to 25 nM DNA or 
dsRNA. The concentration 25 nM of protein was chosen because it is before the 
saturation point of the wild-type at 50 nM when all protein molecules are bound. 
There are several mutations that affect dsRNA binding significantly and have little 
effect on DNA binding; they are K451A, K451A1K570A, K452A and K455A. 
However other mutants reduce both RNA and DNA binding; they are the control 
mutant F433A1F552A, H429G, H429G/H548A, K452A1K571A, K455A1K574A and 
N530A. No mutations affected DNA binding more than dsRNA binding. All the 
mutants are discussed in more detail below. 
6.6.1 2'hydroxyl mutations 
The residues involved in making 2 'hydroxyl contacts with dsRNA were mutated 
with the aim to reduce binding of the dsRBDs of ilf3 to dsRNA to that of the 
dsRBDs affinity for DNA. DNA lacks the 2'hydroxyl on the ribose ring and if the 
dsRBDs of ilf3 bind dsRNA and DNA in the same way these contacts would 
become redundant when binding to DNA. The mutants created for this purpose were 
ilf3(28.5)H429G-GST, Ilf3(28.5)H429G/H548G-GST and ilf3(28.5~530A-GST. 
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F igure 6.18 Percentage binding of all i1f3(28.5)-GST proteins at 25 nM with 
DNA or RNA duplex oligonucleotide. Filter binding assays (section 2.2.4) 
were carried out to measure the percentage binding of purified protein to RNA 
or DNA 36 bp oligonucleotides. The RNA or DNA oligonucleotides were 
labelled with y[P33]. Samples containing 25 nM labelled y[P33] DNA or RNA 
and varying amounts of protein, 0, 25, 50, 100 and 300 nM were filtered and 
the amount of retained nucleic acid measured in a scilliation counter. 
Percentages were calculated using a negative no protein control that was 
filtered (0 %), and a positive control that was unfiltered (100 %). The 
histogram presented here shows percentage binding of all mutants at 25 nM 
DNA or RNA when at a concentration of 25 nM protein. 
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All these mutants did reduce binding of dsRNA but surprisingly they also affected 
DNA binding. At higher protein concentrations the double mutant H429G/H548G 
has a dramatic effect on dsRNA binding when compared to the single mutant 
H429G. However, the effects of the single and the double mutant on DNA binding 
are roughly equivalent. Interestingly, the H429G and the N530A mutants have 
similar effects on both DNA and RNA binding. This is probably because they both 
are involved in 2'hydroxyl contacts, although H429G is in dsRBDl and N530A 
dsRBD2. 
There is an interesting 2'hydroxyl contact revealed by the crystal structure of Xlrbpa 
complexed with dsRNA made by a proline that was not conserved in the consensus 
or the dsRBDs of iiO. The residue located at the corresponding position in the 
dsRBDs of ilO was mutated to a proline, V428P, in the first dsRBD of ilO to see if 
this mutation could increase dsRNA or DNA binding. This mutant seemed to have 
little effect on binding for dsRNA or DNA apart from a slight reduction. It is 
possible that this base might be involved in sequence specificity and may increase 
binding of the dsRBDs of ilO to sequences that are specific for Xlrbpa. 
6.6.2 Lysine mutations 
A series of mutations were made centred on residues that are involved in interacting 
with the non-bridging oxygen of the phosphodiester backbone shown from the 
crystal structure of Xlrbpa (Ryter and Schultz, 1998). These mutants were, 
ilf3(28.5)K451A-GST, ilf3(28.5)K451A1K570A-GST, ilO(28.S)K452A-GST, 
ilf3(28.5)K452A1K571A-GST, ilf3(28.5)K455A-GST and ilf3(28.5)K455A1K574A-GST. 
Mutations of these lysines in other dsRBDs have inactivated dsRNA binding. Here 
we tested if these residues in the dsRBDs of ilf3 were necessary for binding to 
dsRNA and DNA. All these mutations completely ablated dsRNA binding showing 
that each individual residue, at least in the first dsRBD, are critical. DNA binding is 
reduced although not to the extent that dsRNA binding is affected. Surprisingly one 
residue change (K455A) ablates dsRNA binding but has little effect on DNA 
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binding. This suggests that different residues are involved in dsRNA and DNA 
binding. However, since DNA binding is affected by almost all mutants, just not to 
the degree that dsRNA binding is affected, suggests that similar residues are 
involved. 
The results from this study suggest that different residues are critical for DNA and 
dsRNA binding of the dsRBDs of ilf3 which disagrees with the hypothesis that 
dsRNA and DNA binding by the dsRBDs of ilf3 is in the same mode. An alternative 
hypothesis is supported: some of the same residues are involved in both dsRNA and 
DNA binding (as most mutations reduce binding to both dsRNA and DNA). Some 
affect dsRNA binding more and this could be due to these residues being absolutely 
critical for dsRNA binding. It is possible some residues not investigated yet could be 
absolutely critical for DNA binding. 
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Chapter 7: Discussion and future work 
7.1 Discussion 
The research in this thesis was aimed at investigating a proposed interaction between 
the double stranded RNA-binding domains of ilD and an A-form structure at the 
critical region of the gala2 promoter. Gata2 is a critical transcription factor in the 
developmental processes e.g haematopoiesis, the formation of erythrocyte cell 
lineages, urogenital and neural development (Nardelli et aI., 1999; Tsai et aI., 1994; 
Zhou et aI., 1998a). The gala2 promoter is regulated by another transcription factor, 
CBTF (Brewer et aI., 1995). CBTF is a multi-protein complex and one sub-unit, ilD, 
was isolated based on its ability to bind the gata2 promoter. It contains two double 
stranded RNA-binding domains (dsRBDs) (Orford et aI., 1998). Furthermore, these 
dsRBDs are critical for the activation of gala2 transcription (Scarlett et aI., 2004). 
This seems a novel role for dsRBDs since primarily they are involved in binding to 
dsRNA not DNA. The structure of the critical region of the gata2 promoter, -61 to -
27, was investigated by CD analysis and it was found to have a partially A-form 
structure (Scarlett et aI., 2004). This was intriguing as dsRNA also forms an A-form 
structure and a mechanism was suggested in which the dsRBDs of lID could bind to 
the partially A-form gata2 promoter as they would to dsRNA. This was investigated 
first by studying the importance of an A-form structure at the Gata2 promoter and 
secondly investigating whether the residues of lID critical for dsRNA binding were 
also critical in allowing the dsRBDs to bind DNA. 
In chapter 3 the critical region of the Gata2 promoter, -61 to -27, was mutated to be 
more A or B-form, whilst avoiding the critical contacts shown from footprint which 
includes an inverted CCAAT box (Brewer et aI., 1995; Orford et aI., 1998). 
Oligonucleotides were designed to be more A or B-form based on this region, -61 to 
-27, of the Gata2 promoter using A-form prediction tables (Basham et aI., 1995). 
The structure of these oligonucleotides was then tested using circular dichorism 
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(CD). The CD showed that the mutations succeeded in changing the structure to that 
predicted, with the exception of AF2 which was then discarded from further 
analysis. The binding of these mutant oligonucleotides was then investigated with 
competition EMSA which showed that mutations that made the promoter more A-
form increased binding and B-form structures reduced binding of CBTF. These 
sequences were then placed into the context of a larger region of the gata2 promoter, 
417 base pairs upstream of the start of transcription and 192 base pairs of exon I, by 
a PCR based method. These larger regions were cloned into the pLG4.1 0 plasmid, so 
that these mutant promoters were driving expression of the firefly luciferase gene. 
Expression of this gene could then be analysed for levels of transcription. This gave 
a more in vivo idea of how an A-form element could affect transcriptional levels. 
Results from the luciferase assay revealed that the A-form mutant promoters give 
more transcription and the B-form mutant promoters give less transcription relative 
to the wild-type closely mirroring the EMSA data. This suggests that DNA structure 
can playa role in the regulation of transcription and that an A-form element at the 
gala2 promoter is important in transcriptional control. 
In chapter 4 these experiments were extended to now investigate how critical this A-
form element was, could a total A-form element with no resemblance to the critical, 
-61 to -27, region of the gala2 promoter bind CBTF and activate transcription? This 
element contained none of the critical bases involved in direct contacts and therefore 
lacked a CCAA T box. All oligonucleotides used in this chapter were 36 base pairs 
long and none contained the critical CCAA T box, except the wild type 
oligonucleotide. All experiments carried out in chapter 3 were repeated with these 
new sequences, this included CD, competition EMSA and luciferase assays. The 
total A-form oligonucleotide was shown to have a classic A-form CD spectrum but 
it was not able to rescue transcription from the gata2 promoter. However, T AF 
competed relatively well compared to other mutants lacking a CCAA T box. This 
may reflect T AF binding to ilO as a single subunit preventing the formation of the 
full CBTF complex on the labelled wild-type probe, resulting in a reduced band 
corresponding to the CBTF/WT probe complex. This would explain the relatively 
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low transcription from 417T AF, as it is unable to assemble the full CBTF complex 
at the promoter. The other three mutants used, which all had the inverted CCAA T 
box missing had a low affinity for CBTF and gave poor transcriptional activity. This 
showed that the CCAA T box is critical for activation of the gata2 promoter, in 
agreement with previous data (Brewer et aI., 1995). When the results of chapter 3 
and 4 are considered in conjunction it suggests a possible dual regulatory mechanism 
where both sequence and structure are important in the binding of CBTF and 
subsequent activation of the gata2 promoter. 
Chapter 5 was again a continuation of the previous chapters but focused on the 
spatial expression of the 4l7WT promoter. To investigate this transgenic Xenopus 
laevis were created using the 417WT promoter. Transgenics were chosen because 
the trans gene becomes incorporated into the genome and hence into a more in vivo 
environment, allowing for important chromatin affects absence in the luciferase 
assays. The 417WT promoter was cloned into pGEM-3Z plasmid that contained the 
GFP gene, so that the promoter would now be driving expression of the GFP gene. 
A negative control was also produced with the 417NC promoter as from chapter 4 it 
had been shown to have low transcriptional activation, this was used to test whether 
there would be any expression from this inactive promoter in the context of a fully 
chromatinised in vivo environment. The method to create the transgenic Xenopus 
involved the use of a restriction enzyme, I-SceI, which has an 18 bp recognition 
sequence which does not exist within the Xenopus laevis genome. Chicken 5 'HS4 
insulators were also used to reduce chromatin mediated effects. It was found that the 
417WT promoter was able to give visible expression but it was not tissue specific. 
This suggested that a region outside the -417 to + 192 is involved in spatial 
regulation of gata2 expression. 
Chapter 6 focused on whether the critical residues of ilf3 involved in binding to 
dsRNA, revealed by the crystal structure of XlrpbA, are also critical for its DNA 
binding ability (Ryter and Schultz, 1998). Conserved residues were located in the 
dsRBDs of iIf3 and ten site directed mutants were designed. Two controls were used 
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a wild-type iIO(28.5)_GST (positive) and mutant iIO(28.5)F433NF551A-GST 
(negative) provided by Prof Matt Guille. The first set of mutants had residues 
involved in making contacts with the dsRNA 2 'hydroxyl. It was thought that these 
mutants would reduce the affinity of itO to dsRNA to that observed for DNA 
because DNA does not have a 2 'hydroxyl. These mutants reduced dsRNA binding 
and DNA binding, although the effect on dsRNA binding was more pronounced. 
The crystal structure of Xlrbpa revealed some residues making water mediated and 
direct contacts with both the 2' hydroxyl and the functional groups of the bases. This 
may explain our observations since mutation of residues such as these would 
effectively remove two interactions in dsRNA and one in DNA. 
The second set of mutants were based on residues that are involved in interacting 
with the nucleic acid backbone. All these mutants drastically reduced dsRNA 
binding, DNA binding was affected but not to the same extreme and one residue 
change (K455A) had little effect on DNA binding. This suggests that different 
residues have distinct roles in dsRNA and DNA binding. Since DNA binding is 
affected by almost all mutants, just not to the degree that dsRNA binding is affected, 
many common residues must be involved. 
This thesis provides compelling evidence for the importance of an A-form element 
at the critical region of the gala2 promoter in allowing binding of CBTF and 
activation of the gala2 promoter. It also suggests that the gata2 promoter is 
regulated by a dual mechanism in which structure and sequence are both important. 
The inverted CCAA T box and partial A-form element of the critical region of the 
gala2 promoter allow CBTF to bind and activate transcription. It also provides 
evidence that the -417 and 192 of exon I sequence is not capable of spatial 
regulation of the gata2 promoter and that a region further upstream is probably 
responsible. Finally some of the residues of lIO dsRBDs critical for dsRNA binding 
were shown to be critical for dsRNA and DNA binding. 
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7.2 Future work 
The experiments in chapters 3 and 4 indicate a dual mechanism activating 
transcription from the gala2 promoter, one based on both sequence and structure. It 
would be interesting to more closely define the sequence components of this 
interaction by designing a construct which contained the CCAA T box, but not the 
other bases revealed by the footprinting, in the context of a strongly A-form 
structure flanking it. The EMSA experiments could be extended by studying the 
interaction of these sequences with recombinant ilf3 and even further with these 
sequences interacting with the dsRBD protein mutants described in chapter 6. The 
analysis of these sorts of interactions lend themselves to surface plasmon resonance 
(SPR) which would provide a complementary technique to EMSA. Possible future 
work for chapter 5 should focus on elements elsewhere than the -417 to + 192 region, 
to discover the location of the promoter involved in spatial regulation. Transgenesis 
provides a powerful tool to probe critical regulatory regions. 
Future experiments based on chapter 6 should focus on further binding studies of the 
interesting residues revealed from this screen, such as the mutant (K455A) that 
reduced dsRNA binding but not DNA binding. This mutant could be used to probe 
the relative contributions of RNA and DNA binding by itD to its regulatory 
functions. This could most easily be accompolished by expressing this mutant in 
Xenopus embryos by RNA micro-injection. EMSA and SPR could also be 
performed to find the Kos of the mutant ilf3(28.5)_GST proteins used in this study. 
More mutants of other critical residues could also be carried out to possibly find a 
residue that is critical for DNA binding. Finally it would be interesting to solve the 
crystal structure or NMR of ilD complexed with DNA. 
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Appendix I: Solutions 
300TWB 
30mMNaCI 
50 mM Tris (pH 8.0) 
2mMDTT 
1 mMEDTA 
1 mMPMSF 
1 mM Benzamidine 
Ampicillin 
50 mg/mt stock, stored at -20°C 
Working concentration 50J.1g mr) 
dNTPs (10 mM) 
10mMdATP 
10mMdCTP 
10mMdGTP 
10mMdTTP 
Ethidium bromide 
10 mg/ml stock 
Modified barths saline (MBS) 10X 
88mMNaCt 
1 mMKCL 
2.4 mM NaHC03 
0.82 mM MgS04.7H20 
0.33 mM Ca(N03h.2H20 
0.41 mM CaCh.6H20 
10mMHEPES 
The pH was adjusted to 7.6 with 1 M NaOH 
Sterilise by autoclaving, add salts after autoclaving and cool 
When making working stocks of 1 X and 0.1 X add 1 unit of penicillin streptomycin 
(5000 units penicillin and 5 mg streptomycin per mt) per llitre made. 
Orange G DNA loading buffer 
0.25% Orange G 
15% Ficoll (type 400) 
dH20 
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Solution I 
50 mM Glucose 
25 mM Tris HCL pH 8.0 
10mMEDTA 
Solution II 
0.2MNaOH 
I%SDS 
Solution III 
3 M Potassium acetate 
Add glacial acetic till pH 4.5 
Make up to 100 mls with dH20 
TNE (3x) 
30 mM Tris-HCL 
3 mMEDTA 
300mMNaCI 
pH 7.5-8 
TAE (SOx) 
242 g Tris base 
57.1 ml Glaical acetic acid 
100 ml 0.5 M EDTA 
dH20 to 1 litre 
Yang lysis buffer 
20mMHEPES 
60mMKCL 
2mMDTT 
BB 
100mM KCL 
0.2mMEDTA 
10 mM Tris HCL pH 7.6 
50 J.1g1ml BSA (Protease and Nuclease free) 
FB 
100mM KCL 
0.2mMEDTA 
10 mM Tris HCL pH 7.6 
SDS-PAGE loading dye (Sx) 
250 mM Tris-HCL (pH 6.8) 
10% SDS 
5 mM Na2EDTA (pH 7.5) 
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10% Glycerol 
0.05% Bromophenol Blue 
5% 2-J1-mercaptoethanol 
Coomasie brilliant blue staining solution 
10% methanol 
10% acetic acid 
1 g Coomasie brilliant blue for 1 litre 
De-stain solution 
20% methanol 
10% acetic acid 
ED (Ix) 
10 mM HEPES pH 8.5 
2mMMgCh 
1 mMEDTA 
10 mM J1-glycerophosphate 
1 mMDTT 
Protease inhibtor tables, one per 10 mls 
Phosphate buffer 
Stock solution A 
2 M monobasic sodium phosphate, monohydrate (276 giL) 
Stock solution B 
2 M dibasic sodium phosphate, monohydrate (284 giL) 
8.5 ml of stock solution A mixed with 91.5 ml of stock solution B to give a 100 ml 
pH 7.8 phosphate buffer. 
FD1600 ml 
4.8 g Rubidium Chloride 
3.96 g MnCl2.4H20 
2.4 ml 5 M Potassium Acetate 
0.6gCaCh 
60g Glycerol 
Adjust to pH 5.8 with acetic acid (not glacial as too strong use 1:100 diluted) 
Filter sterilise solution using a 0.2 J.1m syringe filter. 
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FB2100 ml 
2 rnl MOPS pH 6.8 
0.12 g Rubidium Chloride 
11 g CaCl2 
15 g Glycerol 
Adjust to pH 6.8 with NaOH (diluted NaOH) 
Filter sterilise solution using a 0.2 !-lrn syringe filter. 
20/0 cyteine 
Cysteine added to make 2% 
pH to 7.8-8 with NaOH 
3% Ficoll 
Ficoll made to 3% with lXMBS 
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Appendix II: Sequence of primers 
peR Primers: 
WUd-type 417WT promoter forward 
GTCGCTGCGGGTACCCTAGATTGTTGGGTGTTTGTG 
WUd-type 417WT promoter reverse 
GCCGACCTGAGATCTAGCTGGAGATCGCCGCTGC 
-31 Gata2 promoter forward 
GTCGCTGCGGGTACCGGGTTATTAGCTGTGCGTTCG 
417AF reverse 
GGCTCAGCCAATCACAAGGCTCCGGCAGCCAGTCGCCCGCTACC 
417 AF3 reverse 
AGCTCACATTGAGCCAATCACAAGCAATGAGAGGAGGCCAGTCGCCCGCTACC 
417BF reverse 
TTTAAAGCCAATCACAAGTTTCCGTCAGCCAGTCGCCCGCTACC 
417BFNC reverse 
TTTAAAGATGGACACAAGTTTCCGTCAGCCAGTCGCCCGCTACC 
417NC reverse 
GGGCCAGATGGACACAAGCCTCCGCCAGCCAGTCGCCCGCTACC 
417T AF reverse 
AGCTCATGCATGCATGCACGGGGGCCCCCGGGGGAGGCCAGTCGCCCGCTACC 
219 
417RAN reverse 
TATCTTAAGGCGCGCAGATATCTTAAGGCCAGTCGCCCGCTACC 
Transgenic GFP forward 
GCTGCATGAGCTCTAGGGATAACAGGGTAATCCGCTAGGGGGCAGCACCGCTA 
GGGGGCAGCAGGTACCGTCAGATCTATGGTGAGCAAGGGCGAGG 
Transgenic GFP reverse 
TAATCTGGATCCACCCCTGTCATTGACTATACAG 
CBTF28.S wild-type forward 
TAATCTGGATCCGACCCCTGTCATTGACTATACAG 
CBTF28.S wild-type reverse 
CTGATCGAATTCGGGTCCACCTCTTGGCATCATAGG 
Site directed mutagenesis: 
H429G SDM (+) strand 
ACAAACTGGACCTGTAGGTGCTCCTGTCTTTACTA 
H429G SDM (-) strand 
TAGTAAAGACAGGAGCACCTACAGGTCCAGTTTGT 
H429GIHS48G (+) strand 
AGACTGGTGGAAGCGGTGACAAGCGCTTTGTA 
H429GIHS48G (-) strand 
TACAAAGCGCTTGTCACCGCTTCCACCAGTCT 
NS30A SDM (+) strand 
CTGTCATGGAACTGGCCGAGAAAAGGCGTGG 
220 
NS30A SDM (-) strand 
CCACGCCTTTTCTCGGCCAGTTCCATGACAG 
V 428P SDM (+) strand 
CACAAACTGGACCTCCACATGCTCCTGTCTT 
V428P SDM (-) strand 
AAGACAGGAGCATGTGGAGGTCCAGTTTGTG 
K4S1A SDM (+) strand 
CTTCAGGTCCTTCAGCGAAGACCGCAAAACT 
K4S1A SDM (-) strand 
AGTTTTGCGGTCTTCGCTGAAGGACCTGAAG 
K4S1AlK570A SDM (+) strand 
GATCTGGCTCTAATGCGAAAGTGGCAAAAGC 
K451AlKS70A SDM (-) strand 
GCTTTTGCCACTTTCGCATTAGAGCCAGATC 
K452A SDM (+) strand 
CAGGTCCTTCAAAGGCGACCGCAAAACTTCA 
K4S2A SDM (-) strand 
TGAAGTTTTGCGGTCGCCTTTGAAGGACCTG 
K452A1KS71A SDM (+) strand 
CTGGCTCT AAT AAGGCAGTGGCAAAAGCTTA 
K4S2A1K571A SDM (-) strand 
TAAGCTTTTGCCACTGCCTTATTAGAGCCAG 
221 
K455A SDM (+) strand 
CAAAGAAGACCGCAPCACTTCATGTAGCAGT 
K455A SDM (-) strand 
ACTGCTACATGAAGTGCTGCGGTCTTCTTTG 
K455A/K574A SDM (+) strand 
ATAAGAAAGTGGCAGCAGCTTATGCTGCACT 
K455A/K574A SDM (-) strand 
AGTGCAGCATAAGCTGCTGCCACTTTCTTAT 
EMSA oligonucleotides: 
Wild-type 417 (+) strand 
GGCTGGCGGAGGCTTGTGATTGGCTGGCCCGGGGTT 
Wild-type 417 (-) strand 
AACCCCGGGCCAGCCAATCACAAGCCTCCGCCAGCC 
AF (+) strand 
GGCTGCCGGAGCCTTGTGATTGGCTGAGCCGGGGTT 
AF (-) strand 
AACCCCGGCTCAGCCAATCACAAGGCTCCGGCAGCC 
AF2 (+) strand 
GGCGAGCCCTCACTTGTGATTGGCTGAGTGGGGGTT 
AF2 (-) strand 
AACCCCCACTCAGCCAATCACAAGTGAGGGCTCGCC 
222 
AF3 (+) strand 
GTGCATGCATGCCTTGTGATTGGCTCAATGGGGGTT 
AF3 (-) strand 
AACCCCCATTGAGCCAATCACAAGGCATGCATGCAC 
BF (+) strand 
GGCTGACGGAAACTTGTGATTGGCTTTAAAGGGGTT 
BF (-) strand 
AACCCCTTTAAAGCCAATCACAAGTTTCCGTCAGCC 
BFNC (+) strand 
GTGCATGCATGCCTTGTGTCCATCTCAATGGGGGTT 
BFNC (-) strand 
AACCCCCATTGAGATGGACACAAGGCATGCATGCAC 
NC (+) strand 
GGCTGGCGGAGGCTTGTGTCCATCTGGCCCGGGGTT 
NC (-) strand 
AACCCCGGGCCAGATGGACACAAGCCTCCGCCAGCC 
TAF (+) strand 
GGCTGCCGGGGGCCCCCGTGCATGCATGCCGGGGTT 
T AF (-) strand 
AACCCCGGCATGCATGCACGGGGGCCCCCGGCAGCC 
223 
RAN (+) strand 
CCGCTTAAGATATCTGCGCGCCTTAAGATAGGGGTT 
RAN (-) strand 
AACCCCTATCTTAAGGCGCGCAGATATCTTAAGCGG 
Oligonucleotides for filter binding assay (U replaces T in RNA 
oligos): 
(+) strand 
CGACTGGCTGGCGGAGGCTTGTGATTGGCTGGCCCG 
(-) strand 
CGGGCCAGCCAATCACAAGCCTCCGCCAGCCAGTCG 
224 
Appendix III: Clone sequences 
Sequences of mutants 
417WT 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGGCTGGCGGAGGCTTGTGATTGGCTGGCCCGGGGTTATTAGCT 
GTGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCC 
AGTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAG 
TCTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCC 
CTCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGC 
GATCTCCAGCT 
417AF 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGGCTGCCGGAGCCTTGTGATTGGCTGAGCCGGGGTTATTAGCTG 
225 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
417AF3 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGTGCATGCATGCCTTGTGATTGGCTCAATGGGGGTTATTAGCTG 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
417BF 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGGCTGACGGAAACTTGTGATTGGCTTTAAAGGGGTTATTAGCTG 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
226 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
417BFNC 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGTGCATGCATGCCTTGTGTCCATCTCAATGGGGGTTATTAGCTG 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
417NC 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGGCTGGCGGAGGCTTGTGTCCATCTGGCCCGGGGTTATTAGCTG 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
227 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
417TAF 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTGGCTGCCGGGGGCCCCCGTGCATGCATGCCGGGGTTATTAGCT 
GTGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCC 
AGTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAG 
TCTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCC 
CTCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGC 
GATCTCCAGCT 
417RAN 
CTAGATTGTTGGGTGTTTGTGATTTTATCTTCATTAAGTGTAAAAGAGCT 
AAATGCATATAAAGACCTGTCCCATATATATATATATGTGTGTGTATATA 
ATTGTGGTGTGTGTGTATTTATGTCTGATATACAAAAACACAAGCAGAAC 
AAATGTATGAGGCAATAAACATTCTCAGTATGTAAATGTTGAAGCAGAC 
AATCCCACCCATTAAATGGACTTTGCTAATAAAGTCCCCCCCCTGCAATC 
CCCCCACCCATAGTAATAAGCCCCCTCCCTTCATAGACTCTTTGCTGTTTG 
GAGTGAATTAGGGAATGTGGCTTTTCAGGGGAGTGACCAATGGTAGCGG 
GCGACTCCGCTTAAGATATCTGCGCGCCTTAAGATAGGGGTTATTAGCTG 
TGCGTTCGCCCCAGTTCAAGCTTAGAGAAGCCGAGTCCAGCTGGCGCCA 
GTGCTGACATAGGATGCTGCGGGGATGTTACAGGCCACAAGCACTGAGT 
CTGCCCCCTGAATAAGACACTCCAGTCCCAGCTTTCCTCCTCCCTCTCCCC 
228 
TCAGTCGGCTCATTCCACTTCGGGACTCTGCGCACTGCCCGGCAGCGGCG 
ATCTCCAGCT 
Transgenic 417WT 
TTTGGCCCTAGGAACAGGTATCCGCTAGGGGGCAGCACCGCTAGGGGGC 
AGCAGGTACACTCGAGGATATCGGTACCCTAGATTGTTGGGTGTTTGTGA 
TTTTATCTTCATTAAGTGTAAAAGAGCTAAATGCATATAAAGACCTGTCC 
CATATATATATATATGTGTGTGTATATAATTGTGGTGTGTGTGTATTTATG 
TCTGATATACAAAAACACAAGCAGAACAAATGTATGAGGCAATAAACAT 
TCTCAGTATGTAAATGTTGAAGCAGACAATCCCACCCATTAAATGGACTT 
TGCTAATAAAGTCCCCCCCCTGCAATCCCCCCACCCATAGTAATAAGCCC 
CCTCCCTTCATAGACTCTTTGCTGTTTGGAGTGAATTAGGGAATGTGGCT 
TTTCAGGGGAGTGACCAATGGTAGCGGGCGACTGGCTGGCGGAGGCTTG 
TGATTGGCTGGCCCGGGGTTATTAGCTGTGCGTTCGCCCCAGTTCAAGCT 
TAGAGAAGCCGAGTCCAGCTGGCGCCAGTGCTGACATAGGATGCTGCGG 
GGATGTTACAGGCCACAAGCACTGAGTCTGCCCCCTGAATAAGACACTC 
CAGTCCCAGCTTTCCTCCTCCCTCTCCCCTCAGTCGGCTCATTCCACTTCG 
GGACTCTGCGCACTGCCCGGCAGCGGCGATCTCCAGCTAGATCTATGGT 
GAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAG 
CTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCG 
AGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCAC 
CGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACG 
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTT 
CTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCT 
TCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGG 
GCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGA 
GGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCAC 
AACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACT 
TCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCA 
CTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGAC 
AACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGA 
229 
AGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCAC 
TCTCGGCATGGACGAGCTGTACAAGTAAAGCGGCCGCGACTCTAGAGTC 
GGGGCGGCCGGCCGCTTCGAGCAGACATGATAAGATACATTGATGAGTT 
TGGACAAACCACAACTAGAATGCAGTG~TGCTTTATTTGTGAA 
ATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACA 
AGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGG 
TGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAAT 
CGATAAGGATCCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAG 
CTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTG 
TCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCTGCTGGCGGATAC 
CCTTTTCCCTTTTAGACTCG 
Transgenic 417NC 
CAGGGTAATCCGCTAGGGGGCAGCACCGCTAGGGGGCAGCAGGTACACT 
CGAGGATATCGGTACCCTAGATTGTTGGGTGTTTGTGATTTTATCTTCATT 
AAGTGTAAAAGAGCTAAATGCATATAAAGACCTGTCCCATATATATATA 
TATGTGTGTGTATATAATTGTGGTGTGTGTGTATTTATGTCTGTATATACA 
AAAACACAAGCAGAACAAATGTATGAGGCAATAAACATTCTCAGTATGT 
AAATGTTGAAGCAGACAATCCCACCCATTAAATGGACTTTGCTAATAAA 
GTCCCCCCCCTGCAATCCCCCCACCCATAGTAATAAGCCCCCTCCCTTCA 
TAGACTCTTTGCTGTTTGGAGTGAATTAGGGAATGTGGCTTTTCAGGGGA 
GTGACCAATGGTAGCGGGCGACTGGCTGGCGGAGGCTTGTGTCCATCTG 
GCCCGGGGTTATTAGCTGTGCGCTTCGCCCCAGTTCAAGCTTAGAGAAGC 
CGAGTCCAGCTGGCGCCAGTGCTGACATAGGATGCTGCGGGGATGTTAC 
AGGCCACAAGCACTGAGTCTGCCCCCTGAATAAGACACTCCAGTCCCAG 
CTTTCCTCCTCCCTCTCCCCTCAGTCGGCTCATTCCACTTCGGGACTCTGC 
GCACTGCCCGGCAGCGGCGATCTCCAGCTAGATCTATGGTGAGCAAGGG 
CGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGC 
GACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATG 
CCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCT 
GCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGT 
230 
GCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCC 
GCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACG 
ACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCT 
GGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC 
ATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATA 
TCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCG 
CCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAG 
AACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACC 
TGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCA 
CATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGG 
ACGAGCTGTACAAGTAAAGCGGCCGCGACTCTAGAGTCGGGGCGGCCGG 
CCGCTTCGAGCAGACATGATAAGATACATTGATGAGTTTGGACAAACCA 
CAACTAGAATGCAGTG~TGCTTTATTTGTGAAATTTGTGATGCT 
ATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGTTAACAACAA 
CAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTT 
TTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAATCGATAAGGATCC 
GTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGG 
GCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCAT 
GCAACTCGTAGGACAGGTGCCGGCTGCTGGCGGATTATCCTGT 
1If328.5 DNA sequence 
ACCCCTGTCATTGACTATACAGTTCAGATTCCACCCAGCACCACCTATGC 
CATGCCGCCTCTCAAGCGCCCTATTGAGGAGGATGGAGATGACAAGTCG 
CCAAGTAAGAAGAAAAAGAAGATTCAGAAGAAAGACGAGAAGAGTGAA 
CCTCCTCAAGTTATGAATGCATTAATGAGGCTGAACCAGCTTAAGCCAG 
GTCTGCAGTACAAGCTAATCTCACAAACTGGACCTGTACATGCTCCTGTC 
TTTACTATGTCGGTGGAAGTGGATGACAAGACATTTGAAGCTTCAGGTCC 
TTCAAAGAAGACCGCAAAACTTCATGTAGCAGTCAAGGTGCTGCAAGAC 
ATGGGTCTCCCTACTGGTATGGAAGAAAAGGAAGAAGGGACGGACGAA 
TCAGAACAGAAACCGGTTGTACAAACTCCAGCACAACCAGATGATTCTG 
CTGAAGTTGATTCTGCTGCTCTAGATCAAGCTGAGAGTGCAAAGCAGCA 
231 
GGGACCTATTCTTACAAAGCATGGCAAGAACCCTGTCATGGAACTGAAT 
GAGAAAAGGCGTGGCCTGAAATACGAACTGATTTCAGAGACTGGTGGAA 
GCCATGACAAGCGCTTTGTAATGGAGGTTGAGGTTGATGGCGTGAAGTT 
CCAAGGATCTGGCTCTAATAAGAAAGTGGCAAAAGCTTATGCTGCACTT 
TCTGCCCTGGAAAAACTCTTCCCAGACTACACAATGTACACAGAAGCTCC 
CAAGAAGAAGAGGCCTCCTATGATGCCAAGAGGTGGACCC 
11028.5 Protein sequence with mutated residues highlighted in red 
TPYIDYTVQIPPSTTY AMPPLKRPIEEDGDDKSPSKKKKKIQKKDEKSEPPQV 
MNALMRLNQLKPGLQYKLISQTGPVHAPYFTMSVEVDDKTFEASGPSKKTA 
KLHYAVKVLQDMGLPTGMEEKEEGTDESEQKPVVQTPAQPDDSAEVDSAA 
LDQAESAKQQGPIL TKHGKNPYMELNEKRRGLKYELISETGGSHDKRFVME 
VEVDGVKFQGSGSNKKY AKA Y AALSALEKLFPDYTMYTEAPKKKRPPMMP 
RGGP 
110 full DNA sequence 
ATGCGTCCCATGCGCATATTTTTGAATGATGACCGCCATGTCATGGCAAA 
GCACTCTGTGGTGTATCCCACTCAGGAGGAGCTGGAGGCTGTACAGAAC 
ATGGTCTCTCACACAGAGCGGGCCCTAAAGGCAGTCTCAGACTGGATTG 
ACCAGCAAGAGAAAGATTGCAGTGGAGAGCAAGAACAACCAATGGCAG 
AAGAAACCGAGACAACAGAGGAGGGCAAGGACAGTGAAATGAAGACTG 
GAGAAAATCCAACAAGGACTCTTCGTGGCGTGATGAGGGTTGGACTTGT 
TGCCAAAGGGCTTCTTCTGAAGGGAGACTTGGATCTTGAACTTGTCTTGT 
TGTGCAGAGATAAACCCACAATTTCTCTTCTGAAAAGGGTTGCTGATAAC 
CTTGTCTTGCAGTTTGAGACTGTGTCTGAGGATAAATATGAAGTCATACA 
GAACATAAGAGAAGCTTTGATTGTTATCAAAAGCACTAAAGAGCCCCCT 
CTGACTCTTAACATCCGTCTTACATCCCCCCTGGTCCGAGAAGAGATGGA 
GAAACTGAGCGCTGGAGAAACGCTAACAGTCAGCGATCCTCCGGACGTT 
CTGGACAGGCACAAATGCCTTGCTGCATTGGCGTCACTCCGACACGCCA 
AGTGGTTCCAGGCTAGGGCTAATGGTCTGAAATCCTGCGTGATTGTCATT 
CGCGTGCTGCGGGATCTGTGCACACGTGTACCGACTTGGGAGCCTCTTCG 
232 
AGGATGGCCTCTGGAACTTCTTTGTGAAAAGGCAATTGGAACAGCAAAC 
CGACCCATGGGTGCCGGGGAGGCACTTAGGAGAGTTCTGGAATGTCTTA 
GCTCTGGGATCCTCATGCCAGATGGTTCTGGATTGTATGACCCTTGTGAA 
AAAGATGCTAGTGATGCACTTGAGCATCTTGAAAGGCAGCAAAGGGAGG 
ACATCACACAGAGTGCACAGCATGCACTGAGGTTAGCAGCTTTTGGGCA 
ATTGCACAAAGTCTTGGGCATGGACCCATTGCCTTCAAAAATGCCAAAG 
AAAACCAAAGTTGAGACCCCTGTCATTGACTATACAGTTCAGATTCCACC 
CAGCACCACCTATGCCATGCCGCCTCTCAAGCGCCCTATTGAGGAGGAT 
GGAGATGACAAGTCGCCAAGTAAGAAGAAAAAGAAGATTCAGAAGAAA 
GACGAGAAGAGTGAACCTCCTCAAGTTATGAATGCATTAATGAGGCTGA 
ACCAGCTTAAGCCAGGTCTGCAGTACAAGCTAATCTCACAAACTGGACC 
TGTACATGCTCCTGTCTTTACTATGTCGGTGGAAGTGGATGACAAGACAT 
TTGAAGCTTCAGGTCCTTCAAAGAAGACCGCAAAACTTCATGTAGCAGT 
CAAGGTGCTGCAAGACATGGGTCTCCCTACTGGTATGGAAGAAAAGGAA 
GAAGGGACGGACGAATCAGAACAGAAACCGGTTGTACAAACTCCAGCA 
CAACCAGATGATTCTGCTGAAGTTGATTCTGCTGCTCTAGATCAAGCTGA 
GAGTGCAAAGCAGCAGGGACCTATTCTTACAAAGCATGGCAAGAACCCT 
GTCATGGAACTGAATGAGAAAAGGCGTGGCCTGAAATACGAACTGATTT 
CAGAGACTGGTGGAAGCCATGACAAGCGCTTTGTAATGGAGGTTGAGGT 
TGATGGCGTGAAGTTCCAAGGATCTGGCTCTAATAAGAAAGTGGCAAAA 
GCTTATGCTGCACTTTCTGCCCTGGAAAAACTCTTCCCAGACTACACAAT 
GTACACAGAAGCTCCCAAGAAGAAGAGGCCTCCTATGATGCCAAGAGGT 
GGACCCAAATTTGCAGGAAAGCATAATCAAGGTTTTGGAATGATGTACA 
GTGAGGTACCCCCTCCCCAAGCCATGAGAGGTCGTGGTAGAGGAGGAAT 
GAATCGTGGTAGAGGAAGAGGCCGAGGTGGATTTGGTGGCGGCTACATG 
AATTCAGGTGGCTATGGTGGAGGTTATGGTGGAAACTACAACTATCAAA 
CTTCTGCAACAGCAGGATACAGTCAGTTCTATAGCAATGGAGGAGCTTC 
AGGCAATGCAGGAGGGGGTGGTGCAGGAACTGGTGGGTACAGCTCTTAC 
TATCAGGGGGACAGTTATAGTGCACCTACTCCACCAAAACCTTTTGTAAA 
CAAGAAGCCACCCCCTCCTCAACAACAGCAGCAACAACAACCGCCCCCA 
CAGCATGCCAGCAACCCTCCCAAACCTTCCTATAACCAAGGCTACCAGG 
233 
GCCATCAAGGTGGACAGCAGCAGCAGCAGCAACAACAGCAGCAGCAGA 
CTTACAACCAGAATCAGTACAGCAACTATGGCCACCTCAGAAACAAAAA 
GGTGGCTATAACCAGGGGGCACAGGGAGCTGGAAGTGGTGGATCTTACA 
ACTACTCCAACTCTTACACAGGCGGTACAGCCCCTGGGTACGGCAGTGG 
AGAGGGTGCAGGAGGGCGAGGCGGCAGCTCTTACACAGCGCCAAGCTCT 
GGTTACAACACAGGCGCACACTCCGGCTATGGTGGAGCCAGCAGTACTT 
CGACGTACCAAGGTTACACGCAGTCTAATTACAATCAAGGTCCCCCCGG 
ACAGAACTACAGTGGCCCTCCAAATAATTACCAGCAGCCTCAGGGAGGA 
GCTGGGAGTTACAGCAGGAATACAGAACACAACATGA 
110 Protein full sequence 
MRPMRIFLNDDRHVMAKHSVVYPTQEELEAVQNMVSHTERALKA VSDWID 
QQEKDCSGEQEQPMAEETETTEEGKDSEMKTGENPTRTLRGVMRVGLVAK 
GLLLKGDLDLELVLLCRDKPTISLLKRVADNLVLQFETVSEDKYEVIQNlRE 
ALIVIKSTKEPPLTLNIRL TSPLVREEMEKLSAGETL TVSDPPDVLDRHKCLA 
ALASLRHAKWFQARANGLKSCVNIRVLRDLCTRVPTWEPLRGWPLELLCE 
KAIGTANRPMGAGEALRRVLECLSSGILMPDGSGL YDPCEKDASDALEHLE 
RQQREDITQSAQHALRLAAFGQLHKVLGMDPLPSKMPKKTKVETPVIDYTV 
QIPPSTTYAMPPLKRPIEEDGDDKSPSKKKKKIQKKDEKSEPPQVMNALMRL 
NQLKPGLQYKLISQTGPVHAPVFTMSVEVDDKTFEASGPSKKTAKLHVA VK 
VLQDMGLPTGMEEKEEGTDESEQKPVVQTPAQPDDSAEVDSAALDQAESA 
KQQGPILTKHGKNPVMELNEKRRGLKYELISETGGSHDKRFVMEVEVDGVK 
FQGSGSNKKV AKA Y AALSALEKLFPDYTMYTEAPKKKRPPMMPRGGPKFA 
GKHNQGFGMMYSEVPPPQAMRGRGRGGMNRGRGRGRGGFGGGYMNSGG 
YGGGYGGNYNYQTSATAGYSQFYSNGGASGNAGGGGAGTGGYSSYYQGD 
SYSAPTPPKPFVNKKPPPPQQQQQQQPPPQHASNPPKPSYNQGYQGHQGGQ 
QQQQQQQQQQTYNQNQYSNYGHLRNKKVAITRGHRELEVVDLTTTPTLTQ 
AVQPLGTAVERVQEGEAAALTQRQALVTTQAHTPAMVEPAVLRRTKVTRS 
LITIKVPPDRTIV ALQIITSSLREELGVTAGIQNTT* 
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Appendix IV: Plasmid maps 
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pGL4 .10[/uc2) 
Vector 
( .12'~2bp) 
po 
236 
pGL4 .13I1uc2/SV401 
Vector 
(.16·11t) ) 
Syll h:ll(; POIr-(A) 
S1L n I!~ u"scr Ip 1m 
PULIS£: SI1C (lo r 
b.aC ~ ~J ,o\Jl1d re(JuCl tO 1) 
01 r 
202 ' 
2015=:.:.:.:..:.:....1-. ' 
237 
pGL4,74[tJRluc/TK] 
Veclor 
(.1237 ) p) 
S:.. ' I 
pGEW·3Z 
Vec tor 
l '?7 ·1:l1lJ)) 
238 
" 
" 
., 
I 
.\ t ) , I " " 
." 
--I. ~ 
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Appendix V: Nucleic acids and protein markers 
2-log DNA ladder (NEB) 1 K b 
Mass (ng) Kilobas.;-s 
40 10.0 -
40 S.O -
43 6 .0 ~1;i1 40 5.0 / 
32 4.0 
120 ?.O 
Kilobases Mass (ng. 
- 10.0 42 
8.0 42 
0.0 50 
S.O 42 
40 2.0 33 
57 15 
3.0 125 
45 1.2 -
122 1.0 
34 0.9 - 2 .0 48 
3 1 0.8 
27 0.7 
23 0.0 - I.S 36 
124 05 
49 0.4 
37 0.3 
32 0.2 -
6 1 0. 1 42 
DNA ladder (NEB) 
240 
10 bp DNA marker (Invitrogen) 
(promega) 
bp 
-, --l'1 :,. _. -
1(1 -
3% agarose 
241 
10 bp DNA taddei' 
P 
100 
90 
-- YO 
20 
Llqarosc/ % !:J rasCl \ 
B enchmark protein ladder (Invitrogen) 
~:CII!I 
1~) - - ~~ .. ) 
1(1) - -1~'1 
!:l) _ - !II) 
-
;:r) 
CII)-
~J) _ 
~)-
~:(I-
,'C 
_.-
~,,) -
15-
10 -
12.5% SDS-polyac rylamide gel stained with Coomassie Brilliant Blue R-250 
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Appendix VI: Triplet code table for predicting A-form 
propensity. 
,.../ 
N/ I C G A T N •• I 
C -05'J (13) 0,7) 01) - )76 m - 1.'n( I) c 
- 0,21,1 ( II ) 0.29 ( \1) ND NO G 
- 0.04 (2) - 0.33 (5) -2. 12 (2) 0.15 (3) }\ 
ND ] . .!~I (1) - I.l li) (.l) , 1 T 
- .49 (8) 0,69 (l) 0.69 (I) 0. 19 (I) C 
lUI (It) - 0.59 (13) - un (I) - 1.76 (2 G 
-0.74 (3) -0.48 ( 1) I 56 (2) - 1.74 ( ~n A 
ND U l (2) IHI (Ii) , I) T 
J\ 1 _ _ (2' NO ND 0.41 (6) C 
2.49 (7) ND ND - 0.10 (5) G 
ND 0.11 (3) 2.06 (J 0.57(5) A 
ND ND 0"56 (6) O. 8 (5)' T 
T - O.4R ( I) - 0.74 (3) - 1.74 (8) 1.56 (2) C 
-0.33 (5) 0.04 (2) 0.15 (3) - 2,12 ( .1) 0 
-1.06 (I) -1.06 (I ) 0.111 (2) 0. 10 (2) ;\ 
0.1 J (.) ND 0.57 (5) Z.O<i (2) T 
Prediction table taken from table 2 in Basham et aI, 1995 . This table was used to 
predict the A-form propensity of the middle base located within a triplet for 
oligonucleotides described in chapters 3 and 4. To find the value for a base within a 
sequence, the base is considered to be Ni the 5' flanking base is Ni= 1 and the 3' 
flanking base is NH 1. Positive numbers indicate a B-form preference and negativ 
numbers indicate an A-form preference. The more extreme the number, whether 
negati ve or positive, the more intense the preference the triplet has for the said 
structure. Some triplets have as yet unassigned APEs and are denoted by ND. J·or 
more infom1ation on the use of this table see chapter 3. 
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